Form 10-Q

Table of Contents

Table of Contents

Table of Contents

Table of Contents

Table of Contents

Table of Contents

Table of Contents

Table of Contents

Table of Contents

Table of Contents

Table of Contents

Table of Contents

Table of Contents

Table of Contents

Table of Contents

Table of Contents

Table of Contents

Table of Contents

Table of Contents

Table of Contents

Table of Contents

Table of Contents

Table of Contents

0001193125-12-225730.txt : 20120510 0001193125-12-225730.hdr.sgml : 20120510 20120510163610 ACCESSION NUMBER: 0001193125-12-225730 CONFORMED SUBMISSION TYPE: 10-Q PUBLIC DOCUMENT COUNT: 10 CONFORMED PERIOD OF REPORT: 20120331 FILED AS OF DATE: 20120510 DATE AS OF CHANGE: 20120510 FILER: COMPANY DATA: COMPANY CONFORMED NAME: BIOLASE TECHNOLOGY INC CENTRAL INDEX KEY: 0000811240 STANDARD INDUSTRIAL CLASSIFICATION: DENTAL EQUIPMENT & SUPPLIES [3843] IRS NUMBER: 870442441 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 10-Q SEC ACT: 1934 Act SEC FILE NUMBER: 000-19627 FILM NUMBER: 12830806 BUSINESS ADDRESS: STREET 1: 4 CROMWELL CITY: IRVINE STATE: CA ZIP: 92618 BUSINESS PHONE: 949-361-1200 MAIL ADDRESS: STREET 1: 4 CROMWELL CITY: IRVINE STATE: CA ZIP: 92618 FORMER COMPANY: FORMER CONFORMED NAME: LASER MEDICAL TECHNOLOGY INC DATE OF NAME CHANGE: 19941117 FORMER COMPANY: FORMER CONFORMED NAME: LASER ENDO TECHNIC CORP DATE OF NAME CHANGE: 19920708 FORMER COMPANY: FORMER CONFORMED NAME: PAMPLONA CAPITAL CORP DATE OF NAME CHANGE: 19911104 10-Q 1 d342348d10q.htm FORM 10-Q Form 10-Q

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 10-Q

(Mark One)

x	QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended March 31, 2012

¨	TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from to

Commission File Number 000-19627

BIOLASE TECHNOLOGY, INC.

(Exact name of registrant as specified in its charter)

Delaware

87-0442441

(State or other jurisdiction of

incorporation or organization)

(I.R.S. Employer

Identification No.)

4 Cromwell

Irvine, California 92618

(Address of principal executive offices, including zip code)

(949) 361-1200

(Registrant’s telephone number, including area code)

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes x No ¨

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§ 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files). Yes x No ¨

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer or a smaller reporting company. See the definition of “large accelerated filer,” “accelerated filer” and “smaller reporting company” in Rule 12b-2 of the Exchange Act. (Check one):

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act.): Yes ¨ No x

The number of shares of the issuer’s common stock, $0.001 par value per share, outstanding, as of May 4, 2012, was 30,879,524 shares.

BIOLASE TECHNOLOGY, INC.

INDEX


		Page

PART I.	FINANCIAL INFORMATION

Item 1.	Financial Statements (Unaudited):

	Consolidated Balance Sheets as of March 31, 2012 and December 31, 2011		3

	Consolidated Statements of Comprehensive Loss for the three months ended March 31, 2012 and March 31, 2011		4

	Consolidated Statements of Cash Flows for the three months ended March 31, 2012 and March 31, 2011		5

	Notes to Consolidated Financial Statements		6

Item 2.	Management’s Discussion and Analysis of Financial Condition and Results of Operations		15

Item 3.	Quantitative and Qualitative Disclosures About Market Risk		21

Item 4.	Controls and Procedures		21

PART II.	OTHER INFORMATION

Item 1.	Legal Proceedings		21

Item 1A.	Risk Factors		21

Item 2.	Unregistered Sales of Equity Securities and Use of Proceeds		21

Item 3.	Defaults Upon Senior Securities		21

Item 4.	Mine Safety Disclosures		21

Item 5.	Other Information		21

Item 6.	Exhibits		22

Signatures			23

PART I. FINANCIAL INFORMATION

ITEM 1.

FINANCIAL STATEMENTS

BIOLASE TECHNOLOGY, INC.

CONSOLIDATED BALANCE SHEETS (Unaudited)

(in thousands, except per share data)


	March 31, 2012			December 31, 2011
ASSETS
Current assets:
Cash and cash equivalents	$	2,772		$	3,307
Accounts receivable, less allowance of $305 and $289 in 2012 and 2011, respectively		8,983			8,899
Inventory, net		10,337			11,312
Prepaid expenses and other current assets		1,163			1,808

Total current assets		23,255			25,326
Property, plant and equipment, net		1,338			1,148
Intangible assets, net		179			212
Goodwill		2,926			2,926
Deferred tax asset		8			8
Other assets		187			187

Total assets	$	27,893		$	29,807

LIABILITIES AND STOCKHOLDERS’ EQUITY
Current liabilities:
Accounts payable	$	7,524		$	7,804
Accrued liabilities		5,442			6,177
Customer deposits		20			165
Deferred revenue, current portion		2,232			2,136

Total current liabilities		15,218			16,282
Deferred tax liabilities		612			594
Deferred revenue, long-term		17			25
Other liabilities, long-term		139			337

Total liabilities		15,986			17,238

Commitments and contingencies (Notes 9 and 13)
Stockholders’ equity:
Preferred stock, par value $0.001, 1,000 shares authorized, no shares issued and outstanding		—			—
Common stock, par value $0.001, 50,000 shares authorized; 32,769 and 32,502 shares issued in 2012 and 2011, respectively; and 30,805 and 30,538 shares outstanding in 2012 and 2011, respectively		33			33
Additional paid-in capital		139,454			138,507
Accumulated other comprehensive loss		(297	)		(360	)
Accumulated deficit		(110,884	)		(109,212	)

		28,306			28,968
Treasury stock (cost of 1,964 shares repurchased)		(16,399	)		(16,399	)

Total stockholders’ equity		11,907			12,569

Total liabilities and stockholders’ equity	$	27,893		$	29,807

See accompanying notes to consolidated financial statements.

BIOLASE TECHNOLOGY, INC.

CONSOLIDATED STATEMENTS OF COMPREHENSIVE LOSS (Unaudited)

(in thousands, except per share data)


	Three Months Ended March 31,
	2012			2011
Products and services revenue	$	12,312		$	10,546
License fees and royalty revenue		8			15

Net revenue		12,320			10,561
Cost of revenue		6,513			5,722

Gross profit		5,807			4,839

Operating expenses:
Sales and marketing		4,028			2,453
General and administrative		2,211			1,699
Engineering and development		1,190			1,093

Total operating expenses		7,429			5,245

Loss from operations		(1,622	)		(406	)

Loss on foreign currency transactions		(17	)		(38	)
Interest income		1			—
Interest expense		(5	)		(73	)
Nonrecurring charge, unamortized debt-related cost expense		—			(225	)

Non-operating loss, net		(21	)		(336	)

Loss before income tax provision		(1,643	)		(742	)
Income tax provision		29			8

Net loss		(1,672	)		(750	)
Other comprehensive loss items:
Foreign currency translation adjustments		63			114

Comprehensive loss	$	(1,609	)	$	(636	)

Net loss per share:
Basic	$	(0.05	)	$	(0.03	)

Diluted	$	(0.05	)	$	(0.03	)

Shares used in the calculation of net loss per share:
Basic		30,721			27,343

Diluted		30,721			27,343

See accompanying notes to consolidated financial statements.

BIOLASE TECHNOLOGY, INC.

CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited)

(in thousands)


	Three Months Ended March 31,
	2012			2011
Cash Flows From Operating Activities:
Net loss	$	(1,672	)	$	(750	)
Adjustments to reconcile net loss to net cash and cash equivalents used in operating activities:
Depreciation and amortization		125			228
Loss on disposal of assets, net		—			7
Provision for bad debts		16			10
Amortization of discounts on term loan payable		—			78
Amortization of debt issuance costs		—			99
Stock-based compensation		583			220
Other equity instruments compensation		25			96
Other non-cash compensation		62			61
Deferred income taxes		—			(1	)
Changes in operating assets and liabilities:
Accounts receivable		(100	)		(2,645	)
Inventory		975			(191	)
Prepaid expenses and other assets		606			212
Customer deposits		(145	)		(2,923	)
Accounts payable and accrued liabilities		(957	)		431
Deferred revenue		(111	)		4

Net cash and cash equivalents used in operating activities		(593	)		(5,064	)

Cash Flows From Investing Activities:
Additions to property, plant and equipment		(266	)		(18	)

Net cash and cash equivalents used in investing activities		(266	)		(18	)

Cash Flows From Financing Activities:
Payments under term loan payable		—			(2,700	)
Proceeds from equity offering, net of expenses		—			7,049
Proceeds from exercise of stock options		277			594

Net cash and cash equivalents provided by financing activities		277			4,943

Effect of exchange rate changes		47			77

Change in cash and cash equivalents		(535	)		(62	)
Cash and cash equivalents, beginning of period		3,307			1,694

Cash and cash equivalents, end of period	$	2,772		$	1,632

Supplemental cash flow disclosure:
Cash activity during the period for:
Interest	$	3		$	73

Income taxes	$	21		$	8

See accompanying notes to consolidated financial statements.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)

NOTE 1 – BASIS OF PRESENTATION

The Company

BIOLASE Technology Inc., (the “Company”) incorporated in Delaware in 1987, is a medical technology company operating in one business segment that develops, manufactures, and markets lasers, and markets and distributes dental imaging equipment and other products designed to improve technologies for applications and procedures in dentistry and medicine.

Basis of Presentation

The unaudited consolidated financial statements include the accounts of BIOLASE Technology, Inc. and its consolidated subsidiaries and have been prepared on a basis consistent with the December 31, 2011 audited consolidated financial statements and include all material adjustments, consisting of normal recurring adjustments and the elimination of all material intercompany transactions and balances, necessary to fairly present the information set forth therein. These unaudited, interim, consolidated financial statements do not include all the footnotes, presentations and disclosures normally required by accounting principles generally accepted in the United States of America (“GAAP”) for complete consolidated financial statements. Certain amounts have been reclassified to conform to current period presentations.

Use of Estimates

The preparation of these consolidated financial statements in conformity with GAAP requires the Company to make estimates and assumptions that affect amounts reported in the consolidated financial statements and the accompanying notes. Significant estimates in these consolidated financial statements include allowances on accounts receivable, inventory and deferred taxes, as well as estimates for accrued warranty expenses, indefinite-lived intangible assets and the ability of goodwill to be realized, revenue deferrals for multiple element arrangements, effects of stock-based compensation and warrants, contingent liabilities and the provision or benefit for income taxes. Due to the inherent uncertainty involved in making estimates, actual results reported in future periods may differ materially from those estimates.

Critical Accounting Policies

Information with respect to the Company’s critical accounting policies which management believes could have the most significant effect on the Company’s reported results and require subjective or complex judgments by management is contained on pages 41 to 43 in Item 7, Management’s Discussion and Analysis of Financial Condition and Results of Operations, of the Company’s Annual Report on Form 10-K for the year ended December 31, 2011 (“2011 Form 10-K”). Management believes that there have been no significant changes during the three months ended March 31, 2012 in the Company’s critical accounting policies from those disclosed in Item 7 of on the Company’s 2011 Form 10-K.

Fair Value of Financial Instruments

The Company’s financial instruments, consisting of cash and cash equivalents, accounts receivable, accounts payable and other accrued expenses, approximate fair value because of the short maturity of these items.

Liquidity and Management’s Plans

The Company has suffered recurring losses from operations during the three years ended December 31, 2011. Although the Company’s revenues increased during the quarter ended March 31, 2012 compared to the same period in 2011, the Company still incurred a loss from operations and a net loss.

At March 31, 2012, the Company had approximately $8.0 million in working capital. The Company’s principal sources of liquidity at March 31, 2012 consisted of approximately $2.8 million in cash and cash equivalents and $9.0 million of net accounts receivable.

The Company’s ability to meet its obligations in the ordinary course of business is dependent upon its ability to sell its products directly to end-users and through distributors, establish profitable operations through increased sales and decreased expenses, and obtain additional funds when needed. Management intends to increase sales by increasing the Company’s product offerings, expanding its direct sales force, and expanding its distributor relationships both domestically and internationally.

There can be no assurance that the Company will be able to increase sales, reduce expenses, or obtain additional financing, if necessary, at a level to meet its current obligations. As a result, the report of the Company’s independent registered public accounting firm on its consolidated financial statements for the year ended December 31, 2011 contained an explanatory paragraph stating that there is a substantial doubt regarding the Company’s ability to continue as a going concern.

The accompanying consolidated financial statements have been prepared on a going concern basis that contemplates the realization of assets and the satisfaction of liabilities in the normal course of business. The consolidated financial statements do not include adjustments relating to the recoverability of recorded asset amounts or the amounts or classification of liabilities that might be necessary should we be unable to continue as a going concern.

From time to time, the Company may attempt to raise capital through either equity or debt offerings. The Company’s capital requirements will depend on many factors, including, among other things, the effects of any acquisitions it may pursue as well as the rate at which its business grows, with corresponding demands for working capital and manufacturing capacity. The Company could be required, or may elect, to seek additional funding through public or private equity or debt financing. However, a credit facility, or additional funds through public or private equity or other debt financing, may not be available on terms acceptable to the Company or at all, or that any such financing activity would not be dilutive to its stockholders. Without additional funds and/or increased revenues, the Company may not have enough cash or financial resources to operate for the next twelve months.

On February 22, 2012, the Company entered into a definitive termination agreement (the “2012 Termination Agreement”) with Henry Schein, Inc. (“HSIC”), a leading U.S. dental product and equipment distributor and the Company’s former exclusive distributor in North America. The 2012 Termination Agreement, which was completed on April 12, 2012 (subsequent to the quarter ended March 31, 2012), terminated and superseded all prior agreements with HSIC. Pursuant to the 2012 Termination Agreement, the Company purchased HSIC’s inventory of Waterlase MD Turbo laser systems and HSIC released its liens on the Company’s assets. The Company paid the entire purchase price by offsetting accounts receivable currently due from HSIC from sales made in the normal course of business. None of the funds used to offset the purchase price were related to the original sales of the MD Turbo laser systems that were purchased. The Company expects to use the purchased equipment as a source of parts to service its installed base of approximately 6,500 Waterlase MD Turbo laser systems and for its newly released Waterlase MDX line of all-tissue lasers, as well as for use in dental schools to promote the Company’s Waterlase technology. See Note 13 – Subsequent Events for further discussion.

NOTE 2 – RECENT ACCOUNTING PRONOUNCEMENTS

Changes to U.S. GAAP are established by the Financial Accounting Standards Board (“FASB”) in the form of accounting standards updates (“ASU’s”) to the FASB’s Accounting Standards Codification (“ASC”).

The Company considers the applicability and impact of all ASU’s. ASU’s not listed below were assessed and determined to not be applicable or are expected to have minimal impact on our consolidated financial position and results of operations.

Newly Adopted Accounting Standards

In September 2011, the FASB issued guidance for the impairment testing of goodwill. The guidance permits an entity to first assess qualitative factors to determine whether it is more-likely-than-not that the fair value of a reporting unit is less than its carrying amount as a basis for determining whether it is necessary to perform the two-step goodwill impairment test. This guidance is effective for annual and interim goodwill impairment tests performed for fiscal years beginning after December 15, 2011. The Company adopted this guidance effective January 1, 2012. The adoption did not have a material impact on the Company’s consolidated financial statements.

In June 2011, the FASB updated the accounting guidance relating to presentation of comprehensive income. This guidance requires companies to present total comprehensive income, the components of net income, and the components of other comprehensive income (“OCI”) either in a single continuous statement of comprehensive income or in two, but consecutive, statements. Additionally, companies are required to present on the face of the consolidated financial statements the reclassification adjustments that are reclassified from OCI to net income, where the components of net income and the components of OCI are presented. This guidance is effective for fiscal years and interim periods within those years beginning after December 15, 2011, and requires retrospective application to all periods presented. The Company adopted this guidance effective January 1, 2012 and elected to present a single continuous statement of comprehensive loss. The adoption did not have a material impact on the Company’s consolidated financial statements.

NOTE 3 – STOCK-BASED AWARDS AND PER SHARE INFORMATION

Stock-Based Compensation

The Company currently has one stock-based compensation plan, the 2002 Stock Incentive Plan (the “2002 Plan”). Eligible persons under the 2002 Plan include certain officers and employees of the Company and directors of the Company. Under the 2002 Plan, 6,950,000 shares of common stock have been authorized for issuance. As of March 31, 2012, 2,393,000 shares of common stock have been issued pursuant to options that were exercised, 3,746,000 shares of common stock have been reserved for options that are outstanding, and 811,000 shares of common stock remain available for future grant.

Compensation cost related to stock options recognized in operating results during the three months ended March 31, 2012 and 2011, totaled approximately $583,000 and $220,000, respectively. The net impact to earnings for the periods ended March 31, 2012 and 2011 was $(0.02) and $(0.01) per basic and diluted share, respectively. At March 31, 2012, the Company had approximately $2.1 million of total unrecognized compensation cost, net of estimated forfeitures, related to unvested share-based compensation arrangements granted under our existing plans. The Company expects that cost to be recognized over a weighted-average period of 1.2 years.

The following table summarizes the income statement classification of compensation expense associated with share-based payments (in thousands):


	Three Months Ended March 31,
	2012		2011
Cost of revenue	$	58	$	30
Sales and marketing		121		85
General and administrative		358		85
Engineering and development		46		20

	$	583	$	220

The Black-Scholes option valuation model is used in estimating the fair value of traded options. This option pricing model requires the Company to make several assumptions regarding the key variables used to calculate the fair value of its stock options. The risk-free interest rate used is based on the U.S. Treasury yield curve in effect for the expected lives of the options at their dates of grant. Since July 1, 2005, the Company has used a dividend yield of zero as it does not intend to pay cash dividends on its common stock in the foreseeable future. The most critical assumption used in calculating the fair value of stock options is the expected volatility of the common stock. Management believes that the historic volatility of the common stock is a reliable indicator of future volatility, and accordingly, a stock volatility factor based on the historical volatility of the common stock over a period of time is used in approximating the estimated lives of new stock options. The expected term is estimated by analyzing the Company’s historical share option exercise experience over a five year period. Compensation expense is recognized using the straight-line method for all stock-based awards. Compensation expense is recognized only for those options expected to vest, with forfeitures estimated at the date of grant based on historical experience and future expectations. Forfeitures are estimated at the time of the grant and revised as necessary in subsequent periods if actual forfeitures differ from those estimates.

The stock option fair values were estimated using the Black-Scholes option-pricing model with the following assumptions:


	Three Months Ended March 31,
	2012	2011
Expected term	4.1 years	4.2 years
Volatility	102%	103%
Annual dividend per share	$0.00	$0.00
Risk-free interest rate	0.93%	2.18%

A summary of option activity under our stock option plans for the three months ended March 31, 2012 is as follows:


	Shares			Weighted average exercise price		Weighted average remaining contractual term (years)		Aggregate intrinsic value(1)
Options outstanding at December 31, 2011		3,858,000		$	3.75
Plus: Options granted		134,000		$	2.82
Less: Options exercised		(109,000	)	$	2.53
Options forfeited, canceled, or expired		(137,000	)	$	2.59

Options outstanding at March 31, 2012		3,746,000		$	3.79		4.25	$	1,539,000

Options exercisable at March 31, 2012		2,250,000		$	4.35		4.26	$	1,015,000

Vested options expired during the quarter ended March 31, 2012		1,000		$	8.46

(1)	The intrinsic value calculation does not include negative values. This can occur when the fair market value on the reporting date is less than the exercise price of the grant.

Cash proceeds along with fair value disclosures related to grants, exercises and vesting options are provided in the following table (in thousands, except per share amounts):


	Three Months Ended March 31,
	2012		2011
Proceeds from stock options exercised	$	277	$	594
Tax benefit related to stock options exercised (1)		N/A		N/A
Intrinsic value of stock options exercised (2)	$	11	$	609
Weighted-average fair value of options granted during period	$	1.99	$	2.39
Total fair value of shares vested during the period	$	557	$	199

(1)	Excess tax benefits received related to stock option exercises are presented as financing cash inflows. We currently do not receive a tax benefit related to the exercise of stock options due to our net operating losses.

(2)	The intrinsic value of stock options exercised is the amount by which the market price of the stock on the date of exercise exceeded the market price of the stock on the date of grant.

On March 2, 2012, the Board of Directors accelerated the vesting period for options to purchase 95,833 shares of common stock held by Federico Pignatelli, the Company’s Chairman and Chief Executive Officer (“CEO”). The options were originally granted in December 2011 at $2.58 per share with monthly vesting over four years. The Board of Directors accelerated the vesting period to March 2, 2012, in part due to the CEO’s continued commitment to maintain his annual salary of one dollar for the year ending December 31, 2012. Accelerating the vesting period of the common stock options resulted in the Company recognizing unamortized compensation cost of approximately $183,000 during March 2012. The transaction did not result in any additional compensation cost primarily as the effects of the decrease in the expected term and volatility offset the effects of the difference between the stock price and the option price on the date the vesting of the common stock options were modified.

Net Loss Per Share – Basic and Diluted

Basic net loss per share is computed by dividing loss available to common stockholders by the weighted-average number of common shares outstanding for the period. In computing diluted net loss per share, the weighted average number of shares outstanding is adjusted to reflect the effect of potentially dilutive securities.

Outstanding stock options and warrants to purchase 4,514,000 shares were not included in the computation of diluted loss per share for the three months ended March 31, 2012 as a result of their anti-dilutive effect.

The Company intends to pay a 2% annual stock dividend, in quarterly installments, for the year ending December 31, 2012. Stock dividends are discussed quarterly by the Company’s Board of Directors and management. The actual declaration of future stock dividends and the establishment of the record and payment dates are subject to final determination by the Company’s Board of Directors after its review of the Company’s financial performance, the expected results of future operations, availability of shares, and other factors that the Board of Directors may deem relevant. The Company’s dividend policy may be changed at any time by the Company’s Board of Directors, and there is no assurance, with respect to the amount or frequency, that any stock dividend will be declared in the future.

In March 2012, the Board of Directors declared a one-half percent stock dividend (the “March Stock Dividend”) payable March 30, 2012 to stockholders of record on March 15, 2012. The March Stock Dividend was deemed to be a special dividend. All stock information presented, other than that related to stock options and warrants, has been adjusted to reflect the effects of the March Stock Dividend.

Warrants

During September 2010, the Company issued warrants (the “IR Warrants”) to purchase an aggregate of 50,000 shares of common stock at a price per share of $0.74 to three service providers who provide investor relations services. The IR Warrants vest quarterly and will be revalued each period until the final vesting date. The holders may convert the IR Warrants into a number of shares, in whole or in part. The first tranche of IR Warrants expire on September 20, 2013. Pursuant to the agreement, the service providers were also entitled to a second tranche of IR Warrants to purchase an aggregate of 50,000 shares of common stock at a price per share of $0.74 as a performance bonus when the Company’s stock price closes at a price in excess of $6.00. The second tranche of IR Warrants were subsequently issued in April 2011 and will expire on April 11, 2014. The Company accounts for these non-employee stock warrants using the Black Scholes option pricing model. The Company has concluded that the vesting date is the ultimate final measurement date, and will revalue any unvested warrants at the end of each reporting period until that date. The Company recognized $25,000 and $96,000 of expense related to the IR Warrants, including the estimated cost associated with the second tranche of IR Warrants, during the quarters ended March 31, 2012 and 2011, respectively.

NOTE 4 – INVENTORY

Inventory is valued at the lower of cost or market (determined by the first-in, first-out method) and is comprised of the following (in thousands):


	March 31, 2012		December 31, 2011
Raw materials	$	3,756	$	4,280
Work-in-process		2,115		2,538
Finished goods		4,466		4,494

Inventory, net	$	10,337	$	11,312

Inventory is net of the provision for excess and obsolete inventory totaling $2.1 million and $2.3 million as of March 31, 2012 and December 31, 2011, respectively.

NOTE 5 – PROPERTY, PLANT AND EQUIPMENT

Property, plant and equipment, net is comprised of the following (in thousands):


	March 31, 2012			December 31, 2011
Land	$	254		$	247
Building		326			317
Leasehold improvements		957			957
Equipment and computers		5,849			5,729
Furniture and fixtures		1,042			1,036
Construction in progress		169			26

		8,597			8,312
Accumulated depreciation and amortization		(7,259	)		(7,164	)

Property, plant and equipment, net	$	1,338		$	1,148

Depreciation and amortization expense related to property, plant, and equipment totaled $92,000 and $195,000 for the three months ended March 31, 2012 and 2011, respectively.

NOTE 6 – INTANGIBLE ASSETS AND GOODWILL

The Company conducted its annual impairment test of intangible assets and goodwill as of June 30, 2011, and determined that there was no impairment. The Company also tests its intangible assets and goodwill between the annual impairment test if events occur or circumstances change that would more likely than not reduce the fair value of the Company or its assets below their carrying amounts. No events have occurred since June 30, 2011, that would trigger further impairment testing of the Company’s intangible assets and goodwill.

Amortization expense for the three months ended March 31, 2012 and March 31, 2011 totaled $33,000 and $33,000, respectively. Other intangible assets consist of an acquired customer list and a non-compete agreement.

The following table presents details of the Company’s intangible assets, related accumulated amortization and goodwill (in thousands):


	As of March 31, 2012									As of December 31, 2011
	Gross		Accumulated Amortization			Impairment		Net		Gross		Accumulated Amortization			Impairment		Net
Patents (4-10 years)	$	1,914	$	(1,735	)	$	—	$	179	$	1,914	$	(1,702	)	$	—	$	212
Trademarks (6 years)		69		(69	)		—		—		69		(69	)		—		—
Other (4 to 6 years)		593		(593	)		—		—		593		(593	)		—		—

Total	$	2,576	$	(2,397	)	$	—	$	179	$	2,576	$	(2,364	)	$	—	$	212

Goodwill (Indefinite life)	$	2,926						$	2,926	$	2,926						$	2,926

NOTE 7 – ACCRUED LIABILITIES AND DEFERRED REVENUE

Accrued liabilities are comprised of the following (in thousands):


	March 31, 2012		December 31, 2011
Payroll and benefits	$	1,645	$	1,928
Warranty accrual		1,926		2,218
Sales tax		419		526
Accrued professional services		689		669
Accrued insurance premium		242		433
Accrued support services		350		200
Other		171		203

Accrued liabilities	$	5,442	$	6,177

Changes in the initial product warranty accrual, and the expenses incurred under our initial and extended warranties, for the three months ended March 31, 2012 and 2011 were as follows (in thousands):


	Three Months Ended March 31,
	2012			2011
Initial warranty accrual, beginning balance	$	2,218		$	2,725
Provision for estimated warranty cost		122			508
Warranty expenditures		(414	)		(505	)

Initial warranty accrual, ending balance		1,926			2,728
Total warranty accrual, long term		—			(524	)

Total warranty accrual, current portion	$	1,926		$	2,204

Deferred revenue is comprised of the following (in thousands):


	March 31, 2012			December 31, 2011
Undelivered elements (training, installation and product and support services)	$	1,171		$	1,105
Extended warranty contracts		1,078			1,056

Total deferred revenue		2,249			2,161

Less long-term amounts:
Extended warranty contracts		(17	)		(25	)

Total deferred revenue, long-term		(17	)		(25	)

Total deferred revenue, current portion	$	2,232		$	2,136

On May 20, 2010, the Company entered into a license agreement (the “2010 P&G Agreement”), with Procter and Gamble Company (“P&G”), which replaced an existing license agreement between the Company and P&G (the “2006 P&G Agreement”). Pursuant to the 2010 P&G Agreement, the Company agreed to continue granting P&G an exclusive license to certain of the Company’s patents to enable P&G to develop products aimed at the consumer market and P&G agreed to pay royalties based on sales of products developed with such intellectual property. On June 28, 2011, the Company entered into an amendment to the 2010 P&G Agreement (the “2011 P&G Amendment”) which extended the effective period for the 2010 P&G Agreement from December 31, 2010 through June 30, 2011, and resulted in the Company recognizing the previously deferred $375,000 of revenue as royalty revenue during the quarter ended June 30, 2011.

The 2011 P&G Amendment also provided that effective January 1, 2011, P&G’s exclusive license to the Company’s patents converted to a non-exclusive license unless P&G paid the Company a license payment in the amount of $187,500 by the end of the third quarter of 2011, and at the end of each quarter thereafter, throughout the term of the 2010 P&G Agreement. As a result of P&G not making any payments to the Company in the third and fourth quarters of the year ended December 31, 2011, their license converted to a non-exclusive license. The Company is currently engaged in an active collaboration with P&G to commercialize a consumer product utilizing its patents.

NOTE 8 – LINE OF CREDIT AND DEBT

The Company entered into a Loan and Security Agreement with MidCap Financial, LLC (whose interests were later assigned to its affiliate MidCap Funding III, LLC) and Silicon Valley Bank in May 2010. In connection with the Loan and Security Agreement, the Company issued two secured promissory notes in an aggregate principal amount of $3 million, at 14.25%, secured by the Company’s assets, and warrants to purchase up to an aggregate of 101,694 shares of Common Stock at an exercise price of $1.77 per share with an expiration date of May 26, 2015. The per share price of the warrants was subsequently reduced in September 2010 to $0.84 per share in connection with Waiver and Amendment No. 1 to the Loan and Security Agreement.

During February 2011, the Company repaid all outstanding balances under the Loan and Security Agreement, which included approximately $2.6 million in principal, $30,000 of accrued interest, and $169,000 of loan related expenses and MidCap Funding III, LLC and Silicon Valley Bank released their security interest in the Company’s assets. Unamortized costs totaling approximately $225,000, excluding interest, associated with the term loan payable were expensed in February 2011. MidCap Financial, LLC and Silicon Valley Bank also performed a cashless exercise of all of their warrants during February 2011, which resulted in the combined issuance of 78,172 shares of unregistered stock. The Loan and Security Agreement was terminated in February 2011.

In December 2011, the Company financed approximately $433,000 of insurance premiums payable in nine equal monthly installments of approximately $48,000 each, including a finance charge of 2.50%. As of March 31, 2012, there was $242,000 outstanding under this arrangement. Such amount is included in Accrued Liabilities in the accompanying consolidated financial statements.

NOTE 9 – COMMITMENTS AND CONTINGENCIES

Litigation

The Company discloses material loss contingencies deemed to be reasonably possible and accrues for loss contingencies when, in consultation with its legal advisors, management concludes that a loss is probable and reasonably estimable. The ability to predict the ultimate outcome of such matters involves judgments, estimates, and inherent uncertainties. The actual outcome of such matters could differ materially from management’s estimates.

Intellectual Property

On April 24, 2012, CAO Group, Inc. filed a lawsuit against the Company in the United States District Court for the District of Utah, Central Division, alleging patent infringement of U.S. Patent No. 7,485,116 involving the Company’s ezlase diode laser. The complaint seeks unspecified damages, attorneys’ fees, interest, costs, and injunctive relief. Management plans to vigorously defend against the allegations.

Other Matters

In the normal course of business, the Company is subject to other legal proceedings, lawsuits and other claims. Although the ultimate aggregate amount of probable monetary liability or financial impact with respect to these matters is subject to many uncertainties and is therefore not predictable with assurance, management believes that any monetary liability or financial impact to the Company from these other matters, individually and in the aggregate, would not be material to the Company’s consolidated financial condition, results of operations or cash flows. However, there can be no assurance with respect to such result, and monetary liability or financial impact to the Company from these other matters could differ materially from those projected.

NOTE 10 – SEGMENT INFORMATION

The Company currently operates in a single business segment. For the quarter ended March 31, 2012, sales in the United States accounted for approximately 68% of net revenue, and international sales accounted for approximately 32% of net revenue. For the quarter ended March 31, 2011, sales in the United States accounted for approximately 81% of net revenue, and international sales accounted for approximately 19% of net revenue.

Net revenue by geographic location based on the location of customers was as follows (in thousands):


	Three Months Ended March 31,
	2012		2011
United States	$	8,364	$	8,525
International		3,956		2,036

	$	12,320	$	10,561

No individual country, other than the United States, represents more than 10% of total net revenue.

Long-lived assets located outside of the United States at our foreign subsidiaries totaled $554,000 and $542,000 as of March 31, 2012 and December 31, 2011, respectively.

NOTE 11 – CONCENTRATIONS

Revenue from Waterlase systems, the Company’s principal product line, which includes the iPlus, MDX systems, and the MD Turbo, comprised 65% and 41% of total net revenues for the three months ended March 31, 2012 and 2011, respectively. Revenue from Diode systems comprised 11% and 36% of total net revenue for the same periods. Revenue from consumables, service and warranty contracts comprised 23% and 22% of total net revenue for the same periods.

Approximately 8% and 35% of the Company’s net revenue in the quarters ended March 31, 2012 and 2011, respectively, was generated through sales to HSIC worldwide.

The Company maintains its cash and cash equivalent accounts with established commercial banks. Such cash deposits periodically exceed the Federal Deposit Insurance Corporation insured limit.

Accounts receivable concentrations from one international distributor totaled $1.3 million, or 15%, at March 31, 2012 and $716,000, or 8%, at December 31, 2011.

The Company currently purchases certain key components of its products from single suppliers. Although there are a limited number of manufacturers of these key components, management believes that other suppliers could provide similar key components on comparable terms. A change in suppliers, however, could cause delays in manufacturing and a possible loss of sales, which could adversely affect the Company’s consolidated results of operations.

NOTE 12 – INCOME TAXES

Accounting for uncertainty in income taxes prescribes a recognition threshold and measurement attribute for the financial statement recognition and measurement of a tax position taken or expected to be taken in a tax return and provides guidance on derecognition, classification, interest and penalties, accounting in interim periods, disclosure and transition. The Company has elected to classify interest and penalties as a component of its income tax provision. For the three months ended March 31, 2012 and 2011, the Company recorded an increase of $1,000 and $1,000, respectively, with respect to the liability for unrecognized tax benefits, including related estimates of penalties and interest.

NOTE 13 – SUBSEQUENT EVENTS

2012 Termination Agreement

On April 12, 2012, the Company completed the 2012 Termination Agreement with HSIC whereby the Company purchased HSIC’s inventory of Waterlase MD Turbo laser systems and HSIC released its liens on the Company’s assets. Pursuant to the terms of the 2012 Termination Agreement, the Company paid the entire purchase price by offsetting accounts receivable currently due from HSIC from sales made in the normal course of business. None of the funds used to offset the purchase price were related to the original sales of the MD Turbo laser systems that were purchased. As a result of the transaction, the Company is no longer required to fulfill certain future service obligations and, accordingly, derecognized approximately $155,000 of accounts receivable due from HSIC related to support services previously provided and approximately $142,000 of accrued warranties as of March 31, 2012. The Company expects to record the remaining effects of the 2012 Termination Agreement in the second quarter ending June 30, 2012.

Non-Qualified Stock Option Award

On May 7, 2012, the Board of Directors granted a non-qualified stock option to purchase 65,000 shares of the Company’s common stock to a consultant, at a price per share of $2.55, the closing market price of the Company’s common stock on the grant date. The shares fully vest and become exercisable upon achieving certain performance conditions, as defined in the consulting agreement, and expire five years from the grant date. The Company is unable to currently estimate the probability of achieving the required performance conditions and, accordingly, no stock-based compensation has been recognized. The Company will reassess whether achievement of the performance conditions is probable on a quarterly basis and recognize stock-based compensation when it is probable that the performance conditions will be achieved.

ITEM 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

This Quarterly Report on Form 10-Q contains “forward-looking statements” as defined in Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, which involve risks and uncertainties, as well as assumptions that, if they never materialize or prove incorrect, could cause the results of Biolase Technology, Inc. (the “Company,” “we”, “us” or “our” ) to differ materially and adversely from those expressed or implied by such forward-looking statements. Such forward-looking statements include any statements, predictions and expectations regarding our earnings, revenue, sales and operations, operating expenses, anticipated cash needs, capital requirements and capital expenditures, needs for additional financing, use of working capital, plans for future products and services and for enhancements of existing products and services, anticipated growth strategies, ability to attract customers, sources of net revenue, anticipated trends and challenges in our business and the markets in which we operate, the adequacy of our facilities, the impact of economic and industry conditions on our customers and our business, customer demand, our competitive position, the outcome of any litigation against us, the perceived benefits of any technology acquisitions, critical accounting policies, the impact of recent accounting pronouncements, statements pertaining to financial items, plans, strategies, expectations or objectives of management for future operations, our financial condition or prospects, and any other statement that is not historical fact. Forward-looking statements are often identified by the use of words such as “may,” “might,” “will,” “intend,” “should,” “could,” “can,” “would,” “continue,” “expect,” “believe,” “anticipate,” “estimate,” “predict,” “potential,” “plan,” “seek” and similar expressions and variations or the negativities of these terms or other comparable terminology. These forward-looking statements are based on the beliefs and assumptions of our management based upon information currently available to management. Such forward looking statements are subject to risks, uncertainties and other factors that could cause actual results and the timing of certain events to differ materially and adversely from future results expressed or implied from such forward-looking statements. Factors that could cause or contribute to such differences include, but are not limited to, those identified under “Risk Factors” in our Annual Report on Form 10-K for the year ended December 31, 2011 (the “2011 Form 10-K”) filed with the Securities and Exchange Commission (the “SEC”). Such forward-looking statements speak only as of the date of this report. We undertake no obligation to update any forward-looking statements to reflect events or circumstances after the date of such statements for any reason except as otherwise required by law.

Overview

We are a medical technology company that develops, manufactures, and markets lasers, and markets and distributes dental imaging equipment and other related products designed to improve technologies for applications and procedures in dentistry and medicine. Our principal products provide dental laser systems that allow dentists, periodontists, endodontists, oral surgeons, and other specialists to perform a broad range of dental procedures, including cosmetic and complex surgical applications. Our systems are designed to provide clinically superior performance for many types of dental procedures with less pain and faster recovery times than are generally achieved with drills, scalpels, and other dental instruments. We have clearance from the FDA to market our laser systems in the United States and also have the necessary approvals to sell our laser systems in Canada, the European Union and various other international markets. Since 1998, we have sold over 8,900 Waterlase systems, including more than 4,900 Waterlase MD and iPlus systems, and more than 19,600 laser systems in over 60 countries.

We offer two categories of laser system products: Waterlase systems and Diode systems. Our flagship product category, the Waterlase system, uses a patented combination of water and laser energy to perform most procedures currently performed using dental drills, scalpels, and other traditional dental instruments for cutting soft and hard tissue. We also offer our Diode laser systems to perform soft tissue and cosmetic procedures, including tooth whitening. We currently have over approximately 160 issued and 120 pending U.S. and international patents, 70 percent of which are related to our core Waterlase technology and medical lasers.

We have suffered recurring losses from operations and have not generated cash from operations for the three years ended December 31, 2011. Our inability to generate cash from operations, the potential need for additional capital, and the uncertainties surrounding our ability to raise additional capital, raises substantial doubt about our ability to continue as a going concern. Accordingly, the accompanying financial statements have been prepared assuming that we will continue as a going concern, which contemplates that we will continue in operation for the next twelve months and will be able to realize our assets and discharge our liabilities and commitments in the normal course of business. The consolidated financial statements do not include any adjustments to reflect the possible future effects of recoverability and classifications of assets or the amounts and classifications of liabilities that may result from our inability to continue as a going concern.

In order for us to continue operations beyond the next twelve months and be able to discharge our liabilities and commitments in the normal course of business, we must sell our products directly to end-users and through multiple distributors; establish profitable operations through increased sales and reduced operating expenses; and potentially raise additional funds, principally through the sales of our securities or debt financings, to meet our working capital needs.

We intend to increase sales by increasing our product offerings, by expanding our direct sales force and our distributor relationships both domestically and internationally. In connection with this strategy, we intend to provide assistance to our domestic and international distribution partners to maximize revenue. However, we cannot guarantee that we will be able to increase sales, reduce expenses or obtain additional funds when needed or that such funds, if available, will be obtainable on terms satisfactory to us. If we are unable to increase sales, reduce expenses or raise sufficient additional capital we may be unable to continue to fund our operations, develop our products or realize value from our assets and discharge our liabilities in the normal course of business. These uncertainties raise substantial doubt about our ability to continue as a going concern.

On September 23, 2010, we entered into the D&S Agreement with HSIC, effective August 30, 2010, which terminated all prior agreements with HSIC. Under the D&S Agreement, we granted HSIC certain non-exclusive distribution rights in North America and several international markets with respect to our dental laser systems, accessories, and related support and services in certain circumstances. In addition, we granted HSIC exclusivity in selected international markets subject to review of certain performance criteria. In connection with the D&S Agreement, HSIC placed two irrevocable purchase orders totaling $9 million for our products. The first purchase order, totaling $6 million, was for the purchase of iLase systems and was required to be fulfilled by June 30, 2011. The first purchase order was fully satisfied during the first quarter of 2011. The second purchase order, totaling $3 million, was for the purchase of a combination of laser systems and was required to be fulfilled by August 25, 2011. The second purchase order was fully satisfied during the third quarter of 2011. The D&S Agreement granted HSIC a security interest in our inventory and assets, including our intellectual property.

On April 12, 2012, we completed a transaction with HSIC (the “2012 Termination Agreement”) whereby we purchased HSIC’s inventory of Waterlase MD Turbo laser systems and HSIC released its liens on our assets. Pursuant to the terms of the transaction, the entire purchase price was paid by offsetting certain accounts receivable currently due from HSIC from sales made in the normal course of business. None of the funds used to offset the purchase price were related to the original sales of the MD Turbo laser systems that were purchased. As a result of the transaction, we are no longer required to fulfill certain future service obligations and, accordingly, derecognized approximately $155,000 of accounts receivable due from HSIC related to support services and approximately $142,000 of accrued warranties as of March 31, 2012. We expect to record the remaining effects of the transaction in the second quarter ending June 30, 2012.

Critical Accounting Policies

The consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America which require us to make estimates and assumptions that affect the reported amounts of assets and liabilities at the date of the consolidated financial statements and revenues and expenses reported during the period. Information with respect to our critical accounting policies which we believe could have the most significant effect on our reported results and require subjective or complex judgments by management is contained on pages 41 to 43 in Item 7, Management’s Discussion and Analysis of Financial Condition and Results of Operations, of the Company’s Annual Report on Form 10K for the year ended December 31, 2011 (the “2011 Form 10-K”). Management believes that there have been no significant changes during the three months ended March 31, 2012 in our critical accounting policies from those disclosed in Item 7 of the 2011 Form 10-K.

Results of Operations

The following table sets forth certain data from our consolidated statements of operations expressed as percentages of net revenue:


	Three Months Ended March 31,
	2012			2011
Net revenue		100.0	%		100.0	%
Cost of revenue		52.9			54.2

Gross profit		47.1			45.8

Operating expenses:
Sales and marketing		32.7			23.2
General and administrative		18.0			16.1
Engineering and development		9.6			10.3

Total operating expenses		60.3			49.6

Loss from operations		(13.2	)		(3.8	)
Non-operating income, net		(0.2	)		(3.2	)

Loss before income taxes		(13.4	)		(7.0	)
Income tax provision		0.2			0.1

Net loss		(13.6	)%		(7.1	)%

The following table summarizes our net revenues by category for the three months ended March 31, 2012 and 2011 (dollars in thousands):


	Three Months Ended March 31,
	2012				2011
Waterlase systems	$	7,982	65	%	$	4,375	42	%
Diode systems		1,342	11	%		3,849	36	%

Total laser systems		9,324	76	%		8,224	78	%
Imaging systems		143	1	%		—	—	%
Consumables and service		1,506	12	%		1,276	12	%
Warranty and training		1,339	11	%		1,046	10	%

Total products and services		12,312	100	%		10,546	100	%
License fees and royalty		8	—	%		15	—	%

Net revenue	$	12,320	100	%	$	10,561	100	%

Three months ended March 31, 2012 and 2011

Net Revenue. Net revenue for the three months ended March 31, 2012, (“First Quarter 2012”) was $12.3 million, an increase of $1.7 million, or 17%, as compared with net revenue of $10.6 million for the three months ended March 31, 2011 (“First Quarter 2011”). Domestic revenues were $8.4 million, or 68% of net revenue, for First Quarter 2012 versus $8.6 million, or 81% of net revenue, for First Quarter 2011. International revenues for First Quarter 2012 were $3.9 million, or 32% of net revenue, as compared with $2.0 million, or 19% of net revenue, for First Quarter 2011. The increase in net revenue is primarily attributable to increases in international laser system sales volume which doubled year-over-year as well as increased domestic consumables and service and warranty and training sales which increased 24% year-over-year due to increased sales and marketing efforts.

Laser system net revenue increased by approximately $1.1 million, or 13% in the First Quarter 2012 compared to the same quarter of 2011. Sales of our Waterlase systems increased $3.6 million, or 82%, in the First Quarter 2012 compared to the same period in 2011 due to increased sales and marketing efforts. Net revenue from our Diode systems decreased by approximately $2.5 million, or 65%, in the First Quarter 2012 compared to the First Quarter 2011, primarily as a result of $3.0 million of iLase sales to HSIC in the First Quarter 2011 under the initial non-refundable prepaid purchase order under the D&S Agreement.

Imaging system net revenue was $143,000 for the First Quarter 2012.

Consumables and service net revenue, which includes consumable products, advanced training programs and extended service contracts, and shipping revenue increased by approximately $523,000 or 23% for First Quarter 2012 as compared to the same period of 2011. Consumable products revenue increased $230,000, or 18%, and service revenues increased approximately $293,000, or 28%. The increased revenues are due to increased sales and marketing efforts.

License fees and royalty revenue of $8,000 for First Quarter 2012 was consistent with $15,000 for First Quarter 2011.

Cost of Revenue. Cost of revenue for First Quarter 2012 increased by $791,000, or approximately 14%, to $6.5 million, compared with cost of revenue of $5.7 million for First Quarter 2011. This increase is primarily attributable to increases in sales. Although cost of revenue increased in First Quarter 2012 on an absolute basis as compared to First Quarter 2011, cost of revenue decreased when expressed as a percentage of net revenues, from 54.2% of net revenues in First Quarter 2011 to 52.9% of net revenues in First Quarter 2012.

Gross Profit. Gross profit for First Quarter 2012 increased by $968,000 to $5.8 million, or 47% of net revenue, as compared with gross profit of $4.8 million, or 46% of net revenue, for First Quarter 2011. The increase was primarily due to higher sales volumes of the Waterlase iPlus system which had lower margins in the First Quarter 2011 due to higher costs associated with the product launch. First Quarter 2012 also included a one time warranty reduction of $142,000 related to 2012 Termination Agreement with HSIC which partially offset increased freight costs of $202,000.

Operating Expenses. Operating expenses for First Quarter 2012 increased by $2.2 million, or 42%, to $7.4 million as compared to $5.2 million for First Quarter 2011. The year-over-year increase in expense is explained in the following expense categories:

Sales and Marketing Expense. Sales and marketing expenses for First Quarter 2012 increased by $1.6 million, or approximately 64%, to $4.0 million, or 33% of net revenue, as compared with $2.4 million, or 23% of net revenue, for First Quarter 2011. The increase is primarily a result of increased payroll and consulting related expenses of $221,000, increased travel and entertainment expenses of $178,000, increased commission expenses of $330,000, increased media and advertising expenses of $271,000, and increased convention costs of $233,000.

General and Administrative Expense. General and administrative expenses for First Quarter 2012 increased by $512,000, or 30%, to $2.2 million, or 18% of net revenue, as compared with $1.7 million, or 16% of net revenue, for First Quarter 2011. The increase in general and administrative expenses resulted primarily from increased payroll and consulting related expenses of $339,000 and increased patent and legal expenses of $43,000.

Engineering and Development Expense. Engineering and development expenses for First Quarter 2012 increased by $97,000, or 9%, to $1.2 million, or 10% of net revenue, as compared with $1.1 million, or 10% of net revenue, for First Quarter 2011. The increase was primarily related to increased payroll and consulting related expenses of $75,000.

Non-Operating Income (Loss)

Gain (Loss) on Foreign Currency Transactions. We realized a $17,000 loss on foreign currency transactions for First Quarter 2012, compared to a $38,000 loss on foreign currency transactions for First Quarter 2011 due to the changes in exchange rates between the U.S. dollar and the Euro, the Australian dollar, and the New Zealand dollar.

Interest Income. Interest income results from interest earned on our cash and equivalents balances. Interest income totaled approximately $1,000 and $0 for First Quarter 2012 and 2011, respectively.

Interest Expense. Interest expense consists primarily of interest on the financing of our business insurance premiums and interest on our term loan payable which was repaid in full in February 2011. Interest expense totaled approximately $5,000 and $73,000 for First Quarter 2012 and 2011, respectively.

Nonrecurring Charge for the Expense of Unamortized Debt-Related Costs. Unamortized debt-related costs in the amount of $225,000 were expensed in First Quarter 2011 as a result of paying off the term loan payable in February 2011.

Income Taxes. Our provision for income taxes was $29,000 for First Quarter 2012, compared to $8,000 for First Quarter 2011.

Net Loss. For the reasons stated above, our net loss was $1.7 million for First Quarter 2011 compared to a net loss of $750,000 for First Quarter 2011.

Liquidity and Capital Resources

At March 31, 2012, the Company had approximately $8.0 million in working capital. The Company’s principal sources of liquidity at March 31, 2012 consisted of $2.8 million in cash and cash equivalents and $9.0 million of net accounts receivable. We define cash and cash equivalents as highly liquid deposits with original maturities of 90 days or less when purchased. The following table summarizes our statements of cash flows (in millions):


	Three Months Ended March 31,
	2012			2011
Net cash flow provided by (used in):
Operating activities	$	(593	)	$	(5,064	)
Investing activities		(266	)		(18	)
Financing activities		277			4,943
Effect of exchange rate changes		47			77

Net change in cash and cash equivalents	$	(535	)	$	(62	)

Operating Activities

Net cash used in operating activities during First Quarter 2012 was $593,000. Cash flow from operating activities consists of net loss, adjusted for our non-cash charges, plus or minus working capital changes. Net cash provided by working capital changes totaled $268,000 for First Quarter 2012. The most significant changes in operating assets and liabilities for First Quarter 2012, as reported in our consolidated statements of cash flows, were decreases of $1.0 million in inventory, $606,000 in prepaid expenses and other assets, and $957,000 in accounts payable and accrued liabilities.

Investing Activities

Cash used in investing activities for First Quarter 2012 consisted of $266,000 of capital expenditures. For fiscal 2012, we expect capital expenditures to total approximately $1.2 million, and we expect depreciation and amortization to total approximately $700,000.

Financing Activities

Net cash provided by financing activities for First Quarter 2012 was $277,000 related to proceeds from the exercise of stock options.

Future Liquidity Needs

At March 31, 2012, we had approximately $8.0 million in working capital. Our principal sources of liquidity at March 31, 2012 consisted of $2.8 million in cash and cash equivalents and $9.0 million of net accounts receivable.

Our ability to meet our obligations in the ordinary course of business is dependent upon our ability to sell our products directly to end-users and through distributors, establish profitable operations through increased sales and decreased expenses, and obtain additional funds when needed. Management intends to seek to increase sales by increasing our product offerings, expanding our direct sales force and expanding our distributor relationships both domestically and internationally. There can be no assurance that we will be able to increase sales, reduce expenses or obtain additional financing, if necessary, at a level to meet our current obligations. As a result, the opinion we received from our independent registered public accounting firm as of and for the year ended December 31, 2011 contained an explanatory paragraph stating that there was substantial doubt regarding our ability to continue as a going concern at that time.

Our capital requirements will depend on many factors, including, among other things, the rate at which our business grows, the corresponding demands for working capital and manufacturing capacity and any acquisitions that we may pursue. From time to time, we could be required, or may otherwise attempt, to raise capital through either equity or debt offerings. We cannot provide assurance that we will enter into any such equity or debt financings in the future or that the required capital would be available on acceptable terms, if at all, or that any such financing activity would not be dilutive to our stockholders.

Contractual and Other Obligations

We lease our Irvine, California facility under a lease that expires in April 2015. In January 2011, we amended the lease to defer a portion of the basic rent to future periods.

In December 2011, the Company financed approximately $433,000 of insurance premiums payable in nine equal monthly installments of approximately $48,000 each, including a finance charge of 2.50%.

Certain members of management are entitled to severance benefits payable upon termination following a change in control, which would approximate $827,000 at March 31, 2012. The Company also has agreements with certain employees to pay bonuses based on targeted performance criteria.

The Company has an outstanding purchase obligation of $919,000 related to a purchase agreement with a supplier that is expected to be completed during the year.

Litigation and Contingencies

For more information on liabilities that may arise from litigation and contingencies, see Note 9 to the Consolidated Financial Statements in Part I, Item 1 of this Quarterly Report on Form 10-Q, which is incorporated herein by reference.

Off-Balance Sheet Arrangements

As part of our on-going business, we have not participated in transactions that generate material relationships with unconsolidated entities or financial partnerships, such as entities often referred to as structured finance or special purpose entities (“SPEs”), which would have been established for the purpose of facilitating off-balance sheet arrangements or other contractually narrow or limited purposes. As of March 31, 2012, we are not involved in any material unconsolidated SPEs.

Recent Accounting Pronouncements

For a description of recently issued and adopted accounting pronouncements, including the respective dates of adoption and expected effects on our results of operation and financial condition, please refer to Part I, Item 1, Note 2 of the Notes to Consolidated Financial Statements included in this Quarterly Report on Form 10-Q, which is incorporated herein by this reference.

Additional Information

BIOLASE^® , ZipTip^®, ezlase^®, eztips^®, MD Flow^®, Comfortpulse^®, Waterlase^®, iLase^®, iPlus^®, WCLI^®, World Clinical Laser Institute^®, Waterlase MD^®, Waterlase Dentistry^®, Proprietary MD^®, and EZLase It’s So Easy^® are registered trademarks of Biolase Technology, Inc., and Diolase™, HydroPhotonics™, LaserPal™, MD Gold™, Waterlase MD Turbo™, HydroBeam™, Occulase™, Diolase 10™, Body Contour™, Radial Firing Perio Tips™, Deep Pocket Therapy with New Attachment™, 2R™ , Intuitive Power™, Comfortprep™ , Rapidprep™ , Bondprep™ , Intuitive Power™, Occulase iPlus™, Flavorflow™, Occulase MD™, Epic Diode™, Epic Diode Laser™, Biolase Epic™, Epic Laser™, Epic™, Dermalase™, Deltalaser™, Delta™, iStarlaser™, iStar™, Biolase DaVinci Imaging™, Oculase™, Waterlase MDX™, Total Technology Solution™, Geyserlaser™, and Geyser™are trademarks of BIOLASE Technology, Inc. All other product and company names are registered trademarks or trademarks of their respective owners.

ITEM 3.

QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

For quantitative and qualitative disclosures about market risk affecting the Company, see “Quantitative and Qualitative Disclosures About Market Risk” in Item 7A of Part II of our Annual Report on Form 10-K for the fiscal year ended December 31, 2011, which is incorporated herein by reference. Our exposure to market risk has not changed materially since December 31, 2011.

ITEM 4.

CONTROLS AND PROCEDURES

Disclosure Controls and Procedures

Under the supervision and with the participation of our management, including our principal executive officer and principal financial officer, we conducted an evaluation of the effectiveness of the design and operation of our disclosure controls and procedures, as defined in Rules 13a–15(e) and 15d–15(e) under the Securities Exchange Act of 1934, as amended (the “Exchange Act”), as of the end of the period covered by this report (the “Evaluation Date”). Based on this evaluation, our principal executive officer and principal financial officer concluded as of the Evaluation Date that our disclosure controls and procedures were effective such that the information relating to the Company, including our consolidated subsidiaries, required to be disclosed in our SEC reports (i) is recorded, processed, summarized and reported within the time periods specified in SEC rules and forms, and (ii) is accumulated and communicated to the Company’s management, including our principal executive officer and principal financial officer, as appropriate to allow timely decisions regarding required disclosure.

Under the supervision and with the participation of our management, including our principal executive officer and principal financial officer, we conducted an evaluation of any changes in our internal control over financial reporting (as such term is defined in Rules 13a–15(f) and 15d–15(f) under the Exchange Act) that occurred during our most recently completed fiscal quarter. Based on that evaluation, our principal executive officer and principal financial officer concluded that there has not been any change in our internal control over financial reporting during that quarter that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.

PART II. OTHER INFORMATION

ITEM 1.

LEGAL PROCEEDINGS

For a description of our legal proceedings, please refer to Part I, Item 1, Note 9 to the Notes to the Consolidated Financial Statements included in this Quarterly Report on Form 10-Q, which is incorporated herein by reference in response to this Item.

ITEM 1A.

RISK FACTORS

There have been no material changes to the risk factors as disclosed in Part I, Item 1A “Risk Factors” in our Annual Report on Form 10-K for the fiscal year ended December 31, 2011.

ITEM 2.

UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS

None.

ITEM 3.

DEFAULTS UPON SENIOR SECURITIES

None.

ITEM 4.

MINE SAFETY DISCLOSURES

Not applicable.

ITEM 5.

OTHER INFORMATION

None.

ITEM 6.

EXHIBITS

The exhibits listed below are hereby filed with the SEC as part of this Quarterly Report on Form 10-Q. Certain of the following exhibits have been previously filed with the SEC pursuant to the requirements of the Securities Act or the Exchange Act. Such exhibits are identified in the chart to the right of the Exhibit and are incorporated herein by reference.

Incorporated by Reference

Exhibit

Description

Filed

Herewith

Form

Period

Ending/Date

of Report

Exhibit

Filing

Date

3.1.1

Restated Certificate of Incorporation, including, (i) Certificate of Designations, Preferences and Rights of 6% Redeemable Cumulative Convertible Preferred Stock of the Registrant; (ii) Certificate of Designations, Preferences and Rights of Series A 6% Redeemable Cumulative Convertible Preferred Stock of The Registrant; (iii) Certificate of Correction Filed to Correct a Certain Error in the Certificate of Designation of The Registrant; and (iv) Certificate of Designations of Series B Junior Participating Cumulative Preferred Stock of the Registrant.

S-1,

Amendment

No. 1

12/23/2005

3.1

12/23/2005

3.1.2

Fifth Amended and Restated Bylaws of The Registrant, adopted on July 1, 2010

8-K

07/02/2010

3.1

07/07/2010

10.4

Form of Securities Purchase Agreement, dated April 7, 2011, by and between the Registrant and the investors’ signatory thereto.

8-K

04/07/2011

10.4

04/12/2011

10.32

Settlement Agreement, dated February 22, 2012, by and between Biolase Technology, Inc. and Henry Schein, Inc.

10-K

12/31/2011

10.32

03/13/2012

31.1

Certification of Chief Executive Officer pursuant to Rule 13a-14 and Rule 15d-14(a) of the Securities Exchange Act of 1934, as amended

31.2

Certification of Chief Financial Officer pursuant to Rule 13a-14 and Rule 15d-14(a) of the Securities Exchange Act of 1934, as amended

32.1

Certification of Chief Executive Officer pursuant to 18 U.S.C. 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002

32.2

Certification of Chief Financial Officer pursuant to 18 U.S.C. 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002

101

The following unaudited financial information from the Company’s Quarterly Report on Form 10-Q, for the period ended March 31, 2012, formatted in XBRL (Extensible Business Reporting Language): (i) Consolidated Balance Sheets, (ii) Consolidated Statements of Comprehensive Loss, (iii) Consolidated Statements of Cash Flows, (iv) Notes to Consolidated Financial Statements

SIGNATURES

Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

Date: May 10, 2012


BIOLASE TECHNOLOGY, INC., a Delaware Corporation (registrant)

By:		/s/ FEDERICO PIGNATELLI
		Federico Pignatelli
		Chief Executive Officer (Principal Executive Officer)

By:		/s/ FREDERICK D. FURRY
		Frederick D. Furry
		Chief Financial Officer (Principal Financial and Accounting Officer)

EX-31.1 2 d342348dex311.htm EX-31.1 EX-31.1

Exhibit 31.1

CERTIFICATION OF THE CHIEF EXECUTIVE OFFICER

PURSUANT TO SECTION 302 OF

THE SARBANES-OXLEY ACT OF 2002

I, Federico Pignatelli, certify that:

1. I have reviewed this quarterly report on Form 10-Q for the period ended March 31, 2012 of BIOLASE Technology, Inc.;

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4. The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation;

Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting;

5. The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s Board of Directors (or persons performing the equivalent functions):

All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.


Date: May 10, 2012	By:	/s/ FEDERICO PIGNATELLI
		Federico Pignatelli
		Chief Executive Officer (Principal Executive Officer)

EX-31.2 3 d342348dex312.htm EX-31.2 EX-31.2

Exhibit 31.2

CERTIFICATION OF THE CHIEF FINANCIAL OFFICER

PURSUANT TO SECTION 302 OF

THE SARBANES-OXLEY ACT OF 2002

I, Frederick D. Furry, certify that:

1. I have reviewed this quarterly report on Form 10-Q for the period ended March 31, 2012 of BIOLASE Technology, Inc.;

Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.


Date: May 10, 2012	By:	/s/ FREDERICK D. FURRY
		Frederick D. Furry
		Chief Financial Officer (Principal Financial and Accounting Officer)

EX-32.1 4 d342348dex321.htm EX-32.1 EX-32.1

Exhibit 32.1

CERTIFICATION OF THE CHIEF EXECUTIVE OFFICER

PURSUANT TO 18 U.S.C. SECTION 1350

AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report of BIOLASE Technology, Inc. (the “Company”) on Form 10-Q for the quarter ended March 31, 2012, as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Federico Pignatelli, Chief Executive Officer of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that, to the best of my knowledge:

(i) the Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934, and

(ii) the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.


Date: May 10, 2012		/s/ FEDERICO PIGNATELLI
		Federico Pignatelli
		Chief Executive Officer (Principal Executive Officer)

EX-32.2 5 d342348dex322.htm EX-32.2 EX-32.2

Exhibit 32.2

CERTIFICATION OF THE CHIEF FINANCIAL OFFICER

PURSUANT TO 18 U.S.C. SECTION 1350

AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report of BIOLASE Technology, Inc. (the “Company”) on Form 10-Q for the quarter ended March 31, 2012, as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Frederick D. Furry, Chief Financial Officer of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that, to the best of my knowledge:

(i) the Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934, and

(ii) the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.


Date: May 10, 2012		/s/ FREDERICK D. FURRY
		Frederick D. Furry
		Chief Financial Officer (Principal Financial and Accounting Officer)

EX-101.INS 6 blti-20120331.xml XBRL INSTANCE DOCUMENT 0000811240 2012-05-04 0000811240 2012-03-31 0000811240 2011-12-31 0000811240 2012-01-01 2012-03-31 0000811240 2011-01-01 2011-03-31 0000811240 2010-12-31 0000811240 2011-03-31 iso4217:USD xbrli:shares xbrli:shares iso4217:USD BIOLASE TECHNOLOGY INC 0000811240 --12-31 Accelerated Filer 10-Q false 2012-03-31 Q1 2012 30879524

2772000

3307000

8983000

8899000

305000

289000

10337000

11312000

1163000

1808000

23255000

25326000

1338000

1148000

179000

212000

2926000

8000

187000

27893000

29807000

7524000

7804000

5442000

6177000

20000

165000

2232000

2136000

15218000

16282000

612000

594000

17000

25000

139000

337000

15986000

17238000

0.001

1000000

0.001

1000000

33000

0.001

50000000

32769000

32502000

30805000

30538000

139454000

138507000

-297000

-360000

-110884000

-109212000

28306000 28968000

16399000

1964000

11907000

12569000

27893000

29807000

12312000 10546000 8000 15000

12320000

10561000

6513000

5722000

5807000

4839000

4028000

2453000

2211000

1699000

1190000

1093000

7429000

5245000

-1622000

-406000

-17000

-38000

1000

5000

73000

225000

-21000

-336000

-1643000

-742000

29000

8000

-1672000

-750000

63000

114000

-1609000

-636000

-0.05

-0.03

-0.05

-0.03

30721000

27343000

30721000

27343000

125000

228000

-7000

-16000

-10000

78000

99000

583000

220000

25000 96000

-62000

-61000

-1000

100000

2645000

-975000

191000

-606000

-212000

-145000

-2923000

-957000

431000

-111000

4000

-593000

-5064000

266000

18000

-266000

-18000

2700000

7049000

277000

594000

277000

4943000

47000

77000

-535000

-62000

1694000

1632000

3000

73000

21000

8000

NOTE 1 – BASIS OF PRESENTATION The Company BIOLASE Technology Inc., (the “Company”) incorporated in Delaware in 1987, is a medical technology company operating in one business segment that develops, manufactures, and markets lasers, and markets and distributes dental imaging equipment and other products designed to improve technologies for applications and procedures in dentistry and medicine. Basis of Presentation The unaudited consolidated financial statements include the accounts of BIOLASE Technology, Inc. and its consolidated subsidiaries and have been prepared on a basis consistent with the December 31, 2011 audited consolidated financial statements and include all material adjustments, consisting of normal recurring adjustments and the elimination of all material intercompany transactions and balances, necessary to fairly present the information set forth therein. These unaudited, interim, consolidated financial statements do not include all the footnotes, presentations and disclosures normally required by accounting principles generally accepted in the United States of America (“GAAP”) for complete consolidated financial statements. Certain amounts have been reclassified to conform to current period presentations. Use of Estimates The preparation of these consolidated financial statements in conformity with GAAP requires the Company to make estimates and assumptions that affect amounts reported in the consolidated financial statements and the accompanying notes. Significant estimates in these consolidated financial statements include allowances on accounts receivable, inventory and deferred taxes, as well as estimates for accrued warranty expenses, indefinite-lived intangible assets and the ability of goodwill to be realized, revenue deferrals for multiple element arrangements, effects of stock-based compensation and warrants, contingent liabilities and the provision or benefit for income taxes. Due to the inherent uncertainty involved in making estimates, actual results reported in future periods may differ materially from those estimates. Critical Accounting Policies Information with respect to the Company’s critical accounting policies which management believes could have the most significant effect on the Company’s reported results and require subjective or complex judgments by management is contained on pages 41 to 43 in Item 7, Management’s Discussion and Analysis of Financial Condition and Results of Operations, of the Company’s Annual Report on Form 10-K for the year ended December 31, 2011 (“2011 Form 10-K”). Management believes that there have been no significant changes during the three months ended March 31, 2012 in the Company’s critical accounting policies from those disclosed in Item 7 of on the Company’s 2011 Form 10-K. Fair Value of Financial Instruments The Company’s financial instruments, consisting of cash and cash equivalents, accounts receivable, accounts payable and other accrued expenses, approximate fair value because of the short maturity of these items. Liquidity and Management’s Plans The Company has suffered recurring losses from operations during the three years ended December 31, 2011. Although the Company’s revenues increased during the quarter ended March 31, 2012 compared to the same period in 2011, the Company still incurred a loss from operations and a net loss. At March 31, 2012, the Company had approximately $8.0 million in working capital. The Company’s principal sources of liquidity at March 31, 2012 consisted of approximately $2.8 million in cash and cash equivalents and $9.0 million of net accounts receivable. The Company’s ability to meet its obligations in the ordinary course of business is dependent upon its ability to sell its products directly to end-users and through distributors, establish profitable operations through increased sales and decreased expenses, and obtain additional funds when needed. Management intends to increase sales by increasing the Company’s product offerings, expanding its direct sales force, and expanding its distributor relationships both domestically and internationally.   There can be no assurance that the Company will be able to increase sales, reduce expenses, or obtain additional financing, if necessary, at a level to meet its current obligations. As a result, the report of the Company’s independent registered public accounting firm on its consolidated financial statements for the year ended December 31, 2011 contained an explanatory paragraph stating that there is a substantial doubt regarding the Company’s ability to continue as a going concern. The accompanying consolidated financial statements have been prepared on a going concern basis that contemplates the realization of assets and the satisfaction of liabilities in the normal course of business. The consolidated financial statements do not include adjustments relating to the recoverability of recorded asset amounts or the amounts or classification of liabilities that might be necessary should we be unable to continue as a going concern. From time to time, the Company may attempt to raise capital through either equity or debt offerings. The Company’s capital requirements will depend on many factors, including, among other things, the effects of any acquisitions it may pursue as well as the rate at which its business grows, with corresponding demands for working capital and manufacturing capacity. The Company could be required, or may elect, to seek additional funding through public or private equity or debt financing. However, a credit facility, or additional funds through public or private equity or other debt financing, may not be available on terms acceptable to the Company or at all, or that any such financing activity would not be dilutive to its stockholders. Without additional funds and/or increased revenues, the Company may not have enough cash or financial resources to operate for the next twelve months. On February 22, 2012, the Company entered into a definitive termination agreement (the “2012 Termination Agreement”) with Henry Schein, Inc. (“HSIC”), a leading U.S. dental product and equipment distributor and the Company’s former exclusive distributor in North America. The 2012 Termination Agreement, which was completed on April 12, 2012 (subsequent to the quarter ended March 31, 2012), terminated and superseded all prior agreements with HSIC. Pursuant to the 2012 Termination Agreement, the Company purchased HSIC’s inventory of Waterlase MD Turbo laser systems and HSIC released its liens on the Company’s assets. The Company paid the entire purchase price by offsetting accounts receivable currently due from HSIC from sales made in the normal course of business. None of the funds used to offset the purchase price were related to the original sales of the MD Turbo laser systems that were purchased. The Company expects to use the purchased equipment as a source of parts to service its installed base of approximately 6,500 Waterlase MD Turbo laser systems and for its newly released Waterlase MDX line of all-tissue lasers, as well as for use in dental schools to promote the Company’s Waterlase technology. See Note 13 – Subsequent Events for further discussion.

NOTE 2 – RECENT ACCOUNTING PRONOUNCEMENTS Changes to U.S. GAAP are established by the Financial Accounting Standards Board (“FASB”) in the form of accounting standards updates (“ASU’s”) to the FASB’s Accounting Standards Codification (“ASC”). The Company considers the applicability and impact of all ASU’s. ASU’s not listed below were assessed and determined to not be applicable or are expected to have minimal impact on our consolidated financial position and results of operations. Newly Adopted Accounting Standards In September 2011, the FASB issued guidance for the impairment testing of goodwill. The guidance permits an entity to first assess qualitative factors to determine whether it is more-likely-than-not that the fair value of a reporting unit is less than its carrying amount as a basis for determining whether it is necessary to perform the two-step goodwill impairment test. This guidance is effective for annual and interim goodwill impairment tests performed for fiscal years beginning after December 15, 2011. The Company adopted this guidance effective January 1, 2012. The adoption did not have a material impact on the Company’s consolidated financial statements. In June 2011, the FASB updated the accounting guidance relating to presentation of comprehensive income. This guidance requires companies to present total comprehensive income, the components of net income, and the components of other comprehensive income (“OCI”) either in a single continuous statement of comprehensive income or in two, but consecutive, statements. Additionally, companies are required to present on the face of the consolidated financial statements the reclassification adjustments that are reclassified from OCI to net income, where the components of net income and the components of OCI are presented. This guidance is effective for fiscal years and interim periods within those years beginning after December 15, 2011, and requires retrospective application to all periods presented. The Company adopted this guidance effective January 1, 2012 and elected to present a single continuous statement of comprehensive loss. The adoption did not have a material impact on the Company’s consolidated financial statements.

NOTE 3 – STOCK-BASED AWARDS AND PER SHARE INFORMATION Stock-Based Compensation The Company currently has one stock-based compensation plan, the 2002 Stock Incentive Plan (the “2002 Plan”). Eligible persons under the 2002 Plan include certain officers and employees of the Company and directors of the Company. Under the 2002 Plan, 6,950,000 shares of common stock have been authorized for issuance. As of March 31, 2012, 2,393,000 shares of common stock have been issued pursuant to options that were exercised, 3,746,000 shares of common stock have been reserved for options that are outstanding, and 811,000 shares of common stock remain available for future grant. Compensation cost related to stock options recognized in operating results during the three months ended March 31, 2012 and 2011, totaled approximately $583,000 and $220,000, respectively. The net impact to earnings for the periods ended March 31, 2012 and 2011 was $(0.02) and $(0.01) per basic and diluted share, respectively. At March 31, 2012, the Company had approximately $2.1 million of total unrecognized compensation cost, net of estimated forfeitures, related to unvested share-based compensation arrangements granted under our existing plans. The Company expects that cost to be recognized over a weighted-average period of 1.2 years. The following table summarizes the income statement classification of compensation expense associated with share-based payments (in thousands):   <table cellspacing="0" cellpadding="0" width="76%" border="0" style="border-collapse:collapse; text-align: left" align="center">  <tr> <td width="84%"> </td> <td valign="bottom" width="5%"> </td> <td> </td> <td> </td> <td> </td> <td valign="bottom" width="5%"> </td> <td> </td> <td> </td> <td> </td> </tr> <tr> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" colspan="6" align="center" style="border-bottom:1px solid #000000">Three Months Ended March 31,</td> <td valign="bottom"> </td> </tr> <tr> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" colspan="2" align="center" style="border-bottom:1px solid #000000">2012</td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" colspan="2" align="center" style="border-bottom:1px solid #000000">2011</td> <td valign="bottom"> </td> </tr>   <tr bgcolor="#cceeff"> <td valign="top"> Cost of revenue </td> <td valign="bottom"> </td> <td valign="bottom">$</td> <td valign="bottom" align="right">58</td> <td nowrap="nowrap" valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom">$</td> <td valign="bottom" align="right">30</td> <td nowrap="nowrap" valign="bottom"> </td> </tr> <tr> <td valign="top"> Sales and marketing </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">121</td> <td nowrap="nowrap" valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">85</td> <td nowrap="nowrap" valign="bottom"> </td> </tr> <tr bgcolor="#cceeff"> <td valign="top"> General and administrative </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">358</td> <td nowrap="nowrap" valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">85</td> <td nowrap="nowrap" valign="bottom"> </td> </tr> <tr> <td valign="top"> Engineering and development </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">46</td> <td nowrap="nowrap" valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">20</td> <td nowrap="nowrap" valign="bottom"> </td> </tr> <tr style="font-size:1px"> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> </tr> <tr bgcolor="#cceeff"> <td valign="top"> </td> <td valign="bottom"> </td> <td valign="bottom">$</td> <td valign="bottom" align="right">583</td> <td nowrap="nowrap" valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom">$</td> <td valign="bottom" align="right">220</td> <td nowrap="nowrap" valign="bottom"> </td> </tr> <tr style="font-size:1px"> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> </tr>  </table> The Black-Scholes option valuation model is used in estimating the fair value of traded options. This option pricing model requires the Company to make several assumptions regarding the key variables used to calculate the fair value of its stock options. The risk-free interest rate used is based on the U.S. Treasury yield curve in effect for the expected lives of the options at their dates of grant. Since July 1, 2005, the Company has used a dividend yield of zero as it does not intend to pay cash dividends on its common stock in the foreseeable future. The most critical assumption used in calculating the fair value of stock options is the expected volatility of the common stock. Management believes that the historic volatility of the common stock is a reliable indicator of future volatility, and accordingly, a stock volatility factor based on the historical volatility of the common stock over a period of time is used in approximating the estimated lives of new stock options. The expected term is estimated by analyzing the Company’s historical share option exercise experience over a five year period. Compensation expense is recognized using the straight-line method for all stock-based awards. Compensation expense is recognized only for those options expected to vest, with forfeitures estimated at the date of grant based on historical experience and future expectations. Forfeitures are estimated at the time of the grant and revised as necessary in subsequent periods if actual forfeitures differ from those estimates.   The stock option fair values were estimated using the Black-Scholes option-pricing model with the following assumptions:   <table cellspacing="0" cellpadding="0" width="76%" border="0" style="border-collapse:collapse; text-align: left" align="center">  <tr> <td width="78%"> </td> <td valign="bottom" width="5%"> </td> <td> </td> <td valign="bottom" width="5%"> </td> <td> </td> </tr> <tr> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" colspan="3" align="center" style="border-bottom:1px solid #000000">Three Months Ended March 31,</td> </tr> <tr> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="center" style="border-bottom:1px solid #000000">2012</td> <td valign="bottom"> </td> <td valign="bottom" align="center" style="border-bottom:1px solid #000000">2011</td> </tr>   <tr bgcolor="#cceeff"> <td valign="top"> Expected term </td> <td valign="bottom"> </td> <td valign="bottom" align="center">4.1 years</td> <td valign="bottom"> </td> <td valign="bottom" align="center">4.2 years</td> </tr> <tr> <td valign="top"> Volatility </td> <td valign="bottom"> </td> <td valign="bottom" align="center">102%</td> <td valign="bottom"> </td> <td valign="bottom" align="center">103%</td> </tr> <tr bgcolor="#cceeff"> <td valign="top"> Annual dividend per share </td> <td valign="bottom"> </td> <td valign="bottom" align="center">$0.00</td> <td valign="bottom"> </td> <td valign="bottom" align="center">$0.00</td> </tr> <tr> <td valign="top"> Risk-free interest rate </td> <td valign="bottom"> </td> <td valign="bottom" align="center">0.93%</td> <td valign="bottom"> </td> <td valign="bottom" align="center">2.18%</td> </tr>  </table> A summary of option activity under our stock option plans for the three months ended March 31, 2012 is as follows:   <table cellspacing="0" cellpadding="0" width="100%" border="0" style="border-collapse:collapse; text-align: left" align="center">  <tr> <td width="60%"> </td> <td valign="bottom" width="5%"> </td> <td> </td> <td> </td> <td> </td> <td valign="bottom" width="5%"> </td> <td> </td> <td> </td> <td> </td> <td valign="bottom" width="5%"> </td> <td> </td> <td> </td> <td> </td> <td valign="bottom" width="5%"> </td> <td> </td> <td> </td> <td> </td> </tr> <tr> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" colspan="2" align="center" style="border-bottom:1px solid #000000">Shares</td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" colspan="2" align="center" style="border-bottom:1px solid #000000">Weighted average exercise price</td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" colspan="2" align="center" style="border-bottom:1px solid #000000">Weighted average remaining contractual term (years)</td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" colspan="2" align="center" style="border-bottom:1px solid #000000">Aggregate intrinsic value(1)</td> <td valign="bottom"> </td> </tr>   <tr bgcolor="#cceeff"> <td valign="top"> Options outstanding at December 31, 2011 </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">3,858,000</td> <td nowrap="nowrap" valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom">$</td> <td valign="bottom" align="right">3.75</td> <td nowrap="nowrap" valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom"> </td> </tr> <tr> <td valign="top"> Plus: Options granted </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">134,000</td> <td nowrap="nowrap" valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom">$</td> <td valign="bottom" align="right">2.82</td> <td nowrap="nowrap" valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom"> </td> </tr> <tr bgcolor="#cceeff"> <td valign="top"> Less: Options exercised </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">(109,000</td> <td nowrap="nowrap" valign="bottom">) </td> <td valign="bottom"> </td> <td valign="bottom">$</td> <td valign="bottom" align="right">2.53</td> <td nowrap="nowrap" valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom"> </td> </tr> <tr> <td valign="top"> Options forfeited, canceled, or expired </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">(137,000</td> <td nowrap="nowrap" valign="bottom">) </td> <td valign="bottom"> </td> <td valign="bottom">$</td> <td valign="bottom" align="right">2.59</td> <td nowrap="nowrap" valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom"> </td> </tr> <tr style="font-size:1px"> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom"> </td> </tr> <tr bgcolor="#cceeff"> <td valign="top"> Options outstanding at March 31, 2012 </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">3,746,000</td> <td nowrap="nowrap" valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom">$</td> <td valign="bottom" align="right">3.79</td> <td nowrap="nowrap" valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">4.25</td> <td nowrap="nowrap" valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom">$</td> <td valign="bottom" align="right">1,539,000</td> <td nowrap="nowrap" valign="bottom"> </td> </tr> <tr style="font-size:1px"> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom"> </td> </tr> <tr> <td valign="top"> Options exercisable at March 31, 2012 </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">2,250,000</td> <td nowrap="nowrap" valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom">$</td> <td valign="bottom" align="right">4.35</td> <td nowrap="nowrap" valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">4.26</td> <td nowrap="nowrap" valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom">$</td> <td valign="bottom" align="right">1,015,000</td> <td nowrap="nowrap" valign="bottom"> </td> </tr> <tr style="font-size:1px"> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom"> </td> </tr> <tr bgcolor="#cceeff"> <td valign="top"> Vested options expired during the quarter ended March 31, 2012 </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">1,000</td> <td nowrap="nowrap" valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom">$</td> <td valign="bottom" align="right">8.46</td> <td nowrap="nowrap" valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom"> </td> </tr>  </table>   <table style="border-collapse:collapse; text-align: left" border="0" cellpadding="0" cellspacing="0" width="100%"> <tr> <td width="4%" valign="top" align="left">(1)</td> <td align="left" valign="top">The intrinsic value calculation does not include negative values. This can occur when the fair market value on the reporting date is less than the exercise price of the grant. </td> </tr> </table> Cash proceeds along with fair value disclosures related to grants, exercises and vesting options are provided in the following table (in thousands, except per share amounts):   <table cellspacing="0" cellpadding="0" width="76%" border="0" style="border-collapse:collapse; text-align: left" align="center">  <tr> <td width="84%"> </td> <td valign="bottom" width="5%"> </td> <td> </td> <td> </td> <td> </td> <td valign="bottom" width="5%"> </td> <td> </td> <td> </td> <td> </td> </tr> <tr> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" colspan="6" align="center" style="border-bottom:1px solid #000000">Three Months Ended March 31,</td> <td valign="bottom"> </td> </tr> <tr> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" colspan="2" align="center" style="border-bottom:1px solid #000000">2012</td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" colspan="2" align="center" style="border-bottom:1px solid #000000">2011</td> <td valign="bottom"> </td> </tr>   <tr bgcolor="#cceeff"> <td valign="top"> Proceeds from stock options exercised </td> <td valign="bottom"> </td> <td valign="bottom">$</td> <td valign="bottom" align="right">277</td> <td nowrap="nowrap" valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom">$</td> <td valign="bottom" align="right">594</td> <td nowrap="nowrap" valign="bottom"> </td> </tr> <tr> <td valign="top"> Tax benefit related to stock options exercised (1) </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">N/A</td> <td nowrap="nowrap" valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">N/A</td> <td nowrap="nowrap" valign="bottom"> </td> </tr> <tr bgcolor="#cceeff"> <td valign="top"> Intrinsic value of stock options exercised (2) </td> <td valign="bottom"> </td> <td valign="bottom">$</td> <td valign="bottom" align="right">11</td> <td nowrap="nowrap" valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom">$</td> <td valign="bottom" align="right">609</td> <td nowrap="nowrap" valign="bottom"> </td> </tr> <tr> <td valign="top"> Weighted-average fair value of options granted during period </td> <td valign="bottom"> </td> <td valign="bottom">$</td> <td valign="bottom" align="right">1.99</td> <td nowrap="nowrap" valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom">$</td> <td valign="bottom" align="right">2.39</td> <td nowrap="nowrap" valign="bottom"> </td> </tr> <tr bgcolor="#cceeff"> <td valign="top"> Total fair value of shares vested during the period </td> <td valign="bottom"> </td> <td valign="bottom">$</td> <td valign="bottom" align="right">557</td> <td nowrap="nowrap" valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom">$</td> <td valign="bottom" align="right">199</td> <td nowrap="nowrap" valign="bottom"> </td> </tr>  </table>   <table style="border-collapse:collapse; text-align: left" border="0" cellpadding="0" cellspacing="0" width="100%"> <tr> <td width="4%" valign="top" align="left">(1)</td> <td align="left" valign="top">Excess tax benefits received related to stock option exercises are presented as financing cash inflows. We currently do not receive a tax benefit related to the exercise of stock options due to our net operating losses. </td> </tr> </table> <table style="border-collapse:collapse; text-align: left" border="0" cellpadding="0" cellspacing="0" width="100%"> <tr> <td width="4%" valign="top" align="left">(2)</td> <td align="left" valign="top">The intrinsic value of stock options exercised is the amount by which the market price of the stock on the date of exercise exceeded the market price of the stock on the date of grant. </td> </tr> </table> On March 2, 2012, the Board of Directors accelerated the vesting period for options to purchase 95,833 shares of common stock held by Federico Pignatelli, the Company’s Chairman and Chief Executive Officer (“CEO”). The options were originally granted in December 2011 at $2.58 per share with monthly vesting over four years. The Board of Directors accelerated the vesting period to March 2, 2012, in part due to the CEO’s continued commitment to maintain his annual salary of one dollar for the year ending December 31, 2012. Accelerating the vesting period of the common stock options resulted in the Company recognizing unamortized compensation cost of approximately $183,000 during March 2012. The transaction did not result in any additional compensation cost primarily as the effects of the decrease in the expected term and volatility offset the effects of the difference between the stock price and the option price on the date the vesting of the common stock options were modified.   Net Loss Per Share – Basic and Diluted Basic net loss per share is computed by dividing loss available to common stockholders by the weighted-average number of common shares outstanding for the period. In computing diluted net loss per share, the weighted average number of shares outstanding is adjusted to reflect the effect of potentially dilutive securities. Outstanding stock options and warrants to purchase 4,514,000 shares were not included in the computation of diluted loss per share for the three months ended March 31, 2012 as a result of their anti-dilutive effect. The Company intends to pay a 2% annual stock dividend, in quarterly installments, for the year ending December 31, 2012. Stock dividends are discussed quarterly by the Company’s Board of Directors and management. The actual declaration of future stock dividends and the establishment of the record and payment dates are subject to final determination by the Company’s Board of Directors after its review of the Company’s financial performance, the expected results of future operations, availability of shares, and other factors that the Board of Directors may deem relevant. The Company’s dividend policy may be changed at any time by the Company’s Board of Directors, and there is no assurance, with respect to the amount or frequency, that any stock dividend will be declared in the future. In March 2012, the Board of Directors declared a one-half percent stock dividend (the “March Stock Dividend”) payable March 30, 2012 to stockholders of record on March 15, 2012. The March Stock Dividend was deemed to be a special dividend. All stock information presented, other than that related to stock options and warrants, has been adjusted to reflect the effects of the March Stock Dividend. Warrants During September 2010, the Company issued warrants (the “IR Warrants”) to purchase an aggregate of 50,000 shares of common stock at a price per share of $0.74 to three service providers who provide investor relations services. The IR Warrants vest quarterly and will be revalued each period until the final vesting date. The holders may convert the IR Warrants into a number of shares, in whole or in part. The first tranche of IR Warrants expire on September 20, 2013. Pursuant to the agreement, the service providers were also entitled to a second tranche of IR Warrants to purchase an aggregate of 50,000 shares of common stock at a price per share of $0.74 as a performance bonus when the Company’s stock price closes at a price in excess of $6.00. The second tranche of IR Warrants were subsequently issued in April 2011 and will expire on April 11, 2014. The Company accounts for these non-employee stock warrants using the Black Scholes option pricing model. The Company has concluded that the vesting date is the ultimate final measurement date, and will revalue any unvested warrants at the end of each reporting period until that date. The Company recognized $25,000 and $96,000 of expense related to the IR Warrants, including the estimated cost associated with the second tranche of IR Warrants, during the quarters ended March 31, 2012 and 2011, respectively.

NOTE 4 – INVENTORY Inventory is valued at the lower of cost or market (determined by the first-in, first-out method) and is comprised of the following (in thousands):   <table cellspacing="0" cellpadding="0" width="76%" border="0" style="border-collapse:collapse; text-align: left" align="center">  <tr> <td width="76%"> </td> <td valign="bottom" width="6%"> </td> <td> </td> <td> </td> <td> </td> <td valign="bottom" width="6%"> </td> <td> </td> <td> </td> <td> </td> </tr> <tr> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" colspan="2" align="center" style="border-bottom:1px solid #000000">March 31, 2012</td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" colspan="2" align="center" style="border-bottom:1px solid #000000">December 31, 2011</td> <td valign="bottom"> </td> </tr>   <tr bgcolor="#cceeff"> <td valign="top"> Raw materials </td> <td valign="bottom"> </td> <td valign="bottom">$</td> <td valign="bottom" align="right">3,756</td> <td nowrap="nowrap" valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom">$</td> <td valign="bottom" align="right">4,280</td> <td nowrap="nowrap" valign="bottom"> </td> </tr> <tr> <td valign="top"> Work-in-process </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">2,115</td> <td nowrap="nowrap" valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">2,538</td> <td nowrap="nowrap" valign="bottom"> </td> </tr> <tr bgcolor="#cceeff"> <td valign="top"> Finished goods </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">4,466</td> <td nowrap="nowrap" valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">4,494</td> <td nowrap="nowrap" valign="bottom"> </td> </tr> <tr style="font-size:1px"> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> </tr> <tr> <td valign="top"> Inventory, net </td> <td valign="bottom"> </td> <td valign="bottom">$</td> <td valign="bottom" align="right">10,337</td> <td nowrap="nowrap" valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom">$</td> <td valign="bottom" align="right">11,312</td> <td nowrap="nowrap" valign="bottom"> </td> </tr> <tr style="font-size:1px"> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> </tr>  </table> Inventory is net of the provision for excess and obsolete inventory totaling $2.1 million and $2.3 million as of March 31, 2012 and December 31, 2011, respectively.

NOTE 5 – PROPERTY, PLANT AND EQUIPMENT Property, plant and equipment, net is comprised of the following (in thousands):   <table cellspacing="0" cellpadding="0" width="76%" border="0" style="border-collapse:collapse; text-align: left" align="center">  <tr> <td width="76%"> </td> <td valign="bottom" width="8%"> </td> <td> </td> <td> </td> <td> </td> <td valign="bottom" width="8%"> </td> <td> </td> <td> </td> <td> </td> </tr> <tr> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" colspan="2" align="center" style="border-bottom:1px solid #000000">March 31, 2012</td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" colspan="2" align="center" style="border-bottom:1px solid #000000">December 31, 2011</td> <td valign="bottom"> </td> </tr>   <tr bgcolor="#cceeff"> <td valign="top"> Land </td> <td valign="bottom"> </td> <td valign="bottom">$</td> <td valign="bottom" align="right">254</td> <td nowrap="nowrap" valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom">$</td> <td valign="bottom" align="right">247</td> <td nowrap="nowrap" valign="bottom"> </td> </tr> <tr> <td valign="top"> Building </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">326</td> <td nowrap="nowrap" valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">317</td> <td nowrap="nowrap" valign="bottom"> </td> </tr> <tr bgcolor="#cceeff"> <td valign="top"> Leasehold improvements </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">957</td> <td nowrap="nowrap" valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">957</td> <td nowrap="nowrap" valign="bottom"> </td> </tr> <tr> <td valign="top"> Equipment and computers </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">5,849</td> <td nowrap="nowrap" valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">5,729</td> <td nowrap="nowrap" valign="bottom"> </td> </tr> <tr bgcolor="#cceeff"> <td valign="top"> Furniture and fixtures </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">1,042</td> <td nowrap="nowrap" valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">1,036</td> <td nowrap="nowrap" valign="bottom"> </td> </tr> <tr> <td valign="top"> Construction in progress </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">169</td> <td nowrap="nowrap" valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">26</td> <td nowrap="nowrap" valign="bottom"> </td> </tr> <tr style="font-size:1px"> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> </tr> <tr bgcolor="#cceeff"> <td valign="top"> </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">8,597</td> <td nowrap="nowrap" valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">8,312</td> <td nowrap="nowrap" valign="bottom"> </td> </tr> <tr> <td valign="top"> Accumulated depreciation and amortization </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">(7,259</td> <td nowrap="nowrap" valign="bottom">) </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">(7,164</td> <td nowrap="nowrap" valign="bottom">) </td> </tr> <tr style="font-size:1px"> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> </tr> <tr bgcolor="#cceeff"> <td valign="top"> Property, plant and equipment, net </td> <td valign="bottom"> </td> <td valign="bottom">$</td> <td valign="bottom" align="right">1,338</td> <td nowrap="nowrap" valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom">$</td> <td valign="bottom" align="right">1,148</td> <td nowrap="nowrap" valign="bottom"> </td> </tr> <tr style="font-size:1px"> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> </tr>  </table> Depreciation and amortization expense related to property, plant, and equipment totaled $92,000 and $195,000 for the three months ended March 31, 2012 and 2011, respectively.

NOTE 6 – INTANGIBLE ASSETS AND GOODWILL The Company conducted its annual impairment test of intangible assets and goodwill as of June 30, 2011, and determined that there was no impairment. The Company also tests its intangible assets and goodwill between the annual impairment test if events occur or circumstances change that would more likely than not reduce the fair value of the Company or its assets below their carrying amounts. No events have occurred since June 30, 2011, that would trigger further impairment testing of the Company’s intangible assets and goodwill. Amortization expense for the three months ended March 31, 2012 and March 31, 2011 totaled $33,000 and $33,000, respectively. Other intangible assets consist of an acquired customer list and a non-compete agreement. The following table presents details of the Company’s intangible assets, related accumulated amortization and goodwill (in thousands):   <table cellspacing="0" cellpadding="0" width="100%" border="0" style="border-collapse:collapse; text-align: left" align="center">  <tr> <td width="48%"> </td> <td valign="bottom" width="2%"> </td> <td> </td> <td> </td> <td> </td> <td valign="bottom" width="2%"> </td> <td> </td> <td> </td> <td> </td> <td valign="bottom" width="2%"> </td> <td> </td> <td> </td> <td> </td> <td valign="bottom" width="2%"> </td> <td> </td> <td> </td> <td> </td> <td valign="bottom" width="2%"> </td> <td> </td> <td> </td> <td> </td> <td valign="bottom" width="2%"> </td> <td> </td> <td> </td> <td> </td> <td valign="bottom" width="2%"> </td> <td> </td> <td> </td> <td> </td> <td valign="bottom" width="2%"> </td> <td> </td> <td> </td> <td> </td> </tr> <tr> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" colspan="14" align="center" style="border-bottom:1px solid #000000">As of March 31, 2012</td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" colspan="14" align="center" style="border-bottom:1px solid #000000">As of December 31, 2011</td> <td valign="bottom"> </td> </tr> <tr> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" colspan="2" align="center" style="border-bottom:1px solid #000000">Gross</td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" colspan="2" align="center" style="border-bottom:1px solid #000000">Accumulated Amortization</td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" colspan="2" align="center" style="border-bottom:1px solid #000000">Impairment</td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" colspan="2" align="center" style="border-bottom:1px solid #000000">Net</td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" colspan="2" align="center" style="border-bottom:1px solid #000000">Gross</td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" colspan="2" align="center" style="border-bottom:1px solid #000000">Accumulated Amortization</td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" colspan="2" align="center" style="border-bottom:1px solid #000000">Impairment</td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" colspan="2" align="center" style="border-bottom:1px solid #000000">Net</td> <td valign="bottom"> </td> </tr>   <tr bgcolor="#cceeff"> <td valign="top"> Patents (4-10 years) </td> <td valign="bottom"> </td> <td valign="bottom">$</td> <td valign="bottom" align="right">1,914</td> <td nowrap="nowrap" valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom">$</td> <td valign="bottom" align="right">(1,735</td> <td nowrap="nowrap" valign="bottom">) </td> <td valign="bottom"> </td> <td valign="bottom">$</td> <td valign="bottom" align="right">—  </td> <td nowrap="nowrap" valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom">$</td> <td valign="bottom" align="right">179</td> <td nowrap="nowrap" valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom">$</td> <td valign="bottom" align="right">1,914</td> <td nowrap="nowrap" valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom">$</td> <td valign="bottom" align="right">(1,702</td> <td nowrap="nowrap" valign="bottom">) </td> <td valign="bottom"> </td> <td valign="bottom">$</td> <td valign="bottom" align="right">—  </td> <td nowrap="nowrap" valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom">$</td> <td valign="bottom" align="right">212</td> <td nowrap="nowrap" valign="bottom"> </td> </tr> <tr> <td valign="top"> Trademarks (6 years) </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">69</td> <td nowrap="nowrap" valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">(69</td> <td nowrap="nowrap" valign="bottom">) </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">—  </td> <td nowrap="nowrap" valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">—  </td> <td nowrap="nowrap" valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">69</td> <td nowrap="nowrap" valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">(69</td> <td nowrap="nowrap" valign="bottom">) </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">—  </td> <td nowrap="nowrap" valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">—  </td> <td nowrap="nowrap" valign="bottom"> </td> </tr> <tr bgcolor="#cceeff"> <td valign="top"> Other (4 to 6 years) </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">593</td> <td nowrap="nowrap" valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">(593</td> <td nowrap="nowrap" valign="bottom">) </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">—  </td> <td nowrap="nowrap" valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">—  </td> <td nowrap="nowrap" valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">593</td> <td nowrap="nowrap" valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">(593</td> <td nowrap="nowrap" valign="bottom">) </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">—  </td> <td nowrap="nowrap" valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">—  </td> <td nowrap="nowrap" valign="bottom"> </td> </tr> <tr style="font-size:1px"> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> </tr> <tr> <td valign="top"> Total </td> <td valign="bottom"> </td> <td valign="bottom">$</td> <td valign="bottom" align="right">2,576</td> <td nowrap="nowrap" valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom">$</td> <td valign="bottom" align="right">(2,397</td> <td nowrap="nowrap" valign="bottom">) </td> <td valign="bottom"> </td> <td valign="bottom">$</td> <td valign="bottom" align="right">—  </td> <td nowrap="nowrap" valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom">$</td> <td valign="bottom" align="right">179</td> <td nowrap="nowrap" valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom">$</td> <td valign="bottom" align="right">2,576</td> <td nowrap="nowrap" valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom">$</td> <td valign="bottom" align="right">(2,364</td> <td nowrap="nowrap" valign="bottom">) </td> <td valign="bottom"> </td> <td valign="bottom">$</td> <td valign="bottom" align="right">—  </td> <td nowrap="nowrap" valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom">$</td> <td valign="bottom" align="right">212</td> <td nowrap="nowrap" valign="bottom"> </td> </tr> <tr style="font-size:1px"> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> </tr> <tr bgcolor="#cceeff"> <td valign="top"> Goodwill (Indefinite life) </td> <td valign="bottom"> </td> <td valign="bottom">$</td> <td valign="bottom" align="right">2,926</td> <td nowrap="nowrap" valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom">$</td> <td valign="bottom" align="right">2,926</td> <td nowrap="nowrap" valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom">$</td> <td valign="bottom" align="right">2,926</td> <td nowrap="nowrap" valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom">$</td> <td valign="bottom" align="right">2,926</td> <td nowrap="nowrap" valign="bottom"> </td> </tr> <tr style="font-size:1px"> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> </tr>  </table>

NOTE 7 – ACCRUED LIABILITIES AND DEFERRED REVENUE Accrued liabilities are comprised of the following (in thousands):   <table cellspacing="0" cellpadding="0" width="76%" border="0" style="border-collapse:collapse; text-align: left" align="center">  <tr> <td width="76%"> </td> <td valign="bottom" width="7%"> </td> <td> </td> <td> </td> <td> </td> <td valign="bottom" width="7%"> </td> <td> </td> <td> </td> <td> </td> </tr> <tr> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" colspan="2" align="center" style="border-bottom:1px solid #000000">March 31, 2012</td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" colspan="2" align="center" style="border-bottom:1px solid #000000">December 31, 2011</td> <td valign="bottom"> </td> </tr>   <tr bgcolor="#cceeff"> <td valign="top"> Payroll and benefits </td> <td valign="bottom"> </td> <td valign="bottom">$</td> <td valign="bottom" align="right">1,645</td> <td nowrap="nowrap" valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom">$</td> <td valign="bottom" align="right">1,928</td> <td nowrap="nowrap" valign="bottom"> </td> </tr> <tr> <td valign="top"> Warranty accrual </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">1,926</td> <td nowrap="nowrap" valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">2,218</td> <td nowrap="nowrap" valign="bottom"> </td> </tr> <tr bgcolor="#cceeff"> <td valign="top"> Sales tax </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">419</td> <td nowrap="nowrap" valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">526</td> <td nowrap="nowrap" valign="bottom"> </td> </tr> <tr> <td valign="top"> Accrued professional services </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">689</td> <td nowrap="nowrap" valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">669</td> <td nowrap="nowrap" valign="bottom"> </td> </tr> <tr bgcolor="#cceeff"> <td valign="top"> Accrued insurance premium </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">242</td> <td nowrap="nowrap" valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">433</td> <td nowrap="nowrap" valign="bottom"> </td> </tr> <tr> <td valign="top"> Accrued support services </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">350</td> <td nowrap="nowrap" valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">200</td> <td nowrap="nowrap" valign="bottom"> </td> </tr> <tr bgcolor="#cceeff"> <td valign="top"> Other </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">171</td> <td nowrap="nowrap" valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">203</td> <td nowrap="nowrap" valign="bottom"> </td> </tr> <tr style="font-size:1px"> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> </tr> <tr> <td valign="top"> Accrued liabilities </td> <td valign="bottom"> </td> <td valign="bottom">$</td> <td valign="bottom" align="right">5,442</td> <td nowrap="nowrap" valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom">$</td> <td valign="bottom" align="right">6,177</td> <td nowrap="nowrap" valign="bottom"> </td> </tr> <tr style="font-size:1px"> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> </tr>  </table>   Changes in the initial product warranty accrual, and the expenses incurred under our initial and extended warranties, for the three months ended March 31, 2012 and 2011 were as follows (in thousands):   <table cellspacing="0" cellpadding="0" width="76%" border="0" style="border-collapse:collapse; text-align: left" align="center">  <tr> <td width="82%"> </td> <td valign="bottom" width="5%"> </td> <td> </td> <td> </td> <td> </td> <td valign="bottom" width="5%"> </td> <td> </td> <td> </td> <td> </td> </tr> <tr> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" colspan="6" align="center" style="border-bottom:1px solid #000000">Three Months Ended March 31,</td> <td valign="bottom"> </td> </tr> <tr> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" colspan="2" align="center" style="border-bottom:1px solid #000000">2012</td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" colspan="2" align="center" style="border-bottom:1px solid #000000">2011</td> <td valign="bottom"> </td> </tr>   <tr bgcolor="#cceeff"> <td valign="top"> Initial warranty accrual, beginning balance </td> <td valign="bottom"> </td> <td valign="bottom">$</td> <td valign="bottom" align="right">2,218</td> <td nowrap="nowrap" valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom">$</td> <td valign="bottom" align="right">2,725</td> <td nowrap="nowrap" valign="bottom"> </td> </tr> <tr> <td valign="top"> Provision for estimated warranty cost </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">122</td> <td nowrap="nowrap" valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">508</td> <td nowrap="nowrap" valign="bottom"> </td> </tr> <tr bgcolor="#cceeff"> <td valign="top"> Warranty expenditures </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">(414</td> <td nowrap="nowrap" valign="bottom">) </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">(505</td> <td nowrap="nowrap" valign="bottom">) </td> </tr> <tr style="font-size:1px"> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> </tr> <tr> <td valign="top"> Initial warranty accrual, ending balance </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">1,926</td> <td nowrap="nowrap" valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">2,728</td> <td nowrap="nowrap" valign="bottom"> </td> </tr> <tr bgcolor="#cceeff"> <td valign="top"> Total warranty accrual, long term </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">—  </td> <td nowrap="nowrap" valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">(524</td> <td nowrap="nowrap" valign="bottom">) </td> </tr> <tr style="font-size:1px"> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> </tr> <tr> <td valign="top"> Total warranty accrual, current portion </td> <td valign="bottom"> </td> <td valign="bottom">$</td> <td valign="bottom" align="right">1,926</td> <td nowrap="nowrap" valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom">$</td> <td valign="bottom" align="right">2,204</td> <td nowrap="nowrap" valign="bottom"> </td> </tr> <tr style="font-size:1px"> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> </tr>  </table> Deferred revenue is comprised of the following (in thousands):   <table cellspacing="0" cellpadding="0" width="100%" border="0" style="border-collapse:collapse; text-align: left" align="center">  <tr> <td width="78%"> </td> <td valign="bottom" width="7%"> </td> <td> </td> <td> </td> <td> </td> <td valign="bottom" width="7%"> </td> <td> </td> <td> </td> <td> </td> </tr> <tr> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" colspan="2" align="center" style="border-bottom:1px solid #000000">March 31, 2012</td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" colspan="2" align="center" style="border-bottom:1px solid #000000">December 31, 2011</td> <td valign="bottom"> </td> </tr>   <tr bgcolor="#cceeff"> <td valign="top"> Undelivered elements (training, installation and product and support services) </td> <td valign="bottom"> </td> <td valign="bottom">$</td> <td valign="bottom" align="right">1,171</td> <td nowrap="nowrap" valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom">$</td> <td valign="bottom" align="right">1,105</td> <td nowrap="nowrap" valign="bottom"> </td> </tr> <tr> <td valign="top"> Extended warranty contracts </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">1,078</td> <td nowrap="nowrap" valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">1,056</td> <td nowrap="nowrap" valign="bottom"> </td> </tr> <tr style="font-size:1px"> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> </tr> <tr bgcolor="#cceeff"> <td valign="top"> Total deferred revenue </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">2,249</td> <td nowrap="nowrap" valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">2,161</td> <td nowrap="nowrap" valign="bottom"> </td> </tr> <tr style="font-size:1px"> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> </tr> <tr> <td valign="top"> Less long-term amounts: </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom"> </td> </tr> <tr bgcolor="#cceeff"> <td valign="top"> Extended warranty contracts </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">(17</td> <td nowrap="nowrap" valign="bottom">) </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">(25</td> <td nowrap="nowrap" valign="bottom">) </td> </tr> <tr style="font-size:1px"> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> </tr> <tr> <td valign="top"> Total deferred revenue, long-term </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">(17</td> <td nowrap="nowrap" valign="bottom">) </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">(25</td> <td nowrap="nowrap" valign="bottom">) </td> </tr> <tr style="font-size:1px"> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> </tr> <tr bgcolor="#cceeff"> <td valign="top"> Total deferred revenue, current portion </td> <td valign="bottom"> </td> <td valign="bottom">$</td> <td valign="bottom" align="right">2,232</td> <td nowrap="nowrap" valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom">$</td> <td valign="bottom" align="right">2,136</td> <td nowrap="nowrap" valign="bottom"> </td> </tr> <tr style="font-size:1px"> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> </tr>  </table> On May 20, 2010, the Company entered into a license agreement (the “2010 P&G Agreement”), with Procter and Gamble Company (“P&G”), which replaced an existing license agreement between the Company and P&G (the “2006 P&G Agreement”). Pursuant to the 2010 P&G Agreement, the Company agreed to continue granting P&G an exclusive license to certain of the Company’s patents to enable P&G to develop products aimed at the consumer market and P&G agreed to pay royalties based on sales of products developed with such intellectual property. On June 28, 2011, the Company entered into an amendment to the 2010 P&G Agreement (the “2011 P&G Amendment”) which extended the effective period for the 2010 P&G Agreement from December 31, 2010 through June 30, 2011, and resulted in the Company recognizing the previously deferred $375,000 of revenue as royalty revenue during the quarter ended June 30, 2011. The 2011 P&G Amendment also provided that effective January 1, 2011, P&G’s exclusive license to the Company’s patents converted to a non-exclusive license unless P&G paid the Company a license payment in the amount of $187,500 by the end of the third quarter of 2011, and at the end of each quarter thereafter, throughout the term of the 2010 P&G Agreement. As a result of P&G not making any payments to the Company in the third and fourth quarters of the year ended December 31, 2011, their license converted to a non-exclusive license. The Company is currently engaged in an active collaboration with P&G to commercialize a consumer product utilizing its patents.   NOTE 8 – LINE OF CREDIT AND DEBT The Company entered into a Loan and Security Agreement with MidCap Financial, LLC (whose interests were later assigned to its affiliate MidCap Funding III, LLC) and Silicon Valley Bank in May 2010. In connection with the Loan and Security Agreement, the Company issued two secured promissory notes in an aggregate principal amount of $3 million, at 14.25%, secured by the Company’s assets, and warrants to purchase up to an aggregate of 101,694 shares of Common Stock at an exercise price of $1.77 per share with an expiration date of May 26, 2015. The per share price of the warrants was subsequently reduced in September 2010 to $0.84 per share in connection with Waiver and Amendment No. 1 to the Loan and Security Agreement. During February 2011, the Company repaid all outstanding balances under the Loan and Security Agreement, which included approximately $2.6 million in principal, $30,000 of accrued interest, and $169,000 of loan related expenses and MidCap Funding III, LLC and Silicon Valley Bank released their security interest in the Company’s assets. Unamortized costs totaling approximately $225,000, excluding interest, associated with the term loan payable were expensed in February 2011. MidCap Financial, LLC and Silicon Valley Bank also performed a cashless exercise of all of their warrants during February 2011, which resulted in the combined issuance of 78,172 shares of unregistered stock. The Loan and Security Agreement was terminated in February 2011.   In December 2011, the Company financed approximately $433,000 of insurance premiums payable in nine equal monthly installments of approximately $48,000 each, including a finance charge of 2.50%. As of March 31, 2012, there was $242,000 outstanding under this arrangement. Such amount is included in Accrued Liabilities in the accompanying consolidated financial statements.

NOTE 9 – COMMITMENTS AND CONTINGENCIES Litigation The Company discloses material loss contingencies deemed to be reasonably possible and accrues for loss contingencies when, in consultation with its legal advisors, management concludes that a loss is probable and reasonably estimable. The ability to predict the ultimate outcome of such matters involves judgments, estimates, and inherent uncertainties. The actual outcome of such matters could differ materially from management’s estimates. Intellectual Property On April 24, 2012, CAO Group, Inc. filed a lawsuit against the Company in the United States District Court for the District of Utah, Central Division, alleging patent infringement of U.S. Patent No. 7,485,116 involving the Company’s ezlase diode laser. The complaint seeks unspecified damages, attorneys’ fees, interest, costs, and injunctive relief. Management plans to vigorously defend against the allegations. Other Matters In the normal course of business, the Company is subject to other legal proceedings, lawsuits and other claims. Although the ultimate aggregate amount of probable monetary liability or financial impact with respect to these matters is subject to many uncertainties and is therefore not predictable with assurance, management believes that any monetary liability or financial impact to the Company from these other matters, individually and in the aggregate, would not be material to the Company’s consolidated financial condition, results of operations or cash flows. However, there can be no assurance with respect to such result, and monetary liability or financial impact to the Company from these other matters could differ materially from those projected.

NOTE 10 – SEGMENT INFORMATION The Company currently operates in a single business segment. For the quarter ended March 31, 2012, sales in the United States accounted for approximately 68% of net revenue, and international sales accounted for approximately 32% of net revenue. For the quarter ended March 31, 2011, sales in the United States accounted for approximately 81% of net revenue, and international sales accounted for approximately 19% of net revenue. Net revenue by geographic location based on the location of customers was as follows (in thousands):   <table cellspacing="0" cellpadding="0" width="76%" border="0" style="border-collapse:collapse; text-align: left" align="center">  <tr> <td width="80%"> </td> <td valign="bottom" width="4%"> </td> <td> </td> <td> </td> <td> </td> <td valign="bottom" width="4%"> </td> <td> </td> <td> </td> <td> </td> </tr> <tr> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" colspan="6" align="center" style="border-bottom:1px solid #000000">Three Months Ended March 31,</td> <td valign="bottom"> </td> </tr> <tr> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" colspan="2" align="center" style="border-bottom:1px solid #000000">2012</td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" colspan="2" align="center" style="border-bottom:1px solid #000000">2011</td> <td valign="bottom"> </td> </tr>   <tr bgcolor="#cceeff"> <td valign="top"> United States </td> <td valign="bottom"> </td> <td valign="bottom">$</td> <td valign="bottom" align="right">8,364</td> <td nowrap="nowrap" valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom">$</td> <td valign="bottom" align="right">8,525</td> <td nowrap="nowrap" valign="bottom"> </td> </tr> <tr> <td valign="top"> International </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">3,956</td> <td nowrap="nowrap" valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">2,036</td> <td nowrap="nowrap" valign="bottom"> </td> </tr> <tr style="font-size:1px"> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> </tr> <tr bgcolor="#cceeff"> <td valign="top"> </td> <td valign="bottom"> </td> <td valign="bottom">$</td> <td valign="bottom" align="right">12,320</td> <td nowrap="nowrap" valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom">$</td> <td valign="bottom" align="right">10,561</td> <td nowrap="nowrap" valign="bottom"> </td> </tr> <tr style="font-size:1px"> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> </tr>  </table> No individual country, other than the United States, represents more than 10% of total net revenue. Long-lived assets located outside of the United States at our foreign subsidiaries totaled $554,000 and $542,000 as of March 31, 2012 and December 31, 2011, respectively.

NOTE 11 – CONCENTRATIONS Revenue from Waterlase systems, the Company’s principal product line, which includes the iPlus, MDX systems, and the MD Turbo, comprised 65% and 41% of total net revenues for the three months ended March 31, 2012 and 2011, respectively. Revenue from Diode systems comprised 11% and 36% of total net revenue for the same periods. Revenue from consumables, service and warranty contracts comprised 23% and 22% of total net revenue for the same periods. Approximately 8% and 35% of the Company’s net revenue in the quarters ended March 31, 2012 and 2011, respectively, was generated through sales to HSIC worldwide. The Company maintains its cash and cash equivalent accounts with established commercial banks. Such cash deposits periodically exceed the Federal Deposit Insurance Corporation insured limit. Accounts receivable concentrations from one international distributor totaled $1.3 million, or 15%, at March 31, 2012 and $716,000, or 8%, at December 31, 2011. The Company currently purchases certain key components of its products from single suppliers. Although there are a limited number of manufacturers of these key components, management believes that other suppliers could provide similar key components on comparable terms. A change in suppliers, however, could cause delays in manufacturing and a possible loss of sales, which could adversely affect the Company’s consolidated results of operations.

NOTE 12 – INCOME TAXES Accounting for uncertainty in income taxes prescribes a recognition threshold and measurement attribute for the financial statement recognition and measurement of a tax position taken or expected to be taken in a tax return and provides guidance on derecognition, classification, interest and penalties, accounting in interim periods, disclosure and transition. The Company has elected to classify interest and penalties as a component of its income tax provision. For the three months ended March 31, 2012 and 2011, the Company recorded an increase of $1,000 and $1,000, respectively, with respect to the liability for unrecognized tax benefits, including related estimates of penalties and interest.

NOTE 13 – SUBSEQUENT EVENTS 2012 Termination Agreement On April 12, 2012, the Company completed the 2012 Termination Agreement with HSIC whereby the Company purchased HSIC’s inventory of Waterlase MD Turbo laser systems and HSIC released its liens on the Company’s assets. Pursuant to the terms of the 2012 Termination Agreement, the Company paid the entire purchase price by offsetting accounts receivable currently due from HSIC from sales made in the normal course of business. None of the funds used to offset the purchase price were related to the original sales of the MD Turbo laser systems that were purchased. As a result of the transaction, the Company is no longer required to fulfill certain future service obligations and, accordingly, derecognized approximately $155,000 of accounts receivable due from HSIC related to support services previously provided and approximately $142,000 of accrued warranties as of March 31, 2012. The Company expects to record the remaining effects of the 2012 Termination Agreement in the second quarter ending June 30, 2012. Non-Qualified Stock Option Award On May 7, 2012, the Board of Directors granted a non-qualified stock option to purchase 65,000 shares of the Company’s common stock to a consultant, at a price per share of $2.55, the closing market price of the Company’s common stock on the grant date. The shares fully vest and become exercisable upon achieving certain performance conditions, as defined in the consulting agreement, and expire five years from the grant date. The Company is unable to currently estimate the probability of achieving the required performance conditions and, accordingly, no stock-based compensation has been recognized. The Company will reassess whether achievement of the performance conditions is probable on a quarterly basis and recognize stock-based compensation when it is probable that the performance conditions will be achieved.

EX-101.SCH 7 blti-20120331.xsd XBRL TAXONOMY EXTENSION SCHEMA 00 - Document - Document and Entity Information link:presentationLink link:definitionLink link:calculationLink 01 - Statement - Consolidated Balance Sheets (Unaudited) link:presentationLink link:definitionLink link:calculationLink 011 - Statement - Consolidated Balance Sheets (Unaudited) (Parenthetical) link:presentationLink link:definitionLink link:calculationLink 02 - Statement - Consolidated Statements of Comprehensive Loss (Unaudited) link:presentationLink link:definitionLink link:calculationLink 03 - Statement - Consolidated Statements of Cash Flows (Unaudited) link:presentationLink link:definitionLink link:calculationLink 06001 - Disclosure - Basis of Presentation link:presentationLink link:definitionLink link:calculationLink 06002 - Disclosure - Recent Accounting Pronouncements link:presentationLink link:definitionLink link:calculationLink 06003 - Disclosure - Stock-Based Awards and Per Share Information link:presentationLink link:definitionLink link:calculationLink 06004 - Disclosure - Inventory link:presentationLink link:definitionLink link:calculationLink 06005 - Disclosure - Property, Plant and Equipment link:presentationLink link:definitionLink link:calculationLink 06006 - Disclosure - Intangible Assets and Goodwill link:presentationLink link:definitionLink link:calculationLink 06007 - Disclosure - Accrued Liabilities and Deferred Revenue link:presentationLink link:definitionLink link:calculationLink 06008 - Disclosure - Line of Credit and Debt link:presentationLink link:definitionLink link:calculationLink 06009 - Disclosure - Commitments and Contingencies link:presentationLink link:definitionLink link:calculationLink 06010 - Disclosure - Segment Information link:presentationLink link:definitionLink link:calculationLink 06011 - Disclosure - Concentrations link:presentationLink link:definitionLink link:calculationLink 06012 - Disclosure - Income Taxes link:presentationLink link:definitionLink link:calculationLink 06013 - Disclosure - Subsequent Events link:presentationLink link:definitionLink link:calculationLink EX-101.CAL 8 blti-20120331_cal.xml XBRL TAXONOMY EXTENSION CALCULATION LINKBASE EX-101.LAB 9 blti-20120331_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE Document and Entity Information [Abstract] ASSETS Assets [Abstract] Current assets: Assets, Current [Abstract] Cash and cash equivalents Cash and Cash Equivalents, at Carrying Value Accounts receivable, less allowance of $305 and $289 in 2012 and 2011, respectively Accounts Receivable, Net, Current Allowances for accounts receivable Allowance for Doubtful Accounts Receivable, Current Inventory, net Inventory, Net Prepaid expenses and other current assets Prepaid Expense and Other Assets, Current Prepaid expenses and other current assets Total current assets Assets, Current, Total Total current assets Property, plant and equipment, net Property, Plant and Equipment, Net Intangible assets, net Intangible Assets, Net (Excluding Goodwill) Goodwill Goodwill Deferred tax asset Deferred Tax Assets, Net, Noncurrent Other assets Other Assets, Noncurrent Other assets Total assets Assets, Total Total assets LIABILITIES AND STOCKHOLDERS' EQUITY Liabilities and Equity [Abstract] Current liabilities: Liabilities, Current [Abstract] Accounts payable Accounts Payable, Current Accrued liabilities Accrued Liabilities, Current Customer deposits Customer Deposits, Current Deferred revenue, current portion Deferred Revenue, Current Deferred revenue, current portion Total current liabilities Liabilities, Current, Total Total current liabilities Deferred tax liabilities Deferred Tax Liabilities, Noncurrent Deferred revenue, long-term Deferred Revenue, Noncurrent Other liabilities, long-term Other Liabilities, Noncurrent Other liabilities, long-term Total liabilities Liabilities, Total Total liabilities Commitments and contingencies (Notes 9 and 13) Commitments and Contingencies Stockholders' equity: Stockholders' Equity Attributable to Parent [Abstract] Preferred stock, par value $0.001; 1,000 shares authorized, no shares issued and outstanding Preferred Stock, Value, Issued Preferred stock, par value Preferred Stock, Par or Stated Value Per Share Preferred stock, shares authorized Preferred Stock, Shares Authorized Preferred stock, shares issued Preferred Stock, Shares Issued Preferred stock, shares outstanding Preferred Stock, Shares Outstanding Common stock, par value $0.001, 50,000 shares authorized; 32,769 and 32,502 shares issued in 2012 and 2011, respectively; and 30,805 and 30,538 shares outstanding in 2012 and 2011, respectively Common Stock, Value, Issued Common stock, par value Common Stock, Par or Stated Value Per Share Common stock, shares authorized Common Stock, Shares Authorized Common stock, shares issued Common Stock, Shares, Issued Common stock, shares outstanding Common Stock, Shares, Outstanding Additional paid-in capital Additional Paid in Capital, Common Stock Accumulated other comprehensive loss Accumulated Other Comprehensive Income (Loss), Net of Tax Accumulated deficit Retained Earnings (Accumulated Deficit) Accumulated deficit Stockholders Equity Excluding Treasury Stock Total stockholders' equity Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity before consideration of Treasury Stock. Stockholders' equity excluding treasury stock Treasury stock (cost of 1,964 shares repurchased) Treasury Stock, Value Treasury stock (cost of 1,964 shares repurchased) Treasury stock, shares repurchased Treasury Stock, Shares Total stockholders' equity Stockholders' Equity Attributable to Parent, Total Total stockholders' equity Total liabilities and stockholders' equity Liabilities and Equity, Total Total liabilities and stockholders' equity Products and Services Revenue Products and services revenue Products and services revenue License Fees and Royalty Revenue License fees and royalty revenue Licensing revenue is consideration received from another party for the right to use, but not own, certain of the entity's intangible assets. Licensing arrangements include, but are not limited to, rights to use a patent, copyright, technology, manufacturing process, software or trademark. Licensing fees are generally, but not always, fixed as to amount and not dependent upon the revenue generated by the licensing party. An entity may receive licensing fees for licenses that also generate royalty payments to the entity. License fees and royalty revenue Net revenue Revenue, Net Net revenue Cost of revenue Cost of Revenue Cost of revenue Gross profit Gross Profit Gross profit Operating expenses: Operating Expenses [Abstract] Sales and marketing Selling and Marketing Expense General and administrative General and Administrative Expense Engineering and development Research and Development Expense Engineering and development Total operating expenses Operating Expenses, Total Total operating expenses Loss from operations Operating Income (Loss) Loss from operations Loss on foreign currency transactions Foreign Currency Transaction Gain (Loss), before Tax Interest income Investment Income, Interest Interest expense Interest Expense Interest expense Nonrecurring Charge Unamortized Debt Related Cost Expense Nonrecurring charge, unamortized debt-related cost expense Nonrecurring charge, unamortized debt-related cost expense Nonrecurring charge, unamortized debt-related cost expense Non-operating loss, net Nonoperating Income (Expense) Non-operating loss, net Loss before income tax provision Income (Loss) from Continuing Operations before Equity Method Investments, Income Taxes, Extraordinary Items, Noncontrolling Interest Loss before income tax provision Income tax provision Income Tax Expense (Benefit) Income tax provision Net loss Net Income (Loss) Attributable to Parent Net loss Other comprehensive loss items: Other Comprehensive Income (Loss), Net of Tax [Abstract] Foreign currency translation adjustments Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax Foreign currency translation adjustments Comprehensive loss Comprehensive Income (Loss), Net of Tax, Attributable to Parent Comprehensive loss Net loss per share: Earnings Per Share [Abstract] Basic Earnings Per Share, Basic Diluted Earnings Per Share, Diluted Shares used in the calculation of net loss per share: Shares Used in Calculation of Net Loss Per Share Abstract Shares used in the calculation of net loss per share: Basic Weighted Average Number of Shares Outstanding, Basic Diluted Weighted Average Number of Shares Outstanding, Diluted Cash Flows From Operating Activities: Net Cash Provided by (Used in) Operating Activities [Abstract] Net loss Adjustments to reconcile net loss to net cash and cash equivalents used in operating activities: Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract] Depreciation and amortization Depreciation, Depletion and Amortization Loss on disposal of assets, net Gain (Loss) on Sale of Property Plant Equipment Loss on disposal of assets, net Provision for bad debts Gains (Losses) on Extinguishment of Debt Provision for bad debts Amortization of discounts on term loan payable Amortization of Financing Costs and Discounts Amortization of debt issuance costs Amortization of Financing Costs Stock-based compensation Share-based Compensation Other Equity Instruments Compensation Other equity instruments compensation Other equity instruments compensation Other non-cash compensation Other Noncash Income (Expense) Other non-cash compensation Deferred income taxes Deferred Income Tax Expense (Benefit) Changes in operating assets and liabilities: Increase (Decrease) in Operating Capital [Abstract] Accounts receivable Increase (Decrease) in Accounts Receivable Accounts receivable Inventory Increase (Decrease) in Inventories Inventory Prepaid expenses and other assets Increase (Decrease) in Prepaid Expense and Other Assets Prepaid expenses and other assets Customer deposits Increase (Decrease) in Customer Deposits Accounts payable and accrued liabilities Increase (Decrease) in Accounts Payable and Accrued Liabilities Deferred revenue Increase (Decrease) in Deferred Revenue Deferred revenue Net cash and cash equivalents used in operating activities Net Cash Provided by (Used in) Operating Activities Net cash and cash equivalents used in operating activities Cash Flows From Investing Activities: Net Cash Provided by (Used in) Investing Activities [Abstract] Additions to property, plant and equipment Payments to Acquire Property, Plant, and Equipment Additions to property, plant and equipment Net cash and cash equivalents used in investing activities Net Cash Provided by (Used in) Investing Activities Net cash and cash equivalents used in investing activities Cash Flows From Financing Activities: Net Cash Provided by (Used in) Financing Activities [Abstract] Payments under term loan payable Repayments of Long-term Debt Payments under term loan payable Proceeds from equity offering, net of expenses Proceeds from Issuance of Common Stock Proceeds from exercise of stock options Proceeds from Stock Options Exercised Proceeds from exercise of stock options Net cash and cash equivalents provided by financing activities Net Cash Provided by (Used in) Financing Activities Net cash and cash equivalents provided by financing activities Effect of exchange rate changes Effect of Exchange Rate on Cash and Cash Equivalents Effect of exchange rate changes Change in cash and cash equivalents Cash and Cash Equivalents, Period Increase (Decrease) Change in cash and cash equivalents Cash and cash equivalents, beginning of period Cash and cash equivalents, end of period Supplemental cash flow disclosure: Supplemental Cash Flow Information [Abstract] Cash activity during the period for: Cash Paid Refunded During Period for Abstract Cash activity during the period for: Interest Interest Paid Income taxes Income Taxes Paid, Net BASIS OF PRESENTATION Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block] Basis of Presentation [Abstract] Basis of Presentation [Abstract] RECENT ACCOUNTING PRONOUNCEMENTS Accounting Changes and Error Corrections [Text Block] Recent Accounting Pronouncements [Abstract] Recent Accounting Pronouncements [Abstract] Stock Based Awards and Per Share Information [Text Block] STOCK-BASED AWARDS AND PER SHARE INFORMATION STOCK-BASED AWARDS AND PER SHARE INFORMATION Stock-Based Awards and Per Share Information [Abstract] Stock-Based Awards and Per Share Information [Abstract] STOCK-BASED AWARDS AND PER SHARE INFORMATION INVENTORY Inventory Disclosure [Text Block] Inventory [Abstract] Inventory [Abstract] PROPERTY, PLANT AND EQUIPMENT Property, Plant and Equipment Disclosure [Text Block] Property, Plant and Equipment [Abstract] Property, Plant and Equipment [Abstract] INTANGIBLE ASSETS AND GOODWILL Goodwill and Intangible Assets Disclosure [Text Block] Intangible Assets and Goodwill [Abstract] Intangible Assets and Goodwill [Abstract] Accrued Liabilities and Deferred Revenue [Text Block] ACCRUED LIABILITIES AND DEFERRED REVENUE ACCRUED LIABILITIES AND DEFERRED REVENUE Accrued Liabilities and Deferred Revenue [Abstract] Accrued Liabilities and Deferred Revenue [Abstract] Bank Line of Credit and Debt [Text Block] LINE OF CREDIT AND DEBT The disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, or any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants. Line of Credit and Debt [Abstract] Line of Credit and Debt [Abstract] COMMITMENTS AND CONTINGENCIES Commitments and Contingencies Disclosure [Text Block] Commitments and Contingencies [Abstract] Commitments and Contingencies [Abstract] SEGMENT INFORMATION Segment Reporting Disclosure [Text Block] Segment Information [Abstract] Segment Information [Abstract] Concentrations [Text Block] CONCENTRATIONS CONCENTRATIONS Concentrations [Abstract] Concentrations [Abstract] CONCENTRATIONS INCOME TAXES Income Tax Disclosure [Text Block] Income Taxes [Abstract] Income Taxes [Abstract] SUBSEQUENT EVENTS Subsequent Events [Text Block] Subsequent Events [Abstract] Subsequent Events [Abstract] Amendment Flag Current Fiscal Year End Date Document Period End Date Document Type Entity Central Index Key Entity Common Stock, Shares Outstanding Entity Filer Category Entity Registrant Name Document Fiscal Period Focus Document Fiscal Year Focus Consolidated Balance Sheets [Abstract] Consolidated Statements of Comprehensive Loss [Abstract] Consolidated Statements of Cash Flows [Abstract] EX-101.PRE 10 blti-20120331_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE XML 11 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; word-wrap: break-word; } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 12 R9.htm IDEA: XBRL DOCUMENT

Inventory

3 Months Ended

Mar. 31, 2012

Inventory [Abstract]

INVENTORY

NOTE 4 – INVENTORY

Inventory is valued at the lower of cost or market (determined by the first-in, first-out method) and is comprised of the following (in thousands):


	March 31, 2012		December 31, 2011
Raw materials	$	3,756	$	4,280
Work-in-process		2,115		2,538
Finished goods		4,466		4,494

Inventory, net	$	10,337	$	11,312

Inventory is net of the provision for excess and obsolete inventory totaling $2.1 million and $2.3 million as of March 31, 2012 and December 31, 2011, respectively.

- Definition

The entire disclosure for inventory. This may include, but is not limited to, the basis of stating inventory, the method of determining inventory cost, the major classes of inventory, and the nature of the cost elements included in inventory. If inventory is stated above cost, accrued net losses on firm purchase commitments for inventory and losses resulting from valuing inventory at the lower-of-cost-or-market may also be included. For LIFO inventory, may disclose the amount and basis for determining the excess of replacement or current cost over stated LIFO value and the effects of a LIFO quantities liquidation that impacts net income.

+ References+ Details

EXCEL 13 Financial_Report.xls IDEA: XBRL DOCUMENT begin 644 Financial_Report.xls M[[N_34E-12U697)S:6]N.B`Q+C`-"E@M1&]C=6UE;G0M5'EP93H@5V]R:V)O M;VL-"D-O;G1E;G0M5'EP93H@;75L=&EP87)T+W)E;&%T960[(&)O=6YD87)Y M/2(M+2TM/5].97AT4&%R=%\P-C%A,3=F-U\Q,#AB7S1F8V%?.6(X,E]F,&8U M9F$Y931A.#0B#0H-"E1H:7,@9&]C=6UE;G0@:7,@82!3:6YG;&4@1FEL92!7 M96(@4&%G92P@86QS;R!K;F]W;B!A'!L;W)E&UL;G,Z=CTS1")U&UL;G,Z;STS1")U&UL/@T*(#QX.D5X8V5L5V]R:V)O;VL^#0H@(#QX M.D5X8V5L5V]R:W-H965T5]);F9O#I%>&-E;%=O#I%>&-E;%=O#I.86UE/@T*("`@(#QX.E=O#I%>&-E;%=O#I.86UE/D-O;G-O;&ED871E9%]3=&%T96UE;G1S7V]F7T-A M#I.86UE/@T*("`@(#QX.E=O#I%>&-E;%=O#I.86UE/E)E8V5N=%]!8V-O=6YT:6YG7U!R;VYO=6YC96UE;CPO>#I. M86UE/@T*("`@(#QX.E=O#I%>&-E;%=O#I.86UE/DEN=F5N=&]R>3PO>#I.86UE/@T*("`@(#QX.E=O#I%>&-E;%=O#I.86UE/E!R;W!E#I7;W)K#I7;W)K M#I7;W)K#I.86UE/@T*("`@(#QX.E=O#I%>&-E;%=O#I.86UE/D-O;6UI=&UE;G1S7V%N9%]#;VYT:6YG96YC:65S/"]X M.DYA;64^#0H@("`@/'@Z5V]R:W-H965T4V]U#I%>&-E;%=O#I.86UE/@T*("`@(#QX.E=O#I%>&-E;%=O#I. M86UE/D-O;F-E;G1R871I;VYS/"]X.DYA;64^#0H@("`@/'@Z5V]R:W-H965T M4V]U#I%>&-E;%=O&5S/"]X.DYA;64^#0H@("`@/'@Z5V]R M:W-H965T4V]U#I%>&-E;%=O#I7;W)K#I3='EL97-H965T($A2968],T0B5V]R M:W-H965T&-E;"!8 M4"!O3X-"CPO:'1M;#X-"@T*+2TM+2TM M/5].97AT4&%R=%\P-C%A,3=F-U\Q,#AB7S1F8V%?.6(X,E]F,&8U9F$Y931A M.#0-"D-O;G1E;G0M3&]C871I;VXZ(&9I;&4Z+R\O0SHO,#8Q83$W9C=?,3`X M8E\T9F-A7SEB.#)?9C!F-69A.64T83@T+U=O'0O:'1M;#L@8VAA7!E(&-O;G1E;G0],T0G=&5X="]H=&UL.R!C:&%R2!);F9O2`P-"P@,C`Q,CQB'0^0DE/3$%312!414-( M3D],3T=9($E.0SQS<&%N/CPO'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$ M'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^ M,C`Q,CQS<&%N/CPO'0^43$\2!&:6QE3PO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^06-C96QE2!#;VUM;VX@ M4W1O8VLL(%-H87)E'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S7!E.B!T97AT+VAT;6P[(&-H87)S970] M(G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^#0H@("`@/$U%5$$@:'1T M<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT/3-$)W1E>'0O:'1M;#L@ M8VAA3PO=&0^#0H@("`@("`@(#QT9"!C;&%S'!E;G-E2P@ M<&QA;G0@86YD(&5Q=6EP;65N="P@;F5T/"]T9#X-"B`@("`@("`@/'1D(&-L M87-S/3-$;G5M<#XQ+#,S.#QS<&%N/CPO6%B;&4\+W1D/@T*("`@("`@("`\ M=&0@8VQAF5D.R`S,BPW M-CD@86YD(#,R+#4P,B!S:&%R97,@:7-S=65D(&EN(#(P,3(@86YD(#(P,3$L M(')E3L@86YD(#,P+#@P-2!A;F0@,S`L-3,X('-H87)E2!S=&]C:SPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S2!S=&]C M:R`H8V]S="!O9B`Q+#DV-"!S:&%R97,@'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQA M7!E.B!T97AT+VAT;6P[(&-H87)S970] M(G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^#0H@("`@/$U%5$$@:'1T M<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT/3-$)W1E>'0O:'1M;#L@ M8VAA'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@ M("`@/'1R(&-L87-S/3-$"!P2!T'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0O:F%V87-C3X- M"B`@("`\=&%B;&4@8VQA'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S6%B;&4\+W1D/@T*("`@("`@("`\=&0@8VQA'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S6%B;&4@86YD(&%C8W)U960@;&EA8FEL:71I M97,\+W1D/@T*("`@("`@("`\=&0@8VQA2P@<&QA M;G0@86YD(&5Q=6EP;65N=#PO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\ M+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S2!O9F9E&5R8VES92!O9B!S=&]C:R!O<'1I;VYS/"]T9#X-"B`@ M("`@("`@/'1D(&-L87-S/3-$;G5M<#XR-S<\2!F:6YA;F-I;F<@86-T:79I M=&EE&5S/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M M<#XD(#(Q/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S3X-"CPO:'1M;#X-"@T*+2TM+2TM/5].97AT M4&%R=%\P-C%A,3=F-U\Q,#AB7S1F8V%?.6(X,E]F,&8U9F$Y931A.#0-"D-O M;G1E;G0M3&]C871I;VXZ(&9I;&4Z+R\O0SHO,#8Q83$W9C=?,3`X8E\T9F-A M7SEB.#)?9C!F-69A.64T83@T+U=O'0O:'1M;#L@8VAA7!E(&-O;G1E;G0],T0G=&5X="]H=&UL.R!C:&%R'0^/"$M+41/0U194$4@:'1M;"!054),24,@(BTO+U&AT;6PQ+T141"]X:'1M;#$M=')A;G-I=&EO;F%L+F1T9"(@+2T^#0H@ M("`\(2TM($)E9VEN($)L;V-K(%1A9V=E9"!.;W1E(#$@+2!U3IT:6UEF4],T0R M/CQB/CPO8CX\+V9O;G0^#0H@("`\<"!S='EL93TS1&UA#MM87)G:6XM8F]T=&]M.C!P>#X\9F]N="!S='EL93TS1"=F;VYT+69A;6EL M>3IT:6UEF4],T0R/CQB/DY/5$4@,2`F(S@R,3$[ M($)!4TE3($]&(%!215-%3E1!5$E/3B`\+V(^/"]F;VYT/CPO<#X-"B`@(#QP M('-T>6QE/3-$;6%R9VEN+71O<#HV<'@[;6%R9VEN+6)O='1O;3HP<'@^/&9O M;G0@2`\+V(^/"]F;VYT/CPO<#X-"B`@(#QP('-T M>6QE/3-$)VUA2!) M;F,N+"`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`Q,"U++B`\+V9O;G0^ M/"]P/@T*("`@/'`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`@/"]F;VYT/CPO<#X-"B`@(#QP M('-T>6QE/3-$)VUA#MM87)G:6XM8F]T=&]M.C!P>#L@ M=&5X="UI;F1E;G0Z-"4G/CQF;VYT('-T>6QE/3-$)V9O;G0M9F%M:6QY.G1I M;65S(&YE=R!R;VUA;B<@6EN9R!C;VYS M;VQI9&%T960@9FEN86YC:6%L('-T871E;65N=',@:&%V92!B965N('!R97!A MF%T:6]N(&]F(&%S'0M:6YD96YT.C0E)SX\9F]N="!S='EL93TS1"=F;VYT M+69A;6EL>3IT:6UEF4],T0R/D9R;VT@=&EM92!T M;R!T:6UE+"!T:&4@0V]M<&%N>2!M87D-"B`@(&%T=&5M<'0@=&\@2X@5&AE($-O;7!A;GD@8V]U;&0@8F4@2!E;&5C="P@=&\@2!O2!N;W0@:&%V92!E;F]U9V@@8V%S:"!O'0M:6YD96YT.C0E)SX\9F]N="!S M='EL93TS1"=F;VYT+69A;6EL>3IT:6UEF4],T0R M/D]N($9E8G)U87)Y)B,Q-C`[,C(L(#(P,3(L('1H92!#;VUP86YY(&5N=&5R M960@:6YT;R!A(&1E9FEN:71I=F4@=&5R;6EN871I;VX@86=R965M96YT("AT M:&4@)B,X,C(P.S(P,3(@5&5R;6EN871I;VX@06=R965M96YT)B,X,C(Q.RD@ M=VET:`T*("`@2&5N28C.#(Q-SMS(&9O&-L=7-I=F4@9&ES=')I8G5T;W(@:6X@3F]R=&@@06UE2!P=7)C:&%S960@2%-)0R8C.#(Q-SMS(&EN M=F5N=&]R>2!O9B!7871E2!P86ED('1H92!E;G1I2!D=64@9G)O;2!(4TE#(&9R;VT@7-T96US('1H870@=V5R92!P=7)C:&%S960N(%1H92!# M;VUP86YY(&5X<&5C=',@=&\@=7-E('1H92!P=7)C:&%S960@97%U:7!M96YT M(&%S(&$@&EM871E;'D@-BPU,#`@5V%T97)L87-E($U$(%1U M2X@ M4V5E(#QI/DYO=&4@,3,@)B,X,C$Q.R!3=6)S97%U96YT($5V96YT7!E.B!T97AT M+VAT;6P[(&-H87)S970](G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^ M#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT M/3-$)W1E>'0O:'1M;#L@8VAA6QE/3-$;6%R9VEN+71O<#HQ M.'!X.VUA6QE/3-$)V9O;G0M9F%M M:6QY.G1I;65S(&YE=R!R;VUA;B<@#MM87)G:6XM M8F]T=&]M.C!P>#L@=&5X="UI;F1E;G0Z-"4G/CQF;VYT('-T>6QE/3-$)V9O M;G0M9F%M:6QY.G1I;65S(&YE=R!R;VUA;B<@'0M:6YD M96YT.C0E)SX\9F]N="!S='EL93TS1"=F;VYT+69A;6EL>3IT:6UEF4],T0R/E1H92!#;VUP86YY(&-O;G-I9&5R2!A;F0@:6UP86-T(&]F(&%L;"!!4U4F(S@R,3<[6QE/3-$)VUA65A28C,38P.S$L(#(P,3(N(%1H92!A9&]P=&EO;@T* M("`@9&ED(&YO="!H879E(&$@;6%T97)I86P@:6UP86-T(&]N('1H92!#;VUP M86YY)B,X,C$W.W,@8V]N2!A9&]P M=&5D('1H:7,@9W5I9&%N8V4@969F96-T:79E($IA;G5A6QE/3-$9F]N="US:7IE.C%P M>#MM87)G:6XM=&]P.C$X<'@[;6%R9VEN+6)O='1O;3HP<'@^)B,Q-C`[/"]P M/@T*/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@(#PO=&%B M;&4^#0H@(#PO8F]D>3X-"CPO:'1M;#X-"@T*+2TM+2TM/5].97AT4&%R=%\P M-C%A,3=F-U\Q,#AB7S1F8V%?.6(X,E]F,&8U9F$Y931A.#0-"D-O;G1E;G0M M3&]C871I;VXZ(&9I;&4Z+R\O0SHO,#8Q83$W9C=?,3`X8E\T9F-A7SEB.#)? M9C!F-69A.64T83@T+U=O'0O:'1M;#L@8VAA'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^/"$M+41/0U194$4@:'1M;"!054), M24,@(BTO+U&AT;6PQ+T141"]X:'1M;#$M=')A;G-I M=&EO;F%L+F1T9"(@+2T^#0H@("`\(2TM($)E9VEN($)L;V-K(%1A9V=E9"!. M;W1E(#,@+2!B;'1I.E-T;V-K0F%S961!=V%R9'-!;F1097)3:&%R94EN9F]R M;6%T:6]N5&5X=$)L;V-K+2T^#0H@("`\<"!S='EL93TS1&UA6QE/3-$)V9O;G0M9F%M M:6QY.G1I;65S(&YE=R!R;VUA;B<@6QE/3-$)V9O;G0M9F%M M:6QY.G1I;65S(&YE=R!R;VUA;B<@'0M:6YD96YT M.C0E)SX\9F]N="!S='EL93TS1"=F;VYT+69A;6EL>3IT:6UEF4],T0R/@T*("`@5&AE($-O;7!A;GD@8W5RF5D(&9O&5R8VES960L#0H@("`S+#F5D(&EN(&]P97)A=&EN9R!R97-U;'1S(&1U2`D-3@S+#`P,"!A;F0@)#(R,"PP M,#`L(')E2X@5&AE(&YE=`T*("`@:6UP86-T('1O(&5A2!H860@87!P2`D,BXQ M(&UI;&QI;VX@;V8@=&]T86P@=6YR96-O9VYI>F5D(&-O;7!E;G-A=&EO;B!C M;W-T+"!N970-"B`@(&]F(&5S=&EM871E9"!F;W)F96ET=7)E2!E>'!E8W1S('1H870@8V]S="!T;R!B92!R96-O9VYI>F5D(&]V M97(@82!W96EG:'1E9"UA=F5R86=E('!E65A'0M:6YD96YT.C0E)SX\9F]N="!S='EL93TS M1"=F;VYT+69A;6EL>3IT:6UEF4],T0R/E1H92!F M;VQL;W=I;F<@=&%B;&4@F4Z M,3)P>#MM87)G:6XM=&]P.C!P>#MM87)G:6XM8F]T=&]M.C!P>#XF(S$V,#L\ M+W`^#0H@("`\=&%B;&4@8V5L;'-P86-I;F<],T0P(&-E;&QP861D:6YG/3-$ M,"!W:61T:#TS1#6QE/3-$)V)OF4],T0Q/B8C M,38P.SPO9F]N=#X\+W1D/B`-"B`@(#QT9"!V86QI9VX],T1B;W1T;VT^/&9O M;G0@"!S;VQI9"`C,#`P,#`P)SX\9F]N="!S='EL M93TS1"=F;VYT+69A;6EL>3IT:6UEF4],T0Q/E1H MF4],T0Q/B8C M,38P.SPO9F]N=#X\+W1D/B`-"B`@(#QT9"!V86QI9VX],T1B;W1T;VT^/&9O M;G0@"!S;VQI9"`C,#`P,#`P)SX\9F]N="!S='EL M93TS1"=F;VYT+69A;6EL>3IT:6UEF4],T0Q/C(P M,3(\+V9O;G0^/"]T9#X@#0H@("`\=&0@=F%L:6=N/3-$8F]T=&]M/CQF;VYT M('-I>F4],T0Q/B8C,38P.SPO9F]N=#X\+W1D/B`-"B`@(#QT9"!V86QI9VX] M,T1B;W1T;VT^/&9O;G0@"!S;VQI9"`C,#`P,#`P M)SX\9F]N="!S='EL93TS1"=F;VYT+69A;6EL>3IT:6UEF4],T0Q/C(P,3$\+V9O;G0^/"]T9#X@#0H@("`\=&0@=F%L:6=N/3-$ M8F]T=&]M/CQF;VYT('-I>F4],T0Q/B8C,38P.SPO9F]N=#X\+W1D/@T*("`@ M/"]T6QE/3-$)VUAF4],T0Q/B8C,38P.SPO9F]N=#X\ M+W1D/B`-"B`@(#QT9"!V86QI9VX],T1B;W1T;VT^/&9O;G0@6QE/3-$)V9O;G0M9F%M:6QY.G1I;65S(&YE=R!R;VUA;B<@ M3IT:6UEF4],T0R/B8C,38P.SPO9F]N=#X\+W1D M/B`-"B`@(#QT9"!V86QI9VX],T1B;W1T;VT^/&9O;G0@3IT:6UEF4] M,T0R/B0\+V9O;G0^/"]T9#X@#0H@("`\=&0@=F%L:6=N/3-$8F]T=&]M(&%L M:6=N/3-$6QE/3-$ M)V9O;G0M9F%M:6QY.G1I;65S(&YE=R!R;VUA;B<@3IT:6UEF4],T0R/E-A;&5S(&%N9"!M87)K M971I;F<\+V9O;G0^/"]P/@T*("`@/"]T9#X@#0H@("`\=&0@=F%L:6=N/3-$ M8F]T=&]M/CQF;VYT('-I>F4],T0Q/B8C,38P.SPO9F]N=#X\+W1D/B`-"B`@ M(#QT9"!V86QI9VX],T1B;W1T;VT^/&9O;G0@3IT M:6UEF4],T0R/B8C,38P.SPO9F]N=#X\+W1D/B`- M"B`@(#QT9"!V86QI9VX],T1B;W1T;VT^/&9O;G0@F4],T0R M/B8C,38P.SPO9F]N=#X\+W1D/B`-"B`@(#QT9"!V86QI9VX],T1B;W1T;VT@ M86QI9VX],T1R:6=H=#X\9F]N="!S='EL93TS1"=F;VYT+69A;6EL>3IT:6UE MF4],T0R/C@U/"]F;VYT/CPO=&0^(`T*("`@/'1D M(&YO=W)A<#TS1&YO=W)A<"!V86QI9VX],T1B;W1T;VT^/&9O;G0@'0M:6YD96YT.BTQ+C`P96TG/CQF M;VYT('-T>6QE/3-$)V9O;G0M9F%M:6QY.G1I;65S(&YE=R!R;VUA;B<@F4] M,T0Q/B8C,38P.SPO9F]N=#X\+W1D/B`-"B`@(#QT9"!V86QI9VX],T1B;W1T M;VT^/&9O;G0@3IT:6UEF4],T0R/B8C,38P.SPO9F]N=#X\+W1D/B`-"B`@(#QT9"!V86QI9VX],T1B M;W1T;VT^/&9O;G0@3IT:6UEF4],T0R/B8C,38P.SPO9F]N=#X\+W1D M/B`-"B`@(#QT9"!V86QI9VX],T1B;W1T;VT@86QI9VX],T1R:6=H=#X\9F]N M="!S='EL93TS1"=F;VYT+69A;6EL>3IT:6UEF4] M,T0R/C@U/"]F;VYT/CPO=&0^(`T*("`@/'1D(&YO=W)A<#TS1&YO=W)A<"!V M86QI9VX],T1B;W1T;VT^/&9O;G0@'0M:6YD96YT.BTQ M+C`P96TG/CQF;VYT('-T>6QE/3-$)V9O;G0M9F%M:6QY.G1I;65S(&YE=R!R M;VUA;B<@6QE/3-$)V9O;G0M9F%M:6QY.G1I;65S M(&YE=R!R;VUA;B<@6QE M/3-$)V9O;G0M9F%M:6QY.G1I;65S(&YE=R!R;VUA;B<@3IT:6UEF4],T0R/B8C,38P.SPO9F]N=#X\+W1D/B`-"B`@(#QT9"!V M86QI9VX],T1B;W1T;VT^/&9O;G0@3IT:6UEF4],T0R/B8C,38P.SPO M9F]N=#X\+W1D/B`-"B`@(#QT9"!V86QI9VX],T1B;W1T;VT@86QI9VX],T1R M:6=H=#X\9F]N="!S='EL93TS1"=F;VYT+69A;6EL>3IT:6UEF4],T0R/C(P/"]F;VYT/CPO=&0^(`T*("`@/'1D(&YO=W)A<#TS M1&YO=W)A<"!V86QI9VX],T1B;W1T;VT^/&9O;G0@6QE/3-$9F]N="US:7IE.C%P M>#X@#0H@("`\=&0@=F%L:6=N/3-$8F]T=&]M/B8C,38P.SPO=&0^(`T*("`@ M/'1D('9A;&EG;CTS1&)O='1O;3XF(S$V,#L\+W1D/B`-"B`@(#QT9"!V86QI M9VX],T1B;W1T;VT^#0H@("`\<"!S='EL93TS1"=B;W)D97(M=&]P.C%P>"!S M;VQI9"`C,#`P,#`P)SXF(S$V,#L\+W`^#0H@("`\+W1D/B`-"B`@(#QT9"!V M86QI9VX],T1B;W1T;VT^#0H@("`\<"!S='EL93TS1"=B;W)D97(M=&]P.C%P M>"!S;VQI9"`C,#`P,#`P)SXF(S$V,#L\+W`^#0H@("`\+W1D/B`-"B`@(#QT M9#XF(S$V,#L\+W1D/B`-"B`@(#QT9"!V86QI9VX],T1B;W1T;VT^)B,Q-C`[ M/"]T9#X@#0H@("`\=&0@=F%L:6=N/3-$8F]T=&]M/@T*("`@/'`@F4],T0Q/B8C,38P.SPO9F]N=#X\+W1D/B`-"B`@(#QT9"!V86QI9VX] M,T1B;W1T;VT^/&9O;G0@6QE/3-$)V9O;G0M M9F%M:6QY.G1I;65S(&YE=R!R;VUA;B<@F4],T0Q/B8C,38P.SPO9F]N=#X\+W1D/B`-"B`@ M(#QT9"!V86QI9VX],T1B;W1T;VT^/&9O;G0@6QE/3-$)V9O;G0M9F%M:6QY.G1I;65S(&YE=R!R;VUA;B<@6QE/3-$9F]N="US:7IE.C%P>#X@#0H@("`\=&0@ M=F%L:6=N/3-$8F]T=&]M/B8C,38P.SPO=&0^(`T*("`@/'1D('9A;&EG;CTS M1&)O='1O;3XF(S$V,#L\+W1D/B`-"B`@(#QT9"!V86QI9VX],T1B;W1T;VT^ M#0H@("`\<"!S='EL93TS1"=B;W)D97(M=&]P.C-P>"!D;W5B;&4@(S`P,#`P M,"<^)B,Q-C`[/"]P/@T*("`@/"]T9#X@#0H@("`\=&0@=F%L:6=N/3-$8F]T M=&]M/@T*("`@/'`@2`M+3X-"B`@(#PO=&%B;&4^#0H@("`\<"!S='EL93TS M1"=M87)G:6XM=&]P.C$R<'@[;6%R9VEN+6)O='1O;3HP<'@[('1E>'0M:6YD M96YT.C0E)SX\9F]N="!S='EL93TS1"=F;VYT+69A;6EL>3IT:6UEF4],T0R/E1H92!";&%C:RU38VAO;&5S(&]P=&EO;B!V86QU M871I;VX@;6]D96P@:7,@=7-E9"!I;B!E2!T;R!M86ME('-E=F5R86P@ M87-S=6UP=&EO;G,@2!Y:65L9"!C=7)V92!I;B!E9F9E8W0@ M9F]R('1H90T*("`@97AP96-T960@;&EV97,@;V8@=&AE(&]P=&EO;G,@870@ M=&AE:7(@9&%T97,@;V8@9W)A;G0N(%-I;F-E($IU;'DF(S$V,#LQ+"`R,#`U M+"!T:&4@0V]M<&%N>2!H87,@=7-E9"!A(&1I=FED96YD('EI96QD(&]F('IE M2!C87-H(&1I=FED96YD M2!O9B!T:&4@8V]M;6]N('-T;V-K M+B!-86YA9V5M96YT(&)E;&EE=F5S('1H870@=&AE(&AI2P@86YD(&%C8V]R9&EN9VQY+"!A M('-T;V-K#0H@("!V;VQA=&EL:71Y(&9A8W1O65A'!E;G-E(&ES(')E8V]G;FEZ960@=7-I;F<@=&AE('-TF5D(&]N;'D@9F]R('1H M;W-E(&]P=&EO;G,@97AP96-T960@=&\@=F5S="P@=VET:"!F;W)F96ET=7)E MF4Z,7!X.VUA#MM87)G:6XM8F]T=&]M.C!P M>#XF(S$V,#L\+W`^#0H@("`\<"!S='EL93TS1"=M87)G:6XM=&]P.C!P>#MM M87)G:6XM8F]T=&]M.C!P>#L@=&5X="UI;F1E;G0Z-"4G/CQF;VYT('-T>6QE M/3-$)V9O;G0M9F%M:6QY.G1I;65S(&YE=R!R;VUA;B<@F4Z,3)P>#MM87)G:6XM=&]P.C!P>#MM M87)G:6XM8F]T=&]M.C!P>#XF(S$V,#L\+W`^#0H@("`\=&%B;&4@8V5L;'-P M86-I;F<],T0P(&-E;&QP861D:6YG/3-$,"!W:61T:#TS1#6QE/3-$)V)OF4],T0Q/B8C,38P.SPO9F]N=#X\+W1D M/B`-"B`@(#QT9"!V86QI9VX],T1B;W1T;VT^/&9O;G0@3IT:6UEF4],T0Q/E1HF4],T0Q/B8C,38P.SPO9F]N=#X\+W1D M/B`-"B`@(#QT9"!V86QI9VX],T1B;W1T;VT@86QI9VX],T1C96YT97(@6QE/3-$)V)O6QE/3-$)V9O;G0M M9F%M:6QY.G1I;65S(&YE=R!R;VUA;B<@6QE M/3-$)VUA6QE/3-$)V9O;G0M9F%M:6QY.G1I;65S(&YE=R!R M;VUA;B<@65AF4],T0Q/B8C,38P.SPO M9F]N=#X\+W1D/B`-"B`@(#QT9"!V86QI9VX],T1B;W1T;VT@86QI9VX],T1C M96YT97(^/&9O;G0@6QE/3-$)VUA6QE/3-$)V9O;G0M9F%M:6QY.G1I;65S(&YE M=R!R;VUA;B<@3IT:6UEF4],T0R/C$P,R4\+V9O;G0^/"]T9#X-"B`@(#PO='(^(`T*("`@/'1R(&)G M8V]L;W(],T0C8V-E969F/B`-"B`@(#QT9"!V86QI9VX],T1T;W`^#0H@("`\ M<"!S='EL93TS1"=M87)G:6XM;&5F=#HQ+C`P96T[('1E>'0M:6YD96YT.BTQ M+C`P96TG/CQF;VYT('-T>6QE/3-$)V9O;G0M9F%M:6QY.G1I;65S(&YE=R!R M;VUA;B<@3IT:6UEF4],T0R/B0P+C`P/"]F;VYT M/CPO=&0^(`T*("`@/'1D('9A;&EG;CTS1&)O='1O;3X\9F]N="!S:7IE/3-$ M,3XF(S$V,#L\+V9O;G0^/"]T9#X@#0H@("`\=&0@=F%L:6=N/3-$8F]T=&]M M(&%L:6=N/3-$8V5N=&5R/CQF;VYT('-T>6QE/3-$)V9O;G0M9F%M:6QY.G1I M;65S(&YE=R!R;VUA;B<@'0M:6YD96YT.BTQ M+C`P96TG/CQF;VYT('-T>6QE/3-$)V9O;G0M9F%M:6QY.G1I;65S(&YE=R!R M;VUA;B<@F4],T0Q/B8C,38P.SPO9F]N=#X\+W1D/B`-"B`@(#QT9"!V86QI9VX] M,T1B;W1T;VT@86QI9VX],T1C96YT97(^/&9O;G0@3IT:6UE MF4],T0R/C(N,3@E/"]F;VYT/CPO=&0^#0H@("`\ M+W1R/@T*("`@/"$M+2!%;F0@5&%B;&4@0F]D>2`M+3X-"B`@(#PO=&%B;&4^ M#0H@("`\<"!S='EL93TS1"=M87)G:6XM=&]P.C$R<'@[;6%R9VEN+6)O='1O M;3HP<'@[('1E>'0M:6YD96YT.C0E)SX\9F]N="!S='EL93TS1"=F;VYT+69A M;6EL>3IT:6UEF4],T0R/D$@2!O9B!O M<'1I;VX@86-T:79I='D@=6YD97(@;W5R('-T;V-K(&]P=&EO;B!P;&%NF4Z,3)P>#MM87)G:6XM=&]P.C!P>#MM87)G:6XM8F]T=&]M M.C!P>#XF(S$V,#L\+W`^#0H@("`\=&%B;&4@8V5L;'-P86-I;F<],T0P(&-E M;&QP861D:6YG/3-$,"!W:61T:#TS1#$P,"4@8F]R9&5R/3-$,"!S='EL93TS M1"=B;W)D97(M8V]L;&%P'0M86QI9VXZ(&QE9G0G M(&%L:6=N/3-$8V5N=&5R/@T*("`@/"$M+2!"96=I;B!486)L92!(96%D("TM M/@T*("`@/'1R/B`-"B`@(#QT9"!W:61T:#TS1#8P)3XF(S$V,#L\+W1D/B`- M"B`@(#QT9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0U)3XF(S$V,#L\+W1D M/B`-"B`@(#QT9#XF(S$V,#L\+W1D/B`-"B`@(#QT9#XF(S$V,#L\+W1D/B`- M"B`@(#QT9#XF(S$V,#L\+W1D/B`-"B`@(#QT9"!V86QI9VX],T1B;W1T;VT@ M=VED=&@],T0U)3XF(S$V,#L\+W1D/B`-"B`@(#QT9#XF(S$V,#L\+W1D/B`- M"B`@(#QT9#XF(S$V,#L\+W1D/B`-"B`@(#QT9#XF(S$V,#L\+W1D/B`-"B`@ M(#QT9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0U)3XF(S$V,#L\+W1D/B`- M"B`@(#QT9#XF(S$V,#L\+W1D/B`-"B`@(#QT9#XF(S$V,#L\+W1D/B`-"B`@ M(#QT9#XF(S$V,#L\+W1D/B`-"B`@(#QT9"!V86QI9VX],T1B;W1T;VT@=VED M=&@],T0U)3XF(S$V,#L\+W1D/B`-"B`@(#QT9#XF(S$V,#L\+W1D/B`-"B`@ M(#QT9#XF(S$V,#L\+W1D/B`-"B`@(#QT9#XF(S$V,#L\+W1D/@T*("`@/"]T MF4],T0Q/B8C,38P.SPO9F]N=#X\+W1D/B`-"B`@ M(#QT9"!V86QI9VX],T1B;W1T;VT@8V]LF4],T0Q/B8C,38P.SPO9F]N=#X\+W1D/B`-"B`@ M(#QT9"!V86QI9VX],T1B;W1T;VT^/&9O;G0@3IT:6UE MF4],T0Q/E=E:6=H=&5D/&)R("\^879EF4],T0Q/B8C,38P.SPO9F]N=#X\ M+W1D/B`-"B`@(#QT9"!V86QI9VX],T1B;W1T;VT^/&9O;G0@3IT:6UEF4],T0Q/E=E:6=H=&5D)B,Q-C`[ M879E65AF4],T0Q/B8C,38P.SPO9F]N M=#X\+W1D/B`-"B`@(#QT9"!V86QI9VX],T1B;W1T;VT@8V]L2`M+3X-"B`@(#QT3IT:6UEF4],T0R/D]P M=&EO;G,@;W5T3IT:6UE MF4],T0R/B8C,38P.SPO9F]N=#X\+W1D/B`-"B`@ M(#QT9"!V86QI9VX],T1B;W1T;VT@86QI9VX],T1R:6=H=#X\9F]N="!S='EL M93TS1"=F;VYT+69A;6EL>3IT:6UEF4],T0R/C,L M.#4X+#`P,#PO9F]N=#X\+W1D/B`-"B`@(#QT9"!N;W=R87`],T1N;W=R87`@ M=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-T>6QE/3-$)V9O;G0M9F%M:6QY.G1I M;65S(&YE=R!R;VUA;B<@6QE/3-$)V9O;G0M9F%M:6QY.G1I;65S(&YE=R!R;VUA;B<@3IT:6UEF4],T0R/C,N-S4\+V9O;G0^/"]T9#X@#0H@("`\=&0@;F]W M3IT:6UEF4],T0R/B8C,38P.SPO M9F]N=#X\+W1D/B`-"B`@(#QT9"!V86QI9VX],T1B;W1T;VT^/&9O;G0@'0M:6YD96YT.BTQ+C`P96TG M/CQF;VYT('-T>6QE/3-$)V9O;G0M9F%M:6QY.G1I;65S(&YE=R!R;VUA;B<@ M6QE/3-$)V9O;G0M9F%M:6QY.G1I;65S(&YE=R!R;VUA;B<@ M6QE/3-$)V9O;G0M9F%M M:6QY.G1I;65S(&YE=R!R;VUA;B<@6QE/3-$)V9O;G0M9F%M:6QY.G1I;65S(&YE=R!R;VUA;B<@ M6QE/3-$)V9O;G0M9F%M M:6QY.G1I;65S(&YE=R!R;VUA;B<@F4],T0R M/C(N.#(\+V9O;G0^/"]T9#X@#0H@("`\=&0@;F]W3IT:6UE MF4],T0R/B8C,38P.SPO9F]N=#X\+W1D/B`-"B`@ M(#QT9"!V86QI9VX],T1B;W1T;VT^/&9O;G0@'0M:6YD96YT.BTQ+C`P M96TG/CQF;VYT('-T>6QE/3-$)V9O;G0M9F%M:6QY.G1I;65S(&YE=R!R;VUA M;B<@&5R8VES960\+V9O;G0^/"]P M/@T*("`@/"]T9#X@#0H@("`\=&0@=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-I M>F4],T0Q/B8C,38P.SPO9F]N=#X\+W1D/B`-"B`@(#QT9"!V86QI9VX],T1B M;W1T;VT^/&9O;G0@6QE/3-$)V9O;G0M9F%M:6QY.G1I;65S(&YE=R!R M;VUA;B<@3IT:6UEF4],T0R/B0\+V9O;G0^ M/"]T9#X@#0H@("`\=&0@=F%L:6=N/3-$8F]T=&]M(&%L:6=N/3-$F4],T0Q/B8C M,38P.SPO9F]N=#X\+W1D/B`-"B`@(#QT9"!V86QI9VX],T1B;W1T;VT^)B,Q M-C`[/"]T9#X@#0H@("`\=&0@=F%L:6=N/3-$8F]T=&]M/B8C,38P.SPO=&0^ M(`T*("`@/'1D('9A;&EG;CTS1&)O='1O;3XF(S$V,#L\+W1D/B`-"B`@(#QT M9"!V86QI9VX],T1B;W1T;VT^/&9O;G0@F4],T0R M/D]P=&EO;G,@9F]R9F5I=&5D+"!C86YC96QE9"P@;W(@97AP:7)E9#PO9F]N M=#X\+W`^#0H@("`\+W1D/B`-"B`@(#QT9"!V86QI9VX],T1B;W1T;VT^/&9O M;G0@3IT:6UEF4],T0R/B8C,38P.SPO9F]N=#X\+W1D/B`-"B`@(#QT M9"!V86QI9VX],T1B;W1T;VT@86QI9VX],T1R:6=H=#X\9F]N="!S='EL93TS M1"=F;VYT+69A;6EL>3IT:6UEF4],T0R/B@Q,S6QE M/3-$)V9O;G0M9F%M:6QY.G1I;65S(&YE=R!R;VUA;B<@3IT:6UEF4],T0R/C(N-3D\+V9O;G0^/"]T9#X@#0H@("`\=&0@;F]W3IT:6UEF4],T0R/B8C,38P.SPO9F]N M=#X\+W1D/B`-"B`@(#QT9"!V86QI9VX],T1B;W1T;VT^/&9O;G0@6QE/3-$9F]N="US:7IE.C%P>#X@#0H@("`\=&0@=F%L:6=N M/3-$8F]T=&]M/B8C,38P.SPO=&0^(`T*("`@/'1D('9A;&EG;CTS1&)O='1O M;3XF(S$V,#L\+W1D/B`-"B`@(#QT9"!V86QI9VX],T1B;W1T;VT^#0H@("`\ M<"!S='EL93TS1"=B;W)D97(M=&]P.C%P>"!S;VQI9"`C,#`P,#`P)SXF(S$V M,#L\+W`^#0H@("`\+W1D/B`-"B`@(#QT9"!V86QI9VX],T1B;W1T;VT^#0H@ M("`\<"!S='EL93TS1"=B;W)D97(M=&]P.C%P>"!S;VQI9"`C,#`P,#`P)SXF M(S$V,#L\+W`^#0H@("`\+W1D/B`-"B`@(#QT9#XF(S$V,#L\+W1D/B`-"B`@ M(#QT9"!V86QI9VX],T1B;W1T;VT^)B,Q-C`[/"]T9#X@#0H@("`\=&0@=F%L M:6=N/3-$8F]T=&]M/B8C,38P.SPO=&0^(`T*("`@/'1D('9A;&EG;CTS1&)O M='1O;3XF(S$V,#L\+W1D/B`-"B`@(#QT9"!V86QI9VX],T1B;W1T;VT^)B,Q M-C`[/"]T9#X@#0H@("`\=&0@=F%L:6=N/3-$8F]T=&]M/B8C,38P.SPO=&0^ M(`T*("`@/'1D('9A;&EG;CTS1&)O='1O;3XF(S$V,#L\+W1D/B`-"B`@(#QT M9"!V86QI9VX],T1B;W1T;VT^)B,Q-C`[/"]T9#X@#0H@("`\=&0@=F%L:6=N M/3-$8F]T=&]M/B8C,38P.SPO=&0^(`T*("`@/'1D('9A;&EG;CTS1&)O='1O M;3XF(S$V,#L\+W1D/B`-"B`@(#QT9"!V86QI9VX],T1B;W1T;VT^)B,Q-C`[ M/"]T9#X@#0H@("`\=&0@=F%L:6=N/3-$8F]T=&]M/B8C,38P.SPO=&0^(`T* M("`@/'1D('9A;&EG;CTS1&)O='1O;3XF(S$V,#L\+W1D/@T*("`@/"]T6QE/3-$)VUAF4],T0Q/B8C,38P M.SPO9F]N=#X\+W1D/B`-"B`@(#QT9"!V86QI9VX],T1B;W1T;VT^/&9O;G0@ M3IT:6UEF4] M,T0R/B8C,38P.SPO9F]N=#X\+W1D/B`-"B`@(#QT9"!V86QI9VX],T1B;W1T M;VT^/&9O;G0@3IT M:6UEF4],T0R/B0\+V9O;G0^/"]T9#X@#0H@("`\ M=&0@=F%L:6=N/3-$8F]T=&]M(&%L:6=N/3-$F4],T0Q/B8C,38P.SPO9F]N=#X\ M+W1D/B`-"B`@(#QT9"!V86QI9VX],T1B;W1T;VT^/&9O;G0@F4] M,T0Q/B8C,38P.SPO9F]N=#X\+W1D/B`-"B`@(#QT9"!V86QI9VX],T1B;W1T M;VT^/&9O;G0@6QE/3-$)V9O;G0M9F%M:6QY M.G1I;65S(&YE=R!R;VUA;B<@6QE/3-$9F]N="US:7IE.C%P>#X@#0H@("`\=&0@=F%L:6=N/3-$8F]T M=&]M/B8C,38P.SPO=&0^(`T*("`@/'1D('9A;&EG;CTS1&)O='1O;3XF(S$V M,#L\+W1D/B`-"B`@(#QT9"!V86QI9VX],T1B;W1T;VT^#0H@("`\<"!S='EL M93TS1"=B;W)D97(M=&]P.C%P>"!S;VQI9"`C,#`P,#`P)SXF(S$V,#L\+W`^ M#0H@("`\+W1D/B`-"B`@(#QT9"!V86QI9VX],T1B;W1T;VT^#0H@("`\<"!S M='EL93TS1"=B;W)D97(M=&]P.C%P>"!S;VQI9"`C,#`P,#`P)SXF(S$V,#L\ M+W`^#0H@("`\+W1D/B`-"B`@(#QT9#XF(S$V,#L\+W1D/B`-"B`@(#QT9"!V M86QI9VX],T1B;W1T;VT^)B,Q-C`[/"]T9#X@#0H@("`\=&0@=F%L:6=N/3-$ M8F]T=&]M/B8C,38P.SPO=&0^(`T*("`@/'1D('9A;&EG;CTS1&)O='1O;3XF M(S$V,#L\+W1D/B`-"B`@(#QT9"!V86QI9VX],T1B;W1T;VT^)B,Q-C`[/"]T M9#X@#0H@("`\=&0@=F%L:6=N/3-$8F]T=&]M/B8C,38P.SPO=&0^(`T*("`@ M/'1D('9A;&EG;CTS1&)O='1O;3XF(S$V,#L\+W1D/B`-"B`@(#QT9"!V86QI M9VX],T1B;W1T;VT^)B,Q-C`[/"]T9#X@#0H@("`\=&0@=F%L:6=N/3-$8F]T M=&]M/B8C,38P.SPO=&0^(`T*("`@/'1D('9A;&EG;CTS1&)O='1O;3XF(S$V M,#L\+W1D/B`-"B`@(#QT9"!V86QI9VX],T1B;W1T;VT^)B,Q-C`[/"]T9#X@ M#0H@("`\=&0@=F%L:6=N/3-$8F]T=&]M/B8C,38P.SPO=&0^(`T*("`@/'1D M('9A;&EG;CTS1&)O='1O;3XF(S$V,#L\+W1D/@T*("`@/"]T6QE/3-$)VUA MF4],T0Q/B8C,38P.SPO9F]N=#X\+W1D/B`-"B`@(#QT9"!V M86QI9VX],T1B;W1T;VT^/&9O;G0@3IT M:6UEF4],T0R/B8C,38P.SPO9F]N=#X\+W1D/B`- M"B`@(#QT9"!V86QI9VX],T1B;W1T;VT^/&9O;G0@F4],T0R M/B0\+V9O;G0^/"]T9#X@#0H@("`\=&0@=F%L:6=N/3-$8F]T=&]M(&%L:6=N M/3-$F4],T0Q/B8C,38P.SPO9F]N=#X\+W1D/B`-"B`@(#QT9"!V86QI9VX],T1B M;W1T;VT^/&9O;G0@F4],T0Q/B8C,38P.SPO9F]N=#X\+W1D/B`- M"B`@(#QT9"!V86QI9VX],T1B;W1T;VT^/&9O;G0@6QE/3-$)V9O;G0M9F%M:6QY.G1I;65S(&YE=R!R;VUA;B<@6QE/3-$9F]N="US:7IE.C%P>#X@ M#0H@("`\=&0@=F%L:6=N/3-$8F]T=&]M/B8C,38P.SPO=&0^(`T*("`@/'1D M('9A;&EG;CTS1&)O='1O;3XF(S$V,#L\+W1D/B`-"B`@(#QT9"!V86QI9VX] M,T1B;W1T;VT^#0H@("`\<"!S='EL93TS1"=B;W)D97(M=&]P.C-P>"!D;W5B M;&4@(S`P,#`P,"<^)B,Q-C`[/"]P/@T*("`@/"]T9#X@#0H@("`\=&0@=F%L M:6=N/3-$8F]T=&]M/@T*("`@/'`@3IT:6UEF4],T0R/E9E MF4],T0Q/B8C,38P.SPO M9F]N=#X\+W1D/B`-"B`@(#QT9"!V86QI9VX],T1B;W1T;VT^/&9O;G0@6QE M/3-$)V9O;G0M9F%M:6QY.G1I;65S(&YE=R!R;VUA;B<@6QE/3-$)V9O;G0M9F%M:6QY.G1I;65S(&YE M=R!R;VUA;B<@3IT:6UEF4],T0R/C@N-#8\+V9O;G0^ M/"]T9#X@#0H@("`\=&0@;F]W3IT:6UEF4],T0R/B8C,38P.SPO9F]N=#X\+W1D/B`-"B`@(#QT9"!V86QI9VX] M,T1B;W1T;VT^/&9O;G0@6QE/3-$9F]N="US:7IE.C$R<'@[ M;6%R9VEN+71O<#HP<'@[;6%R9VEN+6)O='1O;3HP<'@^)B,Q-C`[/"]P/@T* M("`@/'1A8FQE('-T>6QE/3-$)V)O3IT:6UEF4] M,T0R/B@Q*3PO9F]N=#X\+W1D/B`-"B`@(#QT9"!A;&EG;CTS1&QE9G0@=F%L M:6=N/3-$=&]P/CQF;VYT('-T>6QE/3-$)V9O;G0M9F%M:6QY.G1I;65S(&YE M=R!R;VUA;B<@6QE/3-$)VUA#MM87)G M:6XM8F]T=&]M.C!P>#L@=&5X="UI;F1E;G0Z-"4G/CQF;VYT('-T>6QE/3-$ M)V9O;G0M9F%M:6QY.G1I;65S(&YE=R!R;VUA;B<@&-E<'0@<&5R('-H87)E(&%M;W5N=',I.B`\+V9O;G0^ M/"]P/@T*("`@/'`@F4Z,3)P>#MM87)G:6XM=&]P M.C!P>#MM87)G:6XM8F]T=&]M.C!P>#XF(S$V,#L\+W`^#0H@("`\=&%B;&4@ M8V5L;'-P86-I;F<],T0P(&-E;&QP861D:6YG/3-$,"!W:61T:#TS1#6QE/3-$)V)OF4],T0Q/B8C,38P.SPO9F]N=#X\+W1D M/B`-"B`@(#QT9"!V86QI9VX],T1B;W1T;VT^/&9O;G0@3IT:6UEF4],T0Q/E1HF4],T0Q/B8C,38P.SPO9F]N=#X\+W1D M/B`-"B`@(#QT9"!V86QI9VX],T1B;W1T;VT^/&9O;G0@3IT:6UEF4],T0Q/C(P,3(\+V9O;G0^/"]T9#X@ M#0H@("`\=&0@=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-I>F4],T0Q/B8C,38P M.SPO9F]N=#X\+W1D/B`-"B`@(#QT9"!V86QI9VX],T1B;W1T;VT^/&9O;G0@ M"!S;VQI9"`C,#`P,#`P)SX\9F]N="!S='EL93TS M1"=F;VYT+69A;6EL>3IT:6UEF4],T0Q/C(P,3$\ M+V9O;G0^/"]T9#X@#0H@("`\=&0@=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-I M>F4],T0Q/B8C,38P.SPO9F]N=#X\+W1D/@T*("`@/"]T6QE/3-$)VUA6QE/3-$)V9O;G0M9F%M:6QY.G1I;65S(&YE=R!R;VUA;B<@3IT:6UEF4],T0R/C(W-SPO9F]N=#X\+W1D/B`-"B`@(#QT9"!N;W=R M87`],T1N;W=R87`@=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-T>6QE/3-$)V9O M;G0M9F%M:6QY.G1I;65S(&YE=R!R;VUA;B<@6QE/3-$)V9O;G0M9F%M:6QY.G1I;65S(&YE=R!R;VUA M;B<@3IT:6UEF4],T0R/C4Y-#PO9F]N=#X\+W1D/B`- M"B`@(#QT9"!N;W=R87`],T1N;W=R87`@=F%L:6=N/3-$8F]T=&]M/CQF;VYT M('-T>6QE/3-$)V9O;G0M9F%M:6QY.G1I;65S(&YE=R!R;VUA;B<@3IT:6UEF4],T0R/E1A>"!B M96YE9FET(')E;&%T960@=&\@&5R8VES960@*#$I M/"]F;VYT/CPO<#X-"B`@(#PO=&0^(`T*("`@/'1D('9A;&EG;CTS1&)O='1O M;3X\9F]N="!S:7IE/3-$,3XF(S$V,#L\+V9O;G0^/"]T9#X@#0H@("`\=&0@ M=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-T>6QE/3-$)V9O;G0M9F%M:6QY.G1I M;65S(&YE=R!R;VUA;B<@6QE/3-$)V9O;G0M9F%M:6QY.G1I;65S(&YE=R!R;VUA;B<@F4],T0Q/B8C,38P.SPO9F]N M=#X\+W1D/B`-"B`@(#QT9"!V86QI9VX],T1B;W1T;VT^/&9O;G0@3IT:6UEF4],T0R/B8C,38P.SPO M9F]N=#X\+W1D/@T*("`@/"]T6QE/3-$)VUA M6QE/3-$)V9O;G0M9F%M:6QY M.G1I;65S(&YE=R!R;VUA;B<@3IT:6UEF4],T0R/C$Q M/"]F;VYT/CPO=&0^(`T*("`@/'1D(&YO=W)A<#TS1&YO=W)A<"!V86QI9VX] M,T1B;W1T;VT^/&9O;G0@F4],T0Q/B8C,38P.SPO9F]N=#X\ M+W1D/B`-"B`@(#QT9"!V86QI9VX],T1B;W1T;VT^/&9O;G0@6QE/3-$)V9O;G0M9F%M:6QY.G1I;65S(&YE=R!R;VUA;B<@ M'0M:6YD M96YT.BTQ+C`P96TG/CQF;VYT('-T>6QE/3-$)V9O;G0M9F%M:6QY.G1I;65S M(&YE=R!R;VUA;B<@6QE/3-$)V9O;G0M9F%M:6QY.G1I;65S(&YE=R!R M;VUA;B<@3IT:6UEF4],T0R/C$N.3D\+V9O;G0^/"]T M9#X@#0H@("`\=&0@;F]W3IT:6UEF4],T0R/B8C,38P.SPO9F]N=#X\+W1D/B`-"B`@(#QT9"!V86QI9VX],T1B M;W1T;VT^/&9O;G0@3IT:6UEF4],T0R/B0\+V9O;G0^/"]T9#X@#0H@ M("`\=&0@=F%L:6=N/3-$8F]T=&]M(&%L:6=N/3-$'0M:6YD96YT.BTQ+C`P96TG/CQF;VYT('-T>6QE/3-$)V9O;G0M9F%M M:6QY.G1I;65S(&YE=R!R;VUA;B<@6QE/3-$)V9O;G0M9F%M:6QY.G1I;65S(&YE=R!R M;VUA;B<@3IT:6UEF4],T0R/C4U-SPO9F]N=#X\+W1D M/B`-"B`@(#QT9"!N;W=R87`],T1N;W=R87`@=F%L:6=N/3-$8F]T=&]M/CQF M;VYT('-T>6QE/3-$)V9O;G0M9F%M:6QY.G1I;65S(&YE=R!R;VUA;B<@6QE/3-$)V9O;G0M9F%M:6QY M.G1I;65S(&YE=R!R;VUA;B<@3IT:6UEF4],T0R/C$Y M.3PO9F]N=#X\+W1D/B`-"B`@(#QT9"!N;W=R87`],T1N;W=R87`@=F%L:6=N M/3-$8F]T=&]M/CQF;VYT('-T>6QE/3-$)V9O;G0M9F%M:6QY.G1I;65S(&YE M=R!R;VUA;B<@2`M+3X-"B`@(#PO=&%B;&4^#0H@ M("`\<"!S='EL93TS1&9O;G0M'0M86QI9VXZ(&QE9G0G M(&)OF4],T0R M/D5X8V5S6QE M/3-$)V9O;G0M9F%M:6QY.G1I;65S(&YE=R!R;VUA;B<@2`D,3@S+#`P,"!D=7)I;F<@36%R8V@@,C`Q,BXF(S$V,#M4 M:&4@=')A;G-A8W1I;VX@9&ED(&YO="!R97-U;'0@:6X@86YY(&%D9&ET:6]N M86P@8V]M<&5N2!AF4Z,7!X.VUA#MM87)G:6XM M8F]T=&]M.C!P>#XF(S$V,#L\+W`^#0H@("`\<"!S='EL93TS1&UA6QE/3-$)V9O;G0M M9F%M:6QY.G1I;65S(&YE=R!R;VUA;B<@'0M:6YD96YT.C0E)SX\9F]N="!S='EL93TS M1"=F;VYT+69A;6EL>3IT:6UEF4],T0R/D)A2!D:79I9&EN9R!L M;W-S(&%V86EL86)L92!T;R!C;VUM;VX@2!D:6QU=&EV92!S96-U M XML 14 R8.htm IDEA: XBRL DOCUMENT

Stock-Based Awards and Per Share Information

3 Months Ended

Mar. 31, 2012

Stock-Based Awards and Per Share Information [Abstract]

STOCK-BASED AWARDS AND PER SHARE INFORMATION

NOTE 3 – STOCK-BASED AWARDS AND PER SHARE INFORMATION

Stock-Based Compensation

The following table summarizes the income statement classification of compensation expense associated with share-based payments (in thousands):


	Three Months Ended March 31,
	2012		2011
Cost of revenue	$	58	$	30
Sales and marketing		121		85
General and administrative		358		85
Engineering and development		46		20

	$	583	$	220

The stock option fair values were estimated using the Black-Scholes option-pricing model with the following assumptions:


	Three Months Ended March 31,
	2012	2011
Expected term	4.1 years	4.2 years
Volatility	102%	103%
Annual dividend per share	$0.00	$0.00
Risk-free interest rate	0.93%	2.18%

A summary of option activity under our stock option plans for the three months ended March 31, 2012 is as follows:


	Shares			Weighted average exercise price		Weighted average remaining contractual term (years)		Aggregate intrinsic value(1)
Options outstanding at December 31, 2011		3,858,000		$	3.75
Plus: Options granted		134,000		$	2.82
Less: Options exercised		(109,000	)	$	2.53
Options forfeited, canceled, or expired		(137,000	)	$	2.59

Options outstanding at March 31, 2012		3,746,000		$	3.79		4.25	$	1,539,000

Options exercisable at March 31, 2012		2,250,000		$	4.35		4.26	$	1,015,000

Vested options expired during the quarter ended March 31, 2012		1,000		$	8.46

(1)	The intrinsic value calculation does not include negative values. This can occur when the fair market value on the reporting date is less than the exercise price of the grant.

Cash proceeds along with fair value disclosures related to grants, exercises and vesting options are provided in the following table (in thousands, except per share amounts):


	Three Months Ended March 31,
	2012		2011
Proceeds from stock options exercised	$	277	$	594
Tax benefit related to stock options exercised (1)		N/A		N/A
Intrinsic value of stock options exercised (2)	$	11	$	609
Weighted-average fair value of options granted during period	$	1.99	$	2.39
Total fair value of shares vested during the period	$	557	$	199

(1)	Excess tax benefits received related to stock option exercises are presented as financing cash inflows. We currently do not receive a tax benefit related to the exercise of stock options due to our net operating losses.

(2)	The intrinsic value of stock options exercised is the amount by which the market price of the stock on the date of exercise exceeded the market price of the stock on the date of grant.

Net Loss Per Share – Basic and Diluted

Warrants

XML 15 R2.htm IDEA: XBRL DOCUMENT

Consolidated Balance Sheets (Unaudited) (USD $) In Thousands, unless otherwise specified	Mar. 31, 2012	Dec. 31, 2011
Current assets:
Cash and cash equivalents	$ 2,772	$ 3,307
Accounts receivable, less allowance of $305 and $289 in 2012 and 2011, respectively	8,983	8,899
Inventory, net	10,337	11,312
Prepaid expenses and other current assets	1,163	1,808
Total current assets	23,255	25,326
Property, plant and equipment, net	1,338	1,148
Intangible assets, net	179	212
Goodwill	2,926	2,926
Deferred tax asset	8	8
Other assets	187	187
Total assets	27,893	29,807
Current liabilities:
Accounts payable	7,524	7,804
Accrued liabilities	5,442	6,177
Customer deposits	20	165
Deferred revenue, current portion	2,232	2,136
Total current liabilities	15,218	16,282
Deferred tax liabilities	612	594
Deferred revenue, long-term	17	25
Other liabilities, long-term	139	337
Total liabilities	15,986	17,238
Commitments and contingencies (Notes 9 and 13)
Stockholders' equity:
Preferred stock, par value $0.001; 1,000 shares authorized, no shares issued and outstanding
Common stock, par value $0.001, 50,000 shares authorized; 32,769 and 32,502 shares issued in 2012 and 2011, respectively; and 30,805 and 30,538 shares outstanding in 2012 and 2011, respectively	33	33
Additional paid-in capital	139,454	138,507
Accumulated other comprehensive loss	(297)	(360)
Accumulated deficit	(110,884)	(109,212)
Stockholders' equity excluding treasury stock	28,306	28,968
Treasury stock (cost of 1,964 shares repurchased)	(16,399)	(16,399)
Total stockholders' equity	11,907	12,569
Total liabilities and stockholders' equity	$ 27,893	$ 29,807

XML 16 R6.htm IDEA: XBRL DOCUMENT

Basis of Presentation

3 Months Ended

Mar. 31, 2012

Basis of Presentation [Abstract]

BASIS OF PRESENTATION

NOTE 1 – BASIS OF PRESENTATION

The Company

Basis of Presentation

Use of Estimates

Critical Accounting Policies

Fair Value of Financial Instruments

Liquidity and Management’s Plans

- Definition

The entire disclosure for organization, consolidation and basis of presentation of financial statements disclosure.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 720

-SubTopic 15

-URI http://asc.fasb.org/subtopic&trid=2122524

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 810

-SubTopic 10

-Section 50

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=6921930&loc=d3e5614-111684

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 810

-SubTopic 10

-Section 50

-Paragraph 8

-URI http://asc.fasb.org/extlink&oid=6970148&loc=SL6228881-111685

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Name Statement of Position (SOP)

-Publisher AICPA

-Number 94-6

-Paragraph 10

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 272

-SubTopic 10

-Section 50

-Paragraph 3

-URI http://asc.fasb.org/extlink&oid=6373374&loc=d3e70478-108055

Reference 6: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 205

-SubTopic 10

-Section 50

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=6359566&loc=d3e326-107755

Reference 7: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name FASB Staff Position (FSP)

-Number FAS140-4/FIN46(R)-8

-Paragraph 8, C1, C7

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 8: http://www.xbrl.org/2003/role/presentationRef

-Name FASB Interpretation (FIN)

-Publisher FASB

-Number 46R

-Paragraph 4, 14, 15

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 9: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 852

-SubTopic 10

-URI http://asc.fasb.org/subtopic&trid=2209116

Reference 10: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 275

-SubTopic 10

-URI http://asc.fasb.org/subtopic&trid=2134480

Reference 11: http://www.xbrl.org/2003/role/presentationRef

-Publisher AICPA

-Name Accounting Research Bulletin (ARB)

-Number 51

-Paragraph 2-6

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 12: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 915

-SubTopic 235

-Section 50

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=6472506&loc=d3e38932-110933

Reference 13: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 205

-SubTopic 10

-URI http://asc.fasb.org/subtopic&trid=2122150

Reference 14: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 205

-SubTopic 10

-Section 45

-Paragraph 3

-URI http://asc.fasb.org/extlink&oid=6359553&loc=d3e288-107754

Reference 15: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 235

-SubTopic 10

-Section 50

-Paragraph 3

-URI http://asc.fasb.org/extlink&oid=6367646&loc=d3e18780-107790

Reference 16: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 810

-SubTopic 10

-URI http://asc.fasb.org/subtopic&trid=2197480

+ Details

XML 17 Show.js IDEA: XBRL DOCUMENT /** * Rivet Software Inc. * * @copyright Copyright (c) 2006-2011 Rivet Software, Inc. All rights reserved. * Version 2.1.0.1 * */ var moreDialog = null; var Show = { Default:'raw', more:function( obj ){ var bClosed = false; if( moreDialog != null ) { try { bClosed = moreDialog.closed; } catch(e) { //Per article at http://support.microsoft.com/kb/244375 there is a problem with the WebBrowser control // that somtimes causes it to throw when checking the closed property on a child window that has been //closed. So if the exception occurs we assume the window is closed and move on from there. bClosed = true; } if( !bClosed ){ moreDialog.close(); } } obj = obj.parentNode.getElementsByTagName( 'pre' )[0]; var hasHtmlTag = false; var objHtml = ''; var raw = ''; //Check for raw HTML var nodes = obj.getElementsByTagName( '*' ); if( nodes.length ){ objHtml = obj.innerHTML; }else{ if( obj.innerText ){ raw = obj.innerText; }else{ raw = obj.textContent; } var matches = raw.match( /<\/?[a-zA-Z]{1}\w*[^>]*>/g ); if( matches && matches.length ){ objHtml = raw; //If there is an html node it will be 1st or 2nd, // but we can check a little further. var n = Math.min( 5, matches.length ); for( var i = 0; i < n; i++ ){ var el = matches[ i ].toString().toLowerCase(); if( el.indexOf( '= 0 ){ hasHtmlTag = true; break; } } } } if( objHtml.length ){ var html = ''; if( hasHtmlTag ){ html = objHtml; }else{ html = ''+ "\n"+''+ "\n"+' Report Preview Details'+ "\n"+' '+ "\n"+''+ "\n"+''+ objHtml + "\n"+''+ "\n"+''; } moreDialog = window.open("","More","width=700,height=650,status=0,resizable=yes,menubar=no,toolbar=no,scrollbars=yes"); moreDialog.document.write( html ); moreDialog.document.close(); if( !hasHtmlTag ){ moreDialog.document.body.style.margin = '0.5em'; } } else { //default view logic var lines = raw.split( "\n" ); var longest = 0; if( lines.length > 0 ){ for( var p = 0; p < lines.length; p++ ){ longest = Math.max( longest, lines[p].length ); } } //Decide on the default view this.Default = longest < 120 ? 'raw' : 'formatted'; //Build formatted view var text = raw.split( "\n\n" ) >= raw.split( "\r\n\r\n" ) ? raw.split( "\n\n" ) : raw.split( "\r\n\r\n" ) ; var formatted = ''; if( text.length > 0 ){ if( text.length == 1 ){ text = raw.split( "\n" ) >= raw.split( "\r\n" ) ? raw.split( "\n" ) : raw.split( "\r\n" ) ; formatted = "

"+ text.join( "

\n" ) +"

"; }else{ for( var p = 0; p < text.length; p++ ){ formatted += "

" + text[p] + "

\n"; } } }else{ formatted = '

' + raw + '

'; } html = ''+ "\n"+''+ "\n"+' Report Preview Details'+ "\n"+' '+ "\n"+''+ "\n"+''+ "\n"+' '+ "\n"+' '+ "\n"+' '+ "\n"+' '+ "\n"+' '+ "\n"+' '+ "\n"+' '+ "\n"+' '+ "\n"+' '+ "\n"+' '+ "\n"+'

'+ "\n"+' formatted: '+ ( this.Default == 'raw' ? 'as Filed' : 'with Text Wrapped' ) +''+ "\n"+'

'+ "\n"+' '+ "\n"+'

'+ "\n"+'

'+raw+'

'+ "\n"+'

'+ "\n"+''+ "\n"+''; moreDialog = window.open("","More","width=700,height=650,status=0,resizable=yes,menubar=no,toolbar=no,scrollbars=yes"); moreDialog.document.write(html); moreDialog.document.close(); this.toggle( moreDialog ); } moreDialog.document.title = 'Report Preview Details'; }, toggle:function( win, domLink ){ var domId = this.Default; var doc = win.document; var domEl = doc.getElementById( domId ); domEl.style.display = 'block'; this.Default = domId == 'raw' ? 'formatted' : 'raw'; if( domLink ){ domLink.innerHTML = this.Default == 'raw' ? 'with Text Wrapped' : 'as Filed'; } var domElOpposite = doc.getElementById( this.Default ); domElOpposite.style.display = 'none'; }, LastAR : null, showAR : function ( link, id, win ){ if( Show.LastAR ){ Show.hideAR(); } var ref = link; do { ref = ref.nextSibling; } while (ref && ref.nodeName != 'TABLE'); if (!ref || ref.nodeName != 'TABLE') { var tmp = win ? win.document.getElementById(id) : document.getElementById(id); if( tmp ){ ref = tmp.cloneNode(true); ref.id = ''; link.parentNode.appendChild(ref); } } if( ref ){ ref.style.display = 'block'; Show.LastAR = ref; } }, toggleNext : function( link ){ var ref = link; do{ ref = ref.nextSibling; }while( ref.nodeName != 'DIV' ); if( ref.style && ref.style.display && ref.style.display == 'none' ){ ref.style.display = 'block'; if( link.textContent ){ link.textContent = link.textContent.replace( '+', '-' ); }else{ link.innerText = link.innerText.replace( '+', '-' ); } }else{ ref.style.display = 'none'; if( link.textContent ){ link.textContent = link.textContent.replace( '-', '+' ); }else{ link.innerText = link.innerText.replace( '-', '+' ); } } }, hideAR : function(){ Show.LastAR.style.display = 'none'; } } XML 18 R7.htm IDEA: XBRL DOCUMENT

Recent Accounting Pronouncements

3 Months Ended

Mar. 31, 2012

Recent Accounting Pronouncements [Abstract]

RECENT ACCOUNTING PRONOUNCEMENTS

NOTE 2 – RECENT ACCOUNTING PRONOUNCEMENTS

Newly Adopted Accounting Standards

- Definition

The entire disclosure for reporting accounting changes and error corrections. It includes the conveyance of information necessary for a user of the Company's financial information to understand all aspects and required disclosure information concerning all changes and error corrections reported in the Company's financial statements for the period.

+ References+ Details

XML 19 R3.htm IDEA: XBRL DOCUMENT

Consolidated Balance Sheets (Unaudited) (Parenthetical) (USD $) In Thousands, except Per Share data, unless otherwise specified	Mar. 31, 2012	Dec. 31, 2011
Consolidated Balance Sheets [Abstract]
Allowances for accounts receivable	$ 305	$ 289
Preferred stock, par value	$ 0.001	$ 0.001
Preferred stock, shares authorized	1,000	1,000
Preferred stock, shares issued
Preferred stock, shares outstanding
Common stock, par value	$ 0.001	$ 0.001
Common stock, shares authorized	50,000	50,000
Common stock, shares issued	32,769	32,502
Common stock, shares outstanding	30,805	30,538
Treasury stock, shares repurchased	1,964	1,964

XML 20 R17.htm IDEA: XBRL DOCUMENT

Income Taxes

3 Months Ended

Mar. 31, 2012

Income Taxes [Abstract]

INCOME TAXES

NOTE 12 – INCOME TAXES

- Definition

The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 740

-SubTopic 10

-Section 50

-Paragraph 2

-URI http://asc.fasb.org/extlink&oid=6907707&loc=d3e32537-109319

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 109

-Paragraph 136, 172

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 109

-Paragraph 43, 44, 45, 46, 47, 48, 49

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 08

-Paragraph h

-Article 4

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 740

-SubTopic 10

-Section 50

-Paragraph 3

-URI http://asc.fasb.org/extlink&oid=6907707&loc=d3e32559-109319

Reference 6: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 740

-SubTopic 10

-Section 50

-Paragraph 9

-URI http://asc.fasb.org/extlink&oid=6907707&loc=d3e32639-109319

Reference 7: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 740

-SubTopic 10

-Section 50

-Paragraph 15

-URI http://asc.fasb.org/extlink&oid=6907707&loc=d3e32718-109319

Reference 8: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 235

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.4-08.(h))

-URI http://asc.fasb.org/extlink&oid=6881521&loc=d3e23780-122690

+ Details

XML 21 R1.htm IDEA: XBRL DOCUMENT

Document and Entity Information	3 Months Ended
Document and Entity Information	Mar. 31, 2012	May 04, 2012
Document and Entity Information [Abstract]
Entity Registrant Name	BIOLASE TECHNOLOGY INC
Entity Central Index Key	0000811240
Document Type	10-Q
Document Period End Date	Mar. 31, 2012
Amendment Flag	false
Document Fiscal Year Focus	2012
Document Fiscal Period Focus	Q1
Current Fiscal Year End Date	--12-31
Entity Filer Category	Accelerated Filer
Entity Common Stock, Shares Outstanding		30,879,524

XML 22 R18.htm IDEA: XBRL DOCUMENT

Subsequent Events

3 Months Ended

Mar. 31, 2012

Subsequent Events [Abstract]

SUBSEQUENT EVENTS

NOTE 13 – SUBSEQUENT EVENTS

2012 Termination Agreement

Non-Qualified Stock Option Award

XML 23 R4.htm IDEA: XBRL DOCUMENT

Consolidated Statements of Comprehensive Loss (Unaudited) (USD $) In Thousands, except Per Share data, unless otherwise specified	3 Months Ended
	Mar. 31, 2012	Mar. 31, 2011
Consolidated Statements of Comprehensive Loss [Abstract]
Products and services revenue	$ 12,312	$ 10,546
License fees and royalty revenue	8	15
Net revenue	12,320	10,561
Cost of revenue	6,513	5,722
Gross profit	5,807	4,839
Operating expenses:
Sales and marketing	4,028	2,453
General and administrative	2,211	1,699
Engineering and development	1,190	1,093
Total operating expenses	7,429	5,245
Loss from operations	(1,622)	(406)
Loss on foreign currency transactions	(17)	(38)
Interest income	1
Interest expense	(5)	(73)
Nonrecurring charge, unamortized debt-related cost expense		(225)
Non-operating loss, net	(21)	(336)
Loss before income tax provision	(1,643)	(742)
Income tax provision	29	8
Net loss	(1,672)	(750)
Other comprehensive loss items:
Foreign currency translation adjustments	63	114
Comprehensive loss	$ (1,609)	$ (636)
Net loss per share:
Basic	$ (0.05)	$ (0.03)
Diluted	$ (0.05)	$ (0.03)
Shares used in the calculation of net loss per share:
Basic	30,721	27,343
Diluted	30,721	27,343

XML 24 R12.htm IDEA: XBRL DOCUMENT

Accrued Liabilities and Deferred Revenue

3 Months Ended

Mar. 31, 2012

Accrued Liabilities and Deferred Revenue [Abstract]

ACCRUED LIABILITIES AND DEFERRED REVENUE

NOTE 7 – ACCRUED LIABILITIES AND DEFERRED REVENUE

Accrued liabilities are comprised of the following (in thousands):


	March 31, 2012		December 31, 2011
Payroll and benefits	$	1,645	$	1,928
Warranty accrual		1,926		2,218
Sales tax		419		526
Accrued professional services		689		669
Accrued insurance premium		242		433
Accrued support services		350		200
Other		171		203

Accrued liabilities	$	5,442	$	6,177


	Three Months Ended March 31,
	2012			2011
Initial warranty accrual, beginning balance	$	2,218		$	2,725
Provision for estimated warranty cost		122			508
Warranty expenditures		(414	)		(505	)

Initial warranty accrual, ending balance		1,926			2,728
Total warranty accrual, long term		—			(524	)

Total warranty accrual, current portion	$	1,926		$	2,204

Deferred revenue is comprised of the following (in thousands):


	March 31, 2012			December 31, 2011
Undelivered elements (training, installation and product and support services)	$	1,171		$	1,105
Extended warranty contracts		1,078			1,056

Total deferred revenue		2,249			2,161

Less long-term amounts:
Extended warranty contracts		(17	)		(25	)

Total deferred revenue, long-term		(17	)		(25	)

Total deferred revenue, current portion	$	2,232		$	2,136

XML 25 R11.htm IDEA: XBRL DOCUMENT

Intangible Assets and Goodwill

3 Months Ended

Mar. 31, 2012

Intangible Assets and Goodwill [Abstract]

INTANGIBLE ASSETS AND GOODWILL

NOTE 6 – INTANGIBLE ASSETS AND GOODWILL

The following table presents details of the Company’s intangible assets, related accumulated amortization and goodwill (in thousands):


	As of March 31, 2012									As of December 31, 2011
	Gross		Accumulated Amortization			Impairment		Net		Gross		Accumulated Amortization			Impairment		Net
Patents (4-10 years)	$	1,914	$	(1,735	)	$	—	$	179	$	1,914	$	(1,702	)	$	—	$	212
Trademarks (6 years)		69		(69	)		—		—		69		(69	)		—		—
Other (4 to 6 years)		593		(593	)		—		—		593		(593	)		—		—

Total	$	2,576	$	(2,397	)	$	—	$	179	$	2,576	$	(2,364	)	$	—	$	212

Goodwill (Indefinite life)	$	2,926						$	2,926	$	2,926						$	2,926

- Definition

The entire disclosure for the aggregate amount of goodwill and a description of intangible assets, which may include (a) for amortizable intangible assets (also referred to as finite-lived intangible assets), the carrying amount, the amount of any significant residual value, and the weighted-average amortization period, (b) for intangible assets not subject to amortization (also referred to as indefinite-lived intangible assets), the carrying amount, and (c) the amount of research and development assets acquired and written off in the period, including the line item in the income statement in which the amounts written off are aggregated, if not readily apparent from the income statement. Also discloses (a) for amortizable intangibles assets in total and by major class, the gross carrying amount and accumulated amortization, the total amortization expense for the period, and the estimated aggregate amortization expense for each of the five succeeding fiscal years, (b) for intangible assets not subject to amortization the carrying amount in total and by major class, and (c) for goodwill, in total and for each reportable segment, the changes in the carrying amount of goodwill during the period (including the aggregate amount of goodwill acquired, the aggregate amount of impairment losses recognized, and the amount of goodwill included in the gain (loss) on disposal of a reporting unit). If any part of goodwill has not been allocated to a reportable segment, discloses the unallocated amount and the reasons for not allocating. For each impairment loss recognized related to an intangible asset (excluding goodwill), discloses: (a) a description of the impaired intangible asset and the facts and circumstances leading to the impairment, (b) the amount of the impairment loss and the method for determining fair value, (c) the caption in the income statement or the statement of activities in which the impairment loss is aggregated, and (d) the segment in which the impaired intangible asset is reported. For each goodwill impairment loss recognized, discloses: (a) a description of the facts and circumstances leading to the impairment, (b) the amount of the impairment loss and the method of determining the fair value of the associated reporting unit, and (c) if a recognized impairment loss is an estimate not finalized and the reasons why the estimate is not final. May also disclose the nature and amount of any significant adjustments made to a previous estimate of an impairment loss.

+ References+ Details

XML 26 R15.htm IDEA: XBRL DOCUMENT

Segment Information

3 Months Ended

Mar. 31, 2012

Segment Information [Abstract]

SEGMENT INFORMATION

NOTE 10 – SEGMENT INFORMATION

Net revenue by geographic location based on the location of customers was as follows (in thousands):


	Three Months Ended March 31,
	2012		2011
United States	$	8,364	$	8,525
International		3,956		2,036

	$	12,320	$	10,561

No individual country, other than the United States, represents more than 10% of total net revenue.

Long-lived assets located outside of the United States at our foreign subsidiaries totaled $554,000 and $542,000 as of March 31, 2012 and December 31, 2011, respectively.

- Definition

The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 280

-SubTopic 10

-Section 50

-Paragraph 12

-URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e8595-108599

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 280

-SubTopic 10

-Section 50

-Paragraph 10

-URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e8538-108599

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 280

-SubTopic 10

-Section 50

-Paragraph 33

-URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e8971-108599

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 280

-SubTopic 10

-Section 50

-Paragraph 34

-URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e8981-108599

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 280

-SubTopic 10

-Section 50

-Paragraph 29

-URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e8864-108599

Reference 6: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 280

-SubTopic 10

-Section 50

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e8380-108599

Reference 7: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 280

-SubTopic 10

-Section 50

-Paragraph 35

-URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e8984-108599

Reference 8: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 280

-SubTopic 10

-Section 50

-Paragraph 41

-URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e9038-108599

Reference 9: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 280

-SubTopic 10

-Section 50

-Paragraph 32

-URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e8933-108599

Reference 10: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 131

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 11: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 280

-SubTopic 10

-Section 50

-Paragraph 30

-URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e8906-108599

Reference 12: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 280

-SubTopic 10

-Section 50

-Paragraph 26

-URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e8844-108599

Reference 13: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 280

-SubTopic 10

-Section 50

-Paragraph 40

-URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e9031-108599

Reference 14: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 280

-SubTopic 10

-Section 50

-Paragraph 42

-URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e9054-108599

Reference 15: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 280

-SubTopic 10

-Section 50

-Paragraph 31

-URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e8924-108599

+ Details

XML 27 R13.htm IDEA: XBRL DOCUMENT

Line of Credit and Debt

3 Months Ended

Mar. 31, 2012

Line of Credit and Debt [Abstract]

LINE OF CREDIT AND DEBT

NOTE 8 – LINE OF CREDIT AND DEBT

XML 28 R14.htm IDEA: XBRL DOCUMENT

Commitments and Contingencies

3 Months Ended

Mar. 31, 2012

Commitments and Contingencies [Abstract]

COMMITMENTS AND CONTINGENCIES

NOTE 9 – COMMITMENTS AND CONTINGENCIES

Litigation

Intellectual Property

Other Matters

- Definition

The entire disclosure for commitments and contingencies.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 450

-SubTopic 20

-Section 50

-Paragraph 4

-URI http://asc.fasb.org/extlink&oid=6952336&loc=d3e14435-108349

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 460

-SubTopic 10

-Section 50

-Paragraph 8

-URI http://asc.fasb.org/extlink&oid=6398077&loc=d3e12565-110249

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name FASB Interpretation (FIN)

-Number 14

-Paragraph 3

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 440

-SubTopic 10

-Section 50

-Paragraph 2

-URI http://asc.fasb.org/extlink&oid=6394976&loc=d3e25287-109308

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 5

-Paragraph 9, 10, 11, 12

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 6: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.25)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 7: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 825

-SubTopic 20

-Section 50

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=6449706&loc=d3e16207-108621

+ Details

XML 29 R16.htm IDEA: XBRL DOCUMENT

Concentrations

3 Months Ended

Mar. 31, 2012

Concentrations [Abstract]

CONCENTRATIONS

NOTE 11 – CONCENTRATIONS

Approximately 8% and 35% of the Company’s net revenue in the quarters ended March 31, 2012 and 2011, respectively, was generated through sales to HSIC worldwide.

The Company maintains its cash and cash equivalent accounts with established commercial banks. Such cash deposits periodically exceed the Federal Deposit Insurance Corporation insured limit.

Accounts receivable concentrations from one international distributor totaled $1.3 million, or 15%, at March 31, 2012 and $716,000, or 8%, at December 31, 2011.

ZIP 30 0001193125-12-225730-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001193125-12-225730-xbrl.zip M4$L#!!0````(`(F$JD#'8S[,"E(``#!W`P`1`!P`8FQT:2TR,#$R,#,S,2YX M;6Q55`D``\(FK$_")JQ/=7@+``$$)0X```0Y`0``U%U;<^,VLGX_5?L?>'SV MI+)5ED3J9LGCF2U9EB>N>"ROK=DD3RF(A"0DO&@)TK;VUV\W0%(D=2$E0C/> M/&1D$D1_W>AN=#=`\.KO;XZMO5"?,\_]>&;4]3.-NJ9G,7?^\2SD-<)-QL[^ M_NDO_W/UO[6:]NOUT[WVF;K4)P&UM%<6+,2U+\3_4QMZRY7/YHM`^W'X-VVZ MTIZ>M!O/=:EMTY56J\6=7!,.SWJN[*U9-Z)[;U/?U@"/RS^>+8)@>=EHO+Z^ MUO%RW?/GC::NMQK,Y0%Q37HF6U[:S/US3W.\/05Z&G!C&Q+.MLD/ M.C8:OWZY?S87U"&U!`\,K*9=H5PON;CU1&>:D/-EL%K2CV><.4L;<8MK"Y_. M/IZAZ&NQF.MOW#K3&K'V##TWH&^!]DS-`)0VTATSNLJLCV?7Q$;2`SZ>_:ZW MOY`5]H1`KJ@;L&"%OYB%OV>,^IJ`13,\Q1(8WOU\]DF'_WJ&T6SK5XWU8]A) M8]W?DOK,LT3/@O/@$Q*MZ9V:WKYJQ-?PF77+1@1Z'_Z6`:;U'?&W8.2KX;^A M)BK1]\!OU("%P_%/0`GI%[BPX"/7HM9W&`2`ZP/T<9L_^$[V5-H?@*?^ZK+$2PLG MK5V%>`E9^OI\,WI\EI.#=F6Q%P`B_]!DJX?0P1C#\^.K<-VAA(<^_13-II?0 MR54COJC%3S>V/BXZO:&NYS!W1[=BBKWD"^)3OJO?C1ZN&FOPLDF6T6?17HOER9(,VN/GY$N[<>&8H[MRY,\]W2#).5S#Q7XZ$ M*CS1.>.!#V/]0!RJ10/\A'/T/B]Y?3>^'SR/M,EH^-/#^'[\^3?M[F%XU=C5 M<9;H$$#YQ+Z#7M]^ALBQ+-6T8N_L+28U#'T?[MPR;A+[-TK\D?0II:G58F/> MUUN6L5MF4W\(E^>>7YZM@6E2.PJX10]I[C)=QM3BD9U`@%6:#'BG?\B>TX_' M70[@@H47;VTR+]WGC-B6%(L=(-KF%:[PT MN7_DR&STM,'66A\.HX3_WT8KZ2FA%.FXYSB>^QQXYI_2X8S#`#TTIG$9HMM# M8\VB)G-@K#Z>W3WR0 M[N1I+<,U$^@]4QS66B#?BPO(5\!-'$15)OW^<:!LVWM%:K>>?^.%TV`6VIO/ M*A)=2^]D01Y"_!2H2\FVV>NK07WGOL`5F+!@**J*TM!;K:R1I'L_@FHI41A& MRVB6HOKHTR5AUNAM25U.P7C'P8+Z`\YIP!5IDV%TLX98@J8ZB.7DU=-[52`J ME5>SU>SD[*\JW7+VTVDUN^7H/OH>Y%7!ZA&(!"`=]/9+G$%56$RKE1^+W<04 M@"II4.WC0-VY$&',&3@:*4RX/7HS[1##D,^>9[TRVZXLL8M^SM:+:2K$6$ZY M-OS181A5R:K9S^GXD<3*,5V&V`V=43`P:T+>$E$\>*ZI*`K*T-]/2PFJ=H+>2J0*BI)3T($HY+WJJ4:OW]KB]`^B5-(8>KET80NE*#Q[ M)"N%X>P%I(9;@^XLF4I`2HG@HJ;>2S;*56% M4THT7>/BXG`XPY`'GD/]&[KT.%,7@>G9M'8[E6I`RCF%;N=0)+$S?:(0\(>J M3*@)0>E6GYTE4PE(R3BBU3T0B'K;,3I-(SN%[5=3]>9B=)N]Y@$(4E-LJJ&Z M.;1K;%>/7?0482LEJTZ_71E;I%T*@XZ+?5JL#DS)S.]P,"(^.8DN&:W^9B14 M.%)'X2E9YMP2F17B236H[F[ZO>XN8S^<9CD'<]%L[71QF9G/7+K,_G@4PL9^5$4KCQ(02232R=81(_\7BP9$%_1R&"@1V M#%=Y`H_$'_O/`2[0"5J/U!<1X>.;SE%;\DJ=TB M.)14F65-E:R5HW<0*OWM'S_F@/O>JPRGI)=;`J.,B<\CIU\R?DPB*89.J&-?DXD?=!LZ=,%=3E[H7>NZ3GTWN.X7#&> M3E@E2RO3GRQ'7>E MQ`TT>RU=UB8.(JL29]G-0=W><3ACZ6=N*(F)C6XKMQULD\;1"$K6D2L@D#.0 MBAR]WVWO!B&?.1Y%Z13W0!2;.E1]IU0_-U]MTC@:03E]:'9RT>)^!*FBX,"U MU$MD_WSW`WZ-H M%[+P78^^9X6FJ((^4_^%F91'E?JR&[@+5"#>.UA`31F@(IW4.^WN08#NX:++ MZ2T5H_#DK8B-KW2HDU%J)ME'2R&@(AEURB-*+)O8B>CR6^0J*$]N\3Q'I3*` M8F7I&F4!##T.X:=*Q>AVC'RQ*46B(NVB= M#:8(5*);P'&[EULJW$'WF=HV1'9@#7@0`,6%HVAGKQ+VVWHSFZ7OIJ<25='D MU.ZTCD`E3T^PH=7`ME!2`J2HL-'6NX?@N/5\RN:NW-1D MKB8^<3D1[PI_)LS%UM<4@F>:KV(=+ZCL7'8`_9/"+JS`]53`QO>$N-AE(4?C M#I!!WJLH.MQX)6D;J=RK">*:2O_9R:'(4*A,O&@+<*N(NHCA'SS7I[BK",QB MN"#^G'YUB>/Y`2X]9E0"S`,-U(==N7?Y,S0J$B_4N(Y>CO:N-;K=401HGOC+%IHZ ML/X(I:K%*WKRW`GH!8OH](;*?]446;+NYUMA?[_R*GYY];L+;`NYK6O/%>Q, MW]CFLHNB4F!%-MC-!04E<<5KO/'>JFO"F7F4J')[N_!L(+VN=]:(MI)2A&7_ M/K,(2ZL"EAMFAT%N:]+))!,14X:GJG2VX/F%XA&GU!J\0!`QIP^A,Z7^>+:Q M6^A(?=JU4>DB%XX?!./$^(N7?IL7K5Q,JQI_-%+[=XE]BQ'8!>3D/"@,5U16MD^=>MB@F?!FAA M,2#_GOYA0.-"T]C%-;CQ+'-F1G)@AJ)(-UNO+T4YCY7C(Z!0[N@-,_:0\04V M`WVC4S7I$48I>9Q[J9X`8O&^L^,AIC5A/+ME+E@A%H\\+M;K;QB7[[NK*:5E MM;,L[;)XE6#,G_:UAUYF:3`*?;"VYF"RJL[[='*GHFTGI0I,H8?12X(1!4F1 MN,@*![IX7QP]R)6+*%T#+2:I'%V12G4/19?)^_!M5<(7)RC(=IN;6>8V:@HA M%>9>QN&0XK>?3UF8JAFYB74OR5RY+)-CW[F;1]HI6ZO)5<\*"9\&:)$/Z;;S M*SI5D<:'Y>7?HS[:-/H711!3)!5C*RH.]?.K(!XX#`$1)`C MXY<"K.O55XZA2+(M9V`&[$6A3G=R6\3*TS\EZB(GTM%S;X<G?TK4A7E(3P'H M)PA.Y!"-9_>>.Y]0WU%6CVI>Y!*17=2RAV5X)J66V!&!KY-C,7@\V_5J\=$% M*+V=+>\4DMV%4=P<+\6>C]$;]4W&CUS2VA3?Q4Z(6ZF>`.*!Y[,=!'&'QB:E M-<5FGA=G>?*G!%T4&_3;I6;<`M2CV8R:P7@V>C,7Q)W3)Q+0L;O]FP]JWJO( MROH0^J?%7>07U.#>WN*$^VIJG5;N&(P#$)P6>6&AK\SW4HX%?NAG4_3"MTO: M)=">\.LN)5^":57\"$V\21&/VE"BH-OW3F/WU<@>MV=[DVZR31-OJ7JELKF1 M>^:HJ,!PW$;*#`3QZ5PZ9ZYV;6.$-2'S.40(#UY`,^JZ)G:]12?&-!JCAS-M MR[=E)T^--^S+P(>CG[4@]63="JPS$,(/\^"#^$Y>!&2GO`RMIIU*6EM@X/?^ MSEV^#:&\]9:_-0,!:SQ8V?3C&?ZNS8C#[-5EP!P(6ESZJD'P1MPSC;-_4]S) MA$_C@]/X1V/]"SO(]+Z,NW:(#P*J!=[RTF@NWSY$?T^](/"<2WWYEO1;#=## M>#("H?]`G.6'_^LU#>.#=CUXOGO6QK?:X]/H>?0P&4SNQ@_:#N3BCV4A#]T3 MLC!94`T7_HB[.@7*#QI:6(VY^$7.R_;_5T,MZ"=?8:3FPO5L;[[2P+/4S[4? M`^`E'HNF_B%B*[EB?/B;QL`'^4M/?G80;.B&VN05#[Z#WT:_=W&N,:X1S:$6 M,XD-X!,:9B2DY,T,?,1SJ38-.7,IYQJG`*OD?+-?STMB^O"<[BZ]C&PI=%V30,0!HH.P`#CG6.=&E2-<&&'I;R MM65TN@&TY6SN`G.!!P_`Y1>ZY@(S`]S21)9+&_@3Z9'H9(FYDX4(D2OQ]50@ MOY)H41;`85T[1BN,GGKE30@*7<6M=%SS9EK:J[U_74;#"UT26BS:]AEY:/AC M%CMDZ#3VR`(N:*\=6C"@\"R):M[(^:9)G`N;$.,7K8>LN^?AE#.+$;$6B"T6 M!)1D2JD+>D"78`WB,_9$FPK)XK.@#:AOKRQ8".(0L%+<4R=MR^CJ'UK&N88! M@5::(PDNXHC8-J@_!$C8AB0;Q?FYX#N"@,H/W+KX65=;2]XQ2[<7G2)":C/Q M15O4!7@FTS_#2"RVYV"]75T^/94Q+]BE"UQR3L`.P)AFA/GV"B7$I9&CSTB^ M,`O&'Z!I2?GXE+EU#4:8I\;X7-)ESGD)V5@>L!ED!AU90*HSSPO@'@):L0-Z/PTI\U5=0")#A"'39$0+]KW!3TBLD MMA0(O2[68>;&(X5G)@G?@8H2JR,7^A7''C"6#OD3[#81#:HSC'KHR#*>$(28 M6HDHC"2Z`N#`[M8:6\[QQ"Y44$=K$"95UYYA]@1%,PG(:HU%=EV2Z\1A%SB;Z:A/&E:`&)Q=(6#.H^_708#,:4`D]CXNNXY M_)*KC1(>I':"OA/:`;H.\+/R.]P"QUS*X%RC8HB$O^!8BJU-B2S[IC:U(8@( M/A"^-""7W`*+=5(1@F$DLIM[IV`V"!">F@T1=# MER&,@_`PP"Q(W;.E7%#E1$05RQ:D#H&:F%PX<)A5KEF(,5SD:C@\NP)W"XSZ MR+;"._>,Z6^[RZ="XS9 M$AV#''P!+Y<"&!Z%"L76D#D##$H^P,_90_=)W/GF_9':,VE6X&I.X5* MAF7R5$\DN80;7&L;R'N[!6R4`Y?8JRBF M3FH#P)$KS\`5;9XB%J#)^K7C\VAVV,K]P'71L)Z$$!#S+4[AAE[[6=@P/K:B MQ-]1LZQ,WH_O2=S.+432 MFJPU9S0LM17Y_7L?07^R8PC6@0%;\W2>2V-P-[&P)?&#KDOCY]NCA>3B4NYR M2F7_<32P#@(@P_>]-S']B,Q%>Q'RGE*3A#(&1?7A"[1%:!3Z,@R(YUIH`O&# M\XYFKD1[[AE(RD*XR/\.CX9;//X+E0@<$H>9`&,*,4W$":XMWJ.1_L%+W.VF M=T('R@L]:%T;V.!EPOEBSU0E@CX1S8K5+BM-[%\A@7G,W^\%H\3=D?6$*"#C MQ(D#*'1LB.8\DP:`==AH-2*O@_A?L+[!N$@-0*B!N'VDDFXM#*L=WT&P13H" M%4HHR_F"6&FKA5#RK[VZK@$1&R==D-:KYXMHU92'S]=WNI\HL<>\Q`M]4^;M M]MINMJ&2,U=Q8LX&QBAU8G--'GNW]#M\N M^<9I$^:L%!C#"ILWM=D\4L]H_O=\"^8!'TO'H2^=;E(K9EBI75*!4PN7*-)( M,*G..:9_V/FZN@NAHAG8XBX\7`NQ@!RE<[ZPZ*1N[&%E&5(0$#&#`5J*TRW% MO)$RI/BIM9ES//8TRD?C:ZEI!:>`+JUYX M'PO2$9F(RG057P&U3M*\[1HM!``B!->(;[*?(ZCH-6*6"";J%^))DTJP^5:) M<$`!Y:D4?,&6``4F4LV"+)*+\,Q>1=5)<'.RB(C7#M!4H6.H2Y?&6D^+UJ,2 M>RQI`_HW,0'\*A!QL2C@>E)#.0]]\9YT'$HG3DQ4$*986+#IYH!C,0&&D:84 M"@9BBS[%&XK.-39;5V'/T7/!C(`K*QG;BXN`*1N$.0[7<62F)1VM'V4>NU,4 ME%ELDSZ=HR/$26@90K^F9'T=M<\81-C2;DM4A0Y+<=:Y'0@>A`71#!%U(BS# MS7VR7(B^Y7R<9#-BY0J+^P&D,$C?\L*IX(3X5CQW%_@S688)L5($G_75F7I>\9CL6O;(VHFDB6L[8G"3D!%]VK6!=>$RMAD@GAT/O139@>G@FPKKNAU=\ M5$O""<1;)X`ED&EDY>4=BX'!+YAGVJ M]F[5[%:DZ,R1)4;X-QO$.60E_42`BB)*43YA6#>6,5LRX5(F$CV.[>*.HKJ1'&;A=J7O0A5V$`HJG8@!I%X(;PK#B;FG(!TLY#PJ%LO6 MY5I\E.!^>;D)!;0T$)7.)6BG'*NH*"WU"?-+&'59-HM#F"3*F?O>*Y`0U3E0 M,RS0>7(VMBB`M*1?_$][7_O4-I(\_*],\342A/WKG^Z>&;T8VQ@'8TG,A\UB6YJ7[IY^FWZ9T6O5%;F^ M-%>_."X`J@06Y9$C9[6\WR)Q@HOE`6S'DBH4_SZKJDA6*/$@>3N^!TKS+>YF M!B69+&JQ/Z([$#TQ@)&!5//0^0RKPH.$$TN\SRI%J\PC\5&>S:)]X+%&:7KK M^(%4W8!E\'@BU#6=/DI%$L3+@01O'RQYB/$#&E8I("@;'MW<&*H+$IN`J";R ML$`*NB!1=`,]B$(CBA;[YJ/5F#S8I-QYZ.U)5[Q2&K4)^>"`T&3$>WE(L"$# M`M[-F1L0BC)<8"%27>69"`WA.+,$J/!6N^.JRRXN0_:)#V*PE^]S,=_I6'/L M/QY*;0-TS@@H3-WA$#(`X_HJ&Z0_EVKU;+0+V6_]PJ/'^M'2S2R>10++'SP$ MWGSCCKD?JFB!HF?UCYOSD^*+%FE>#AV>KZV;E@Y*T9HY*=M98$I1T=:B<*ZC M#&0?LD%LHH1US4HO@GR\H!MU=>4L3__B?5J*#=TY(KM\)GYX#& MBK>H,,'"Z4X_6MV]`0#1>"$U#<,J@%`%)UD:(&!\W+Q>G)!<$,':8E?(3)U\ MQF5[*M((,&%W3*>KB!ZEN^J[1&#BW_`^"J.+V)=3UD_C021CC9BX%^C6H_7B M$$J#">21Q2,?^*"9+W,O2P6GS(DQR5@*$A#I>$6FUHE``'5_@(L:PFN)9#T/ MG)M:@P>SRP,A0^X>7)[\2QIU$\?C*ZA,%QB2I71\R8)3(?U/<@GR)E&MC[8O MUWB'&G0L"Q-KM$2Q#\P!E2U:@1IU`4B)T](H&9;*0$*C!X4L#(XNV.(ZBD>' MM"')_G!&T$OE.T(VK2$DH5<9:`PC.AP)@+*OYL#JM=N/4H'FV_(.-2$F1M$B MBAR*[_\;"$,"%N;=!9T6E8$L?BU7"G`HW)V*(D/8N>,H"F@+L,0)AJDN(JU\ MPCSNKL5N."<>[E/$)86Y=DLAES?Y"3[#0R!(`-#CM)YA&DL)FUUS+1$8A:H? MSQQ`JX.=SP#BBT*=5P^&SJ]L3^1=%28TQG$4GZ">)<.9&ASIW"E$.C\)%#-S MO/CU!84,=TKT>WUVH:0W55Q&&8M(RYA)A+N@JRAC.0Q#?L`?TWY3H^3>I4^B6IP"$AD<^-]$_IR!SZL4@4R:%& M#Z1,K9>T7P2?R6@0[RY(1?`IM&82Q1@[]QU4J5U0Z\)=),_,UUVX3L?SH/S* MN$Q,A<+W`YP37Y3.897GIIQI4L&37L4A>1GD(O")\C)*X<>P21GSBI>]=]$N M'*XI[3X+W)N!&P(*!LG`"W]+-P\!@>PR"LC)[CG\R<*QA)Z>2V5Q"-H-O"JO MFP1U(V.J,(R\S7^PPG+=K.RO.0H]#:<7H*! MYWNY5\$I!'IG#&)A/,[CL%D>#/A(RSA^-8*D!W,@4K3>4NX,VP_E6["LI/ M2/_8O/%*@O?RY+PDSI6+5<7"@4T%&U:UX_PPC5*18WG1OIGT0L!YL\#$I`L` MP5URD5DE&LG[PP?W5@$J3IQ[)XL@4A0)O"@S5A_W\RL'?MD/7_3V2V=?7'Q* M20^RHP%`)&L+`+^CBZ-E2%F`$QP+9U(;DK;N4G93XAE%IJ/C:=$_0JH=QK\] ME;58Q6!*="TD<431H#!]4:T@F*&##3TT:N+2'GZ>/TE76)"I+!KG3Z1`&=E2 M9'7KL[DLB>:Y6-WBZ^TE6M'.SQ'6I5:-ZK.OF% M$.,&V])=L*77@<0*IO3<"(7GM*1G/$']RY/_M_OQ^.;LE!U_.[X^O6''%Z?L MZNR:W?QQ?'W&SB\^75Y_J7I.+N%AEQ#!2G6`*^\(>!#0F#MV,;01?;,+\T$P MRL%2[O!VA\EZ2^?`?2`Y[$7\HF]UG@RWP7],CC)68*VXOSL6DL M?5^N,D/0/^R[.IP*K_FC>YYY?8O9!"K1#GD2&A+E@)(6^_IP+HL=6.][;:O= M;C-!W0<4OY]@YB!M-`]&<%(0@3$FWTC'K"H(11$M\-:"^PCXU^J^[ZXVA3*] MIH5K""EBBFYLKNLFR8C%KG6X?[#:\"CPXENU_M+`J#)$>>,%*;6/0'PO&3?F M$XH/RBY!I4^7]:IUIM1715]^9MN]7NO).SX]_V.QR&3&17G379&X<(9'9A$$G>!&A#\'>D"G^!?2F5`%/+WUN%EPA;TZ2,SPA MV14ZM?@/E3"`W%$LN%"2L4DBR7+WLO5CL`]HBG>J'\JN(QNBZ!!LV(/=ZDAE MN[JGJ$_.7DRG).(G'B#2"V2JY./XA6*D-=!2"B?RC"SB2828G7 MLT4TZ7*![*TR(3'Z06#4RKL/:VG*G;*JO$0W6A8(*O?O\B`0&!03CG[;:>_0 MYRD&9JC/=[Z7C'_;.3SX98<-,,`KIJ_5HN0WNRX`U9D*_D'_H?#F@/@,/["` M#Y,=1A]^VW$I/F%G@5+9IT7]P>&,S6B%24SW;>)]^"%6[4& M":9L<[T5WW_AAVJPW#R2\P%Z'J)K9COEHTS'U)ZWL=+A>!Q*&QH6CCV>$_CB M8):49PZ#.H-@SS(RD]G_40'1]KJ\RU:\"\1TO@5I*N:?R6@DO3]F>_C\0U'V MPL!\C:31V0IIH(I2(7`T%\KVEH]025ZBPVJQM)R5J!\C[_ZA1&6#$4`U`I'^ M?Z[+^7"XLW`WH&B49?:L$H="_H/=:K?YI*RU[Q,_UM1_Y_YUE!4$G>4VND=MLU0.I: MVL*6>=)-EN$HZ^V!R=10OO23DOOY:-GNK":##8>J)7J/>C7`[C)651^%ZG=9 MJ$]60/`P;$@D,04V&1ZV87ELM*PFH[?V/*RJ'.LLA#DXEX5:*?"7"B-38IIA M61NEZ?V#&M"TP>Z:"^G4W4"<&TRV6/,J+OBI=S!KO_20:2IO)5U^SG=5+KN] MJ\ZT!HX;AN,S&QSKX:IBS'/;3K7>4;<&3--@]8F2T(C";;/P+O!2+#<5\)?E MX<\TKX'DQB&YXJWHO!O//8IYFK^#+<2B?0P<]_ONC3N.J"J$S,W`A$`96S:) M/!Y@_DNJRC>K,$$=N5G.'TQB!R,E502HS**A7:IQL3H%OBE'7=HZ06!U(O0- MYDT39HJ_?>?W,'/L(SCSPABN$[@IABS.65Y6!:BX0LYB7WS?'6($JJ^ZVLE2 M4'++@LD(.I600BGA?2P+E,;W[-[G@8=QX91EI[DBB@H!O?,S/^4<:S*;DM'NSD:!J[P[S?.QD"L0G5P6#_<7C"%,T M_01.`Q>JLAI6L*1<'N=>EBO2+XJ\!&`A9#G/4.>"!N(WQ1EWA3V5O9\N:61L_S6X$`DPBH[I%19+G! MF`=$35@[$8,M,>![J*.S\P%DH#>F(A(Q8I*<(X>A/1=FDNFY90+2*P)@/;(F M%>^:A[=2J;;"6C-SP[,\A^CP/G<<32G#+7L7&.E@U_Z]E918+ MVZ`X4U;(8-7!]C1)[',D9;69(68_4-U(N:U6.:)U;4BQ\3P96AH)_:\G[+SA=#Z7/5/2H_N='.BANM M8VS"OS)K\G60K=WN_-)00K7;W85;>^:;N"T1JVJ@E[FL,$>:_`BO@W;?M`&& M#27>I7NK(V.]GN\??AV4VFZ]7\R+:KZW3LL^6IG/UO.*YU@5%[B754)EE0;= M+B&OS%!R6W6Y7UXMUT*Z2%^OY'C++?>7+ M?44^KRTGCE/9NRJ9]0V%\S=5FP@'T#Y@5::H^)6^(,TW2WT[*@3(IN,GV\4< M[,@:;2J35G^)A3)C=6&J78/ZM[?D2WI7(3@W%'W'HQ'&`"6%@P,F6>R'PG>+ M"*';V;?V2V/$N-$SN^-215$4ZB-BY,+B-J&/&0I5.4MU3;#I6D>](ZR%N-(Z M3,AXG4+&NZW#.B1\;@NM+Q8*7:FLENWNNHY^WJL@%1^8EERJ?*F12YOE779W MWTBE1DJE3NMHM9B;UXE6(Y6J)97J8UM]YJ(@I[+*]D92;9:?O;7;[RLAJMY5 MEZG55U;U3"YU5;GVZ]SU!BVH[J:]?BJCB'L6<['=2X!_1=@`8HK-XXRDVK2D MZAX:2=582?5^ZWBM+EJ-I*J6I*I]+9!FEG.J#O#-2Z_MI68X819<<"\(C34: M[Z9OMU4_1Z,:-4[C[;8.C<;;X+.[W^J8Z(7F'5O;ZG6KX2]_>N">L6"J,FT% M]%7SDGFI_L%-,]?%%&1L[)6M>7&M3J]=$^%8-R1O6_'9;W6-/MO@LPOVBFE% MTKQC:UMMNU<3EMQH>Z6I-<.K`W[STFM[J1EW+O_B(LG+R^MH(N:EL2Z[^V?J MQ`F/E]SSSQ7I*NC.SUF, M:HVB4H625+.EJV9+6Q5+6-I^:QJ78/!RRQRW31F=V,>YIU+ M@`*^\T2-J_IZQ'P:Q=2(@SI`P-L!%]2))%3]3%13#"KUHEHW$"14RY=5C;V5 M*/B%R\R=8!N9:1R!_N@)P&D$8)#M,O)&+YXOW"`2U&8BYH&C>FO0[H65P4=0 M(POLN(&PS!KEQ!)6,`=6#/7RKC2Z=X(\8F_I^R@5,`@-ZO)IDE<799" M>6'CBA?;=KAT#@]76L'K]+?4%:N]]_LU MP&H=8YSZS@\VX"$?^DG1PES`M-A<%T4C&%=EK@(N]HYK0.L&O8U&;S,N/\]G MW)D/^B87&%NGJ8QMV[)[14O$L+,Z(?6@78?\LCHJ9+K<^JZJLC[3]STJE]K4 M@1RR0[7A8)OA8*WW=:!V@]:GEH7IU@&MS5#%^E'B!#.\C*X7!=U;ED/2##?; MI"^E9SQDS<.J70L196*/3.S1_`[B+@7^Y,Y(C'=QN7\+@F&!6[(8_1)CB!`7 MG%1B[*7HATZ(D&8N1MGXX1!;*[;8-\[<-([AN>">>1&%,ZEYF%.N!$\D&?P(':%#'D"7X/F3J$X020$1D8]^3SDU,Y>,U'.<\IL-2!NB0?) M%Z2[R&@I-KAG=V/?'=-W*O:M&,6FAY$A613^!C]D)(9!6!QCMAY[GLHVY7ZZ(PJAM-)H`6">`Q#SS$Y2=`!H`_8E=`6S!-$/AR M,2?19.J$]W*I1QW[\%?!3L:@YL*N*"KO9.SS(3O[P=V4@B4OAT-`8\S>ZEBAFPS4S\=U,`&%^$.UCEUXD1S2X)>OG&" M'':,\\,4AD8L^,D$R`F?Q>9R"?S',,+4D7W0A1/H'KTAD#_ROSCKP(N;P8P6 M7-GFO:#IG9FSIZ)0+1R`'B28,D#[)4=('2)1J%_E\X3!H" MR>O;&/NI@6HBTC@NOLFA%+"1"" MP`[%&*7K>TJJX7IP-;@*Y/CX,X"M.#$!@28'W@*'&DXF2D\*O1T.`>%"[]GC M;LSQN/@Z,G<*/R,)\'@BHT\CC!,.L$=R-!P*X%?SAO'A,XA?X&,#GMQQ%2`L M02GY&XZ59%2OF5Z!3181LPPC=%PF$4SI0WP\=K6L2]I'ZRF3\]CH$KUT M;>T;7AS@'Q<`^\^@>+`K./[4Q91EA\S^E7UT4)P!F&F!IWZ0(AYIW8,,-JL` MJK"=@\T+!;EL5*]0J2JP-HPY!YJF70"G]OQ;W].Z%W-N'3\@O0FX2)%,QE$` M'%W@&TA!=S->5]IMF!)/+<@$)20*]0LUPY$LHL7.0[4:BFI7P'VX:JLT*].^ MWGS&.5,AZ_/^EPJEEL9\&,#9*APS?&\:)0!MGP0$38\R1X#PB8$!S%=%'T?O MBPC]PD[+!QDYPIT34\P[;CP3W?M6SZ9.2!I:=.0+*0H9-Y8HD MZC5/80'R@0W#\<)E898*"!G9E!:D&B@-&5D,TR2-^W/N!2 MK6#>Z\H&AAF!P@$5$^PJ8)6EMZ1:4=B\LEWAW%F:>6JA+M%/)\VBS48P%JA< MCEQ;,G:21?KY!`C)XWR"9C6_=30:YBU;PQTX6>"[]_3J`$[PV`E'R"D34FB0 MFI\&.TOC48J,,()S*])8`H748]C75&&J8,@!#0]C_F<*2LN]19LD..`BRH0" M@P0!+E5252'?AB!;W<-_'A94RX4F5K8K!_7MW;$3#)&P,*I9`H+VD0'C+0Y3 M,''D#/*$GZJ'BC8/GAR2T[-5%'0#Z!;7Q[@#Y*<,8>"+?B!Y&XDT;8ZAU).CZU.*W!N,>E!O)5$79P5%`YAPKO.6 MY`OP3MA.@`X/[3B0(P_]&!:+)J\[)K`4AY3E+9`C9&@M."(D*^FVV%4:B]0) M#*$Q%GG,[3R@6S6Q,*T4-)9_$#\GK*(@HWQRTVFT)\.5[),B`CB-(1*); M71T:&.X8!@Z42TJ35(XA^K7`LW.?S'Y).T"/$R6@:GU2H(X?[O+)-(CNN=;7 MLD.:"NV^^1@X\,.-BW0DB@X%?&`2>3R8<:3H&9$WPZ:5#9$I-D4RU^Y>4)_( M7Z-.PH0[F*V;Z8!6OG-UDEB&%9PU#=7MMUZ^Y@`D`4*2P73R\E3IF3/H)(5C M-^MU@H'?=*A"%ZWCS7LJ^"X]S>@%XC/W'$746LJ*TM#$S4_H6?(8@?84@;BD MM:/VE#Q&*M:.`Z]*QZ3/^0\E^9]D"@?`WCR[_"BOH6D+U@?#BSL[@(L:K:[JW^7B4J+ MGDC%[LAQIA_.`:_`WN+[TRR#.YN)O)SPX9H/?]NA5$F9($EID?_MV@`(W/C. MW]7%Z.GE2?\_5V=LG$P"=O7UX^?S$[:SN[?WK7NRMW?:/V7__J/_Y3.S6VW6 M1T^@\O3M[9U=[+"=<9),/^SMW=W=M>ZZK2@>[?6O]W[@6#:^K/[<30IOMKS$ MVUFH"H!KF[/;U=/L5WW_A1^JP7+7BA$V2F'W-)T2S1PW)R# M=34IW=UY@8BUK>Z*;G@CE3OEP(BZ#T:QDP2]%[`D.^,&Y,A;91V/H`M!V>R!A)^6:" MU4DPMN%-IV4SF#/`]RADJM/JTA:S+RD^;EFPTL(4AZ>$,*T23O.\(4M7,<;^ M)_=7@1,FQZ%W]F?J3S&0[56$,/4*(4Q/@<0*(4T;S?7#B*9>*:+IZOKRZNRZ M_Q^+77T^ONBSXXM3=O;/K^=77\[@$U'9(*.W)5KMEJ*<-/`M-D7PTXGB&@&D MCL^&*)GPI,J')QU5)]ZG9LLUX4DF/,E@TH0GF?"D&3WA,XCWQT1[54Y6S?PW MG5X=KE0,5I^(U?TZ^%KK&)'T,?4#5.<;RHXJ<]G;[9B[_":CUZX[@ZJ1]H3% MO#!)F_D3=)12QJH)1]HPA;\WI9<->K>-WCIJ6)D'GMS!JMQ;;/C5A@FZ9QWM MUZ&LN$'PV@@^[-0!PA3E37D8D/_!_YMF-BFHY&L]GX=@I$,@M=' M<+<.CH$Z*EXG42B2.)6UI;$.5QR-8I-UMWF:/JB#6#;H7=<77W=^5?OHV&;F M6A@X;CYG90U[8SU<&>8Y?R%'5N]]'1QM!L%K([C^Z2-55>B/73>=I++FI\>G M,9:\3G2PNVI/0U\8#7^S1/[VT.KTMJ_DOS-\;),HM@^V'TJU`HJ-JE\[%=7` ML9*J_G*QOK&$]<>S9AHJS[<=56E;W5I43S)X?2I>[?TZX+71DKNIB=<&DB:% MO7C,3Y<9XO-:=4S+XMXJRWN9SHZ]/]YW=.\/VN,;^[UL!J([\SVER^'3VW"L MDT_]O#GMOT>1A\U78-+S,''"D0\H/Q:")^)59+4?%++:GP:+2K3J.)AIU=$_ MOOC]_./G,W9\8RX[0?H8I;+C#$UG!8J10J8I1_",->>'$MG6Q"7WL"TU` M="\C;`GN4!?$?-*9KDO8[0J7(6B)CRRDV,UYP6[\(>-8RP*6[+IIC%U*7#]V MTPFV?74!;++%HUSB790&'C`F6&?@?\=NV-1D3W:V!LC)-M!#F`!%4LIG&F%2 MUS#=3$DN=\"#Z$XU9W6=.+['6@&RQZ-HP6G1BQL[MURN$)L="A][:RT"<&&I M">B<(^R&F<;4$W!F]X5FU?,ZK6W9C?]4Z%(OJ M6'2J4\?"+--E-?>6V7T5\7TW%B6+ M2QUN#2NO\7QNI\S2[W$T+Q&@N6=N.V`N1&S1Z5-EJXZ7QFH9)#PO$LXS=TZ% M@-)06%_,"U8P0#;,NX9@-LR[`D@PS+O)S'O%$(#74!/S"O@,WF&]W=^UV^R> M.[%X]Q!L)N[O6>+#WMO;#^VN)`NJ-5[?VM9A=_O]3AN8EK%MS&;WG9TB%)X& M#W.6ZX1Q^W#[^54&JT;R&KRN*GG;VT_[-9+72%Z#\9^M;V/R]S=DXO=CQ^,P MTW>P\@^:;>+_I"/L^:C9U.)J,G;?5@"]#50Z*H-?HWT8U!O4OS;45X"I&^P: MF6WP:QBW0?WK0OTRMT)]8@ED'N7;?2PW8!P-+T/[O??=&M"W0>^Z6DL5\&O4 M%B.[#.H-Z@WJC=0VZ#52VR#8L&Z#^MJB?JFSH>[U/YM9<=K`T<#1P-'`L2H; M,G`T<*S2A@PVU]2!QJW=8ASZH!J]/=)AU MK&X%&C0VT&6V;1M)EY1\M:CX:3!K)&\!N/-3J$UUT_; MG-;`T<"Q2M,:.!HX5FE:`T<#QRI-:^#8I$;O&[N0^CUKN'8.HP[]T$^P1>*0 M-S4Y:^MVF/6^8WQE%3#5UGO)[-J<87.Y?)5Y?)Y=ZG;LV9WBS9[C1GNXN MF%Y>E&(/C!_.2H?BZ4KR!9/VHW[QD*/Z)%#^KXF2?RYVTYG7) MVDOP)S73W_92L3MRG.D'[:T\#KWS,''"D0]/'0O!$W'J"S>(1!KS/O^1?`PB M]_O?X54]%7T!$XY&W&,74<)A1OV[;-FUZ(E!D/@?CETW3KGWV7<&?N`G/A>P MA%,^Y'',O6M^R\,TGY>YH+?!AVL^_&VG/XXY_P)?C`6L@WO_[=I?G!@;3>_\ M7<'B]/*D_Y^K,S9.)@&[^OKQ\_D)V]G=V_O6/=G;.^V?LG__T?_RF=FM-NO' M3BA\;//G!'M[9Q<[;&><)-,/>WMW=W>MNVXKBD=[_>N]'SB6C2^K/W>3PILM M+_%V%CPB)0[;+G@Z'F0EF'=ODHS^:_OA5?99D^Z&M5-WU=>]`]92^N.R? MP=*S6"?[5W9\R4?3X__GC^^;Q_?G;#CB].V>G9I[/K:_CA^NQ?9Q=? MSR01#C*=?8D??-ZV#N;MJNR]W__EYW:I,,&"'!7,B3G0WF0:^P)^B88L&7,V MC((@NO/#$7L+N$W&42JTY4\$_Z#\4F(D7?F!X M>S+;N'`!V2_NZSA^#_&$@ M6=F`AWSH)W.Z89L+]&?IUW:PO_V&FI5D4C7'Z_O.40WPNI;>L67V],V)P?Q+ M[IF#5D-C,]!_4L0_+RW7X1+*('CM6\:.77=F51_MZL8)X,?$^6'XUF;)>M\V MZ=D-1F^O%D*IC@J6]L9.XVC(A2`O.Q,\OO5=WE1#L#)D?7!DN%:3T5N!YERO M1=/2?,P/10H6H\N!H_&)GTX,#]NP0;%?A_1\@]YU%>ON]FO^-UOS$NET&L6) M4;I>B**[O78-*-J@=UUYU*X#>INA=%%K1,.O-NR2/USM>MSPJUJBM].NNX)5 M^Z2?9I9Y,'#,`:2!>#RS[=YDFY.Q$X[@9TJ@X0RK M9/E.0*N:QI&7N@F[FPFQLR@6&)_F/Z8\%/2VFV*>%$MA53&+TEB/1,_">CEF MB.FA0-NPV#"*:9`$T\C8),(\,B8?>QB6SS`6G\;":'!VQV/.'*$R@(3)_WG^ M_)^CSD_F__2JDU!3L^6N95#4//?D8"NY)Y3"FF]!)K/FGRFM%0?7J2CS\X6V MF)CR&DAC.VE))OGKA:!L`'<98FKUP`DP6N8QC:HJ)Z-F M7H2Z1-L;O#X5KX>=.J3RU3$NYBJ.;GT,1"83D@MXV$ERX_(>9)I(&LJO*G,K M:7>,4[O!Z.VUZR"5FA$DDZ6PDCO-\Y,T;NQM7&4(_.V^;=K_-1K!O?;V%;`5 M$-SH^[EF!GP8.%8^<&8++A,4W8WWEU2&O9LZ%`U','I0C`WR4O&`_2B9R]2" M"%A:PF.3);EA.U8G?;VI?4K%]9-#58WD*Q4V/]"P;TXSO]Y@_-U^Q$6 MR_XCS!<-[()AM]O5#8,_/#)M,$P8?,.C<.>$M6-CA+2%)07!U`X<-*Z'NJ9"7A/Q:G=-6(?)6FJ(`&\J)&?)/_M< MJ_RORY!]<>[S#7;:U`@%_L7$KY-H,G7">T9I"M39/HF8PP+?Q:8LS!G%G&+5 MV5M\6HYRU.E0-D&;7S.3\;L*HY"XL%0G9/R'+Q+,6GNXW@%/[C@/2YO$F8O# MS]E4^Z#\Q-P-M=A5&HO4@6D`6CC&`VCD+Y;@3$"B17KX*EYC^)B3-Z*.-K"1 MTABT0S=(A7_+LRWB:SQ.'#_4R7MJ;+U"^_!7P:9.0AD&\#0/B4Q+(\/7'NAR M0335>0:".4!%`-6$QH25B70"V`+J_,Z3AZ#+-S%U[H'N[IT`6_*P@4-IA2$3 M3@`?88G9!&I&O,=!>A"I.R9X`,WQ(.!NDH*N"4]/87OW+0:$^X\T+'36Z!P1 MY=K+*#=D#@#=(Q)X'#?SJ-J>>58/5R0`18I92R+J8S0`4:WK8&!J(FY2(.$H%`"3LS=:!3Z?R%IX?=3 MT.#]*!7!?:[4O^D>]BQ@GH@KG2/J"(72^^PK+XWU*'^F3HPG66Y^_KI:[#&C M8%L,D1;0EXA9A&Q0]D2$M'CK2_S"L<@1_`\G!`@4>*JM<3&/>=%YG'N.'SN\ M<`AOX2S(8^:`,ACN/APG#0,,!RCM8^KX1)2TU8S[9:_`B:5-*F*1\0.(_C?V MT:'5`U(8W$N:#K,,X63LQUZ&>?@R)S[%,M3#W(&3H9_#UMW<&<*?EJ;C*)6/ M4^B"&GS)$6GE4#X&'J4H'5\L/1]&";"J[TBAN%>U0Z&@7(*#VK7<$*Y_&*5Q MDJU9Z$7=3^,(3*GF1'V>@705E+:*^;#E"6],!,K.1,Y+'&%F9)#?*60:] M1^:&25DZP\S=:`+,VO5!@_H+$)JS;\5\"0!IX@>2%?A)1F1+SNG?]@;`TS^H M-J^?\RZOQZ&GL\JO)7?HP_G\&$3N][_#:UH]HB]`21KACBZBA(.6I'^7J7V+ MGJ!Y/SKA]\]^R"^')S"1G]"L@R2;BJ0G?+CFP]]VJ`F3;+U$#9?^V[6_.#'F MG>[\7:ELIY/G\]/V,[NWMZW[LG>WFG_E/W[C_Z7S\QN MM5D?Q+'P$=Q.L+=W=K'#=L9),OVPMW=W=]>ZZ[:B>+37O][[@6/9^++Z*`X.-B\-^HN5X,^1(U,Q;SB< M4!]D82ZXZ11^\;T39\H^^:$3XMFSV.?/)^SMW3@2G+0:8%9PTJC18."0[BL$ MF#C,J<1"K3 MR",%+=OE4N"U#@]189,O2JC1DU-?\5M/S5`VH@Z(_?N#+VGXC7WP M'I^@[HXPT>M024"%2C9D#0(2/!DIHLK;"P4>`1KB\;Z&B^0_H=[1:4,;1` M"0+$"]6VB?9+J&TM8*F+0""U=!Z#J46V*W,=,29U.#OJB!BDC:$"4W8HO;FD MI7T,97,*U*L!B&./>"32%8YW>&39AYT"QTE#X$>^D#)$(-^1[`$)3QK^"V0) ML`>$%NPYF0N4E8]HR1E;XX;"(,JTRIT?^9(2/R0">7A2][M=?1Y]4(%C0A98 MO1,_G0A-B0CB$/#)@"&#Z**VP<&]+L$@#0>DFYFACVADM&\LQ2GHG.BU,)!/ M\8A(H]/JM7]IL6,A!JXKP8?#HXF`UY]$8R! M5.R.'&?Z`06ZG]#28*(3@W6P'BPJ82Z\+YD+ M)Y=?OISWOYQ=]&_(5CBYO.B?7_Q^=G%R?G;#-F`U/--6/@/V1E(QK+QIDSFZ M--/T)&G`&\C38CSN\%$H-[2B'^:A6"+_Q8"#)'1$A`[D>S:%1WWDGN3S(2XC MR,DY9XR[,0\MI;6B*"VX+M#D"4!O!Y/!N_7!M@!E'Y;N2-:&+Q`O$]+IYLC1 M%0\$?CQP]!(*2Y/]^^`'*7`EX[LGLP$9DRL]3K`.8N;(98$1$J=&)S1"@QP_ M?G@;!;?,`Y!,IN0SU[*[]:>JJN/O=D_\J*\2,_2VGXHB\%=\&5?Z5<^7+9 M?M5/RB7(3M#L@X*5MZ]%]UH*W:^ACQ+V!N6J8,"=DQ@)\@2=CMD=0?8U$,W7Q`$%XX1CADL`O\@^E1:J ML2@91LIS!^,/48.5QP;?:]VTV!7]1OLIV8*'UOY1S[+M`T7DVI4_SSC@?P5H M:'M^Y*'?0O!8TC:O?,H%`IL`$H\#+$(Z&I<9=^[RR=U-F4P`-9XG M:#0%OA8`<+IRS=:'M2E/.`DB(,6I6B%,`MO)Q$!I]1/<4(G;2[H54G^'$\SI M]D%)&EJ*=",)97^4Y-L`B?PV$V\P]FKKGKDODE)#KEM"3JT>CYD'/,-+2;C( M(Y:93QD`P=(E<80K'_!<'UAR*[7`8("O/5)I+64VD]&#G%\>2-P,FN5L&$1W M@-D_HCO8?ZS-']<)<0%AE,/K`7I(C,K!)=-8"V0$@$5@6RZ=$_+H`J4A47!O MJ66TGHK^O*;2#2?UY9I3?&8X>A7VD=TN&$@K0*`25A$LNF@6W9S]CC81.[_X M='G]Y;A_?GE1?3NC:&+D5YF2`Z@[`W@^'`%CU.("-(B1]&1\4AI0.:9@H<]$ M1I44.%I9O4(/!\@%+J,OR@Z<@Z-?D#,!Y\CCF"5[A'E#1U*=FF#9.-W.[#A/ MVX5=WL43=G!DZYG5#<)/[,)^_W`75;T*N,@7B9$)(QZ-8F,V6NRQ< M>Z7(X&##8?H;J+1]L)5*VZ0O,:DP,=*82*K';`]_G5,)_65!]QH)83LEUTUA M^Q>"LJEU"'CF`&KT_%:Z\"F?H;TABVS)?. MBQ9O0_G23\KMYR/DKO6^%I7(#8+7SDENFYSD;6?2-K,4AH%C)4N*K(>KBO'/ M;2MX=L?J=MHUX)L&L4]$;-OJF=KMVV;D32TM82!IBG24;CBC0M@.HUO;^-Y2 M(2K)V)ES4XSA-M.8"\I6F&`4$CUGM^E>E])X2K>[ZP>0OL#^/V-A4&R/Z:G4 M)'E_BU>Z:2)\+\NIF[DL3^#W&&^W.1`EY=CYGN_$&*1%$,#R!KW>/N564#96 M3R5:.!BE1-M>$&I`CR_+^U;Q2;#FX/Y94G26Q)K,/2QYJ-$*P2[/F)=]$H4N M!:=2>%>3`XILG8^]8,LK1!`M"0=86R4(2@%$]DQ>Q<7)V47_FD*'-I)(\;P' M7]4/D&%VWS#LCF*/Q;U(^*0<55HND9$E'NL^N8$?\ID\3@K19/Y5D,)(7T[_ MG0\+ASN+%/ERROII/(@L"G".?0PD.>C]0@Q@WY[/3446N9W05?!$7@4O#5ZB M`>?QCA(,3BGJ6BVTL"+;EBOJ'LQ?4;8@X4QT"1HQ,[:L"H%"3UBT?=5/N)AL M7>BM4)B]TY6S=SI/FKVJXN:X'%:E(-O[1XL"DD8\ MI%`Y+ROU(\.WDHC]<0-<\2Z*`^\.A&!U`4H+*,8!3C!6&@/T*=^'XG\1!/0' M_S/U08VD,CLR0DW(D%\N4"/SQ9BRD75%$S9PPN]"Y3S2`!X(.D$U3(C0?)99$,T@0/HU9_[%:A'@/\8&,Q!E"5YE^0*2&,@FUM% MK*L:5;`T`(43/]A&2)^#@04R6X>J:*V69#`WG^#QM.0% MVMKSAMB?AYCDUW=^O([8^DXAMG[9UJL15-\IZ<3G%R>77\Y8__C?FTDM?F;= M1+)_/&.H5.691Y11Z!/L6>+\X,B;<`=Q M).O:)5)"9!H;;7=.^G]IO-E1L#@"KH&1>*49G>\\1&F!M3W<),L?EM]3"@`^ M'W-@'W(\Q;A`_4GAN%--C1"X36%:"[/!@+<,?1G*G6<0R@%X*&M.6EJ-D$5) MY%/^1*NAELY[3F.IZ>8GH?5`;P&9P'B0[4`MX'[!S.A&<')VJX5&CB2Y2\S? MS',$UK(89HLZQIZL@`I381ZT*F:4^SEL*;YGE,V':6\$@#R+2E*.36%# M\S],?,=,JZQ&3:X]8_XW3Y2-M63;Q&>DZ8H:L2HFJH?1JK='CY2T/S]$TL1R M<\!-JDB[881DN MNMHJU@_TL0B<+E4GJ\$-<#=#F(_DDS//NLO,$D^[:FA?TN8@7\#$\3*7P\(D M[!8<^U"[RJ5@3T-/``N0TDPN0Q8"+J^1RG)IGJY@$<4^D%Z63*:`L@`79*'0 M*!EZJ?Y1L6`K`1CYF>-*<3Z3,AY&U"`,1HW111#+I0S38`CF:V:G#5.TH#+7 M530(5$$6(@CIUT(@QRBG4.IE.L5?#\M%V;U>H7S;`\24T5&`#UI-49SH58AB M8>6L:C#529F93]=YRLO%*;^;TB86UXLJ5XV5:A;YB*0ZD*$<5#0`$Y*:+%B\ M`CEKPA(3N56`?@-6 M998\6Z__L,B*/T:P#T3H*1P/%SBED*7CJ1@)%AO^,]L_%:`#NUFJYX4"F@>2 MY/.Z=3.UU6;L<:JB*0>CJJBZH@]R02K0(SE(7JL2-=%."PZ6+)T'RAQ2D:HC M7RJ0^>B$BH/3%JD0ISP$:NG`&>!,W6JM?,!)ZU:5_^C\IE,T7MRQSZG@B68A MJF*@+-JFRQ>@&2'EA@?:;E@L_D<;)N:="P"++G` MYE)9CQ^MB[SNLU*C59%VK&BARAH,"^O''S/6.'\3Q`/+_`_8*D%S5^;(HA0' M"2E9`)H[`\Y#Q3DTFRRO^0[9+UH9`C.W0:23(THN*[,'$UD'==Z2?)$7Z4!\ M:`8#^X8E^4)5\1ET`\XP8]!',"?_Q]02P,$%`````@`B82J0#=^:GY=#```R(T``!4` M'`!B;'1I+3(P,3(P,S,Q7V-A;"YX;6Q55`D``\(FK$_")JQ/=7@+``$$)0X` M``0Y`0``[5U;<]LV%G[?F?X'KOK2SJPLRV[3)M-L1[XDXQDG\LC.3M\Z$`E) MV%*`"I"VU%^_`$A(O``@*&LE,+M/<40<\#O?=XC+(0#^\NMZ&0?/D#)$\/O> M\.R\%T`ROJ`A0CU?OWG-W_[Y>_]?O#;U>0^^`@QI""!4?""DH7\ M[1.@?P379+6A:+Y(@N^NOP^FFV`R"6X(QC".X2;H]U4E5X!Q6X*SVB[.AOFU M&.$_IOQ:P#%A]KZW2)+5N\'@Y>7E;#VE\1FA\\'%^?GE0!7L927?K1DJE7ZY M5&6'@]\^W3^&"[@$?819`G"XLQ+5Z.R&;]^^'F<8*X_?#B_#*S_O:&A.D2XF2$HUN$+B7F7B#J_3*YVX*?(A)S M"&E$BJC@_#_J! M*E_\$^`HR(R#.E1%8Z/;5R`6,?&X@#!A311K"YL7='P#E?BU@@CC1K:!H M+>NXVB![3/@#+GAFX]DU6:XH7$#,T#.\XZW#LC$8'`AJIR_FFMYY=A:C<*0I!SL!(:0`Y_&\#-, M+)%E+>Z?,G:\N2`7/@ERAY\Y-D(W'*A&@/)E_P@OX\L)OO2)X`<*5P!%M^L5 M[PDA?VS'O,>F34VJDY5_5,HC&ONVD7-<:&2V=/_I$YP,E*TB3 MS0,?V,C1/N^F5F+HHV]E[,4]HMX.-%?BC4]*W&$^^9TCWA-E'G&@M^LP3L5, M_R,AT0N*8VV[[V+FD3)N@'.%?O))(8L*7C)=8_-GG]B\@3/(&\;H":RW@?"9 MX-#8TS89>,1\$]1)]7L$IBA&"8*6,::N MT*GF@P]@(V9+S3/!:L&3!(B9WNI$L`I718MODW*:PL@I:"QE_97"A%BIX=6, M_#IE"5E">@-7A"';)-%8TE,EC'B5#EY-W%5O.X'/$*>6ILE4T%,53'"5"%[- MRPONV'NPT]-=Y=G6X'@U62\,*PN870?-!A/?U&A&K+3Q:OI>>5B=1-&4]54- M#50E@U=S=#GV=WTX;(5]$\*&52GAU?R^@'6$H\>$A'\L2,R!,I&+2S;V7L)@ M:Z]??F(M??J^#VN;4GB@$+*4;6:1">DO;$[R1R5H?>7_3 MVV%MJ:,'REXR%-[&U%U0+R&]RE=]2+=$J..7RGA5RX@BE`&XP&@ MZ`Y?@Q5*0%Q`KTL*.!AU2RT7CY1^7F4/1F&8+@7%,'OWJEF%=4^8R!R/9WPL MK,_PM*NA8\JV=4_)[%5R8@(3@#",;@'%W&-6\(J/K5&(=`-3%Z-NB>GBD=+/ MJ[R&T\#5FZ&J?7#:4D&EAU!LC$&@N_Y/3&#'Z!\ M$"=D`^)D8Z'87MY+DNV0%+:+X2'D+P(-CIAW6E:Z>A'(-OFU+755#K='U M+/_`^'!?'^?9Y+UTW3>2*_`4Q>;$0O\4.?25V#W(QX.[298N>:XK=1*^+7BW M2^&*DBC6O4H';)W(EV1;*=^5.?IT",:\SCEOC\6.4E@`HQM66`J?-E*J)&\; M00MB%39>I1>RK;XQ!SR*E@@CE@@'GZ%9E$8+/Y5IA*WD\2I[,($,<@K$)K`; MWNC'1*Y!-XO34-Y/:1I`*V&:TP@>=AP:YY4_#K/S(T;:SH4/W#\^8^6@4XX[ M=X#/8*_@C-!\QOL$UI!]0IA0N;<[@10RL4VB7$LV8?\$DP6)Q/XMELAYKR9N MCWKWD\3*"?BMQ6`Q3%44>K7ZXC/!I`S6W-19RAX;]@>N&YKC;/%7N'FB`#,0 M"CX_`H0%WYFV^M7JUR,"UX,@_0>1L@_Y=S'OT[S1YZQ<(#I$@T!J%8 M;P!O8/:O+LE\M%O['BC'8T+%8/..EO_*BHC:.6OY.HC+%NL@>!V!K,2_]0_B M9"<.[X&29\1O?[7YPB`789M6&7'MGDT[U]H8_W_LH^TD6Y+?T$Y[E?"Z@;QQ M")$D@/\=P[P5&&63#_F[1A@WLX[IY>:4DM&KK)'*;HVQ6`4QGI5.#]H>':1[ MF>9HV#$I7=U28IH33J<8RPKT3,"'W(';M7`U16PA((]G(AM@$++!IH,:-GBD M#B0[5.+J0!LC"NW%>/8!88!#D=K77B4+ M_)8R?E72[>3R*J?VN``4RD/@Q>R'3WU,XQA3P8Y)9')#B7.@;)DAKR^GF5G& M[@ZSA,K3TYF%>6>K#LG@[)/2Q*ME/A*XV)'/'6]Z[VTIVR&]&CQ1*IF3:J<8 M6:C#+-P3SHT6'9.LT1\EG%=GJU039G>X?GRW_FV!@UG'%'1S2LEH3I:<:(U: M!;LZ%5R?>VLHWWGE2MXHR#.BD=-VH\ZK675)GBGNU7 M#`YDJ[7V?"FM-3[ZH6U@(],V3V04X]D]P?,G2)>&-Z7FHCX] MD!9)=ML638ZHV/-KAQ]W,80PD@M\[QA+Q9P:;#ZAD\4NHU+Q#Z"KH^+66*`:^V<=W.9C!, MQK/;=;@`>`XG((%CK*=$$\KMS#LG;SOWU,?-FE-%FN6^W[SF&^17@"$FUG-! MQJ'DKU1%=0U?P=985342\$J(VGUQ7'N/O+I\.?*;<_EU9K'8)28LI3"0GZI' M<@&R!MS^-(E7*7Q,GJ5^^-/)'UO,_PQAOHVFD;&F"@Y,7M/M:CQ>5'G,:@AV M501:R/M3*EM[N<9B]`)H)%8M\4=+KKPH?1V^D5K7B@Y,L>MM:U1?5JF6-?5E M54%65P!P%/#:`EE=4'=C?]JWG]UU8+90]L#D%6JN\?-#E9\JC/V=M\RP&\EH MD7AX)3F-^9$"63]6R5+&_PBDN8RD*M371$_Y6YTZCD@[Q9+$^>(19[E6C M\4T]YI1YD-E+(BMH]^>Q_LI`GI5324,W$NI6S8&9=;MIC>*?JA3G]02%BB3) MJJJ@[,#^9'-_Q8R05XD2"77J\KQKK0Y,I?8>->9^KC(GS.0>*VF8DS9]_=,M M)LTHVQDL1JERY_$<\ND(=!GB6*T/3)SU7C4"WU8)+)A+]G1@7S&R@?/L,(Y6 MHQB-T:%'+)I;5+D:GM=&)YG500&UL550)``/")JQ/PB:L3W5X"P`! M!"4.```$.0$``-U=;7/CN)'^?E7W'W"35.U,E3QCS]SF,IOLIF19,U'%8SFR M9Y.M5&J+)B&+68I40,JV[MNSNYM-`-X!N`(T__NEE M':$G3-(PB;]_=?'V_!7"L9\$8?SX_:MM>N:E?AB^^M,/__D??_ROLS/T]\O% M-?J,8TR\#`?H.)OUWC.!O'P33. MPFPWBY<)67-K&C^D&?'\K-YRC(VVS,7[\P_"-GYC(8CW$?_^F-0Q>L0OOD-_ M;%$XIWCG)]1G-ME9)-I4L"])LNZ@7998,/T0%P=(?`U5/H?^47SPGW\4+$;64_,?_O&EESYP M!'1,?O2\#45R M)C,8.45A'WN<;`EA+FIBE@U:*.M4@&X:Z0$AH*U*D31,(Z="'N?Y#L!VS7`*VA$J\$+; M\L1+5W268?^;_GL;/GD1196.LXE'R(XNH7_THNWA%&7)Z][6K92JVKX1H]6L MWI,K6`!KN@9EXI.[SW[`>W:G3M*+!OR'"OL(>1DJ)"`N`FR1XOO)ED):8!]3 M>`\1OL%9[N6J<4/+`C!%&*A0FRDT]!!.THZG.1SG+(B4/",4X31%7A0ESRS8 M1LD2_?;#^;?<`'_[_O$KSQPF#ZLL%QBNGR<9ZM,*G%6PH5C3C=VZV% M0E5S-F"#L')C6`WSRCD1%JPI7TLEC!OYM4C>J5\>-L(<=2G<+K*)MV)FM3U M5)ML,,EVMQ0AWW?Z]S;$T0-^RF84.:]B('8J74?AYER58=?^I^2%BEA!"VK@'2,!>1!P((F.U!EL:LL&,W^:KC&Q2K-K,K?U?A]Y#&(59B%,:\]]EB?_+*HD"ZN8LD,]V+4S\>7L>G8_F]ZA\W`3V=68)D=-]8Q@'J/P<%C-36TA]@=08[VC&[/ M(5LCKC`,YT1R<2+FUML9G/=2$,,=GI3#EAV;K%-"'IB4(5&?&]P(:I!SCG9( ML M!3FX:1=IWP5^PO&V96&B(H;;6I##EFTIU"DAMQ)D2-3I>"*H1^6)FDU"V!5F MD!T%.^B+`CK@,<%3-3ITR&P<+0TC1#8+C2&\TGAA4C_7!K6<,H8K6S\!YGO[ M;&:PS?B*$C;;\0HVT`UYK2J*+7DI#_"FO`:3?EL>RH&/Q!J>99]YSB"))51[T^B;)Z/\^\C]=?'CC-F%^M#(U'BB7L#X0 M-JPC8':'O@9VS,OZ(%25X1M^E3#;N3W%;H;C&Y8TUMI+R:&=IOVM12 MNY**$]Z[],@L'`[073KKD'L0Y4<)04*"\"=$92`N9!@>Q:&DXW+X,FJ7)A.T M!ZG44'O.(0>\Q\@1M7M*8PH"]!AK'7)/$7QH+-$!WCO$#&BA?\$P#*^HPV_S M"$$]%&^HHC'VA/!@Q0+D!8;8ZQXPI-66@#3?KUPME*]Q#<,/)(JT.4.%92@> MT8!D[!;#"$'LM:@[R%RFA?LD;A*WANA-,IATK0SJ88ZV2@.5F&UBD"8PDU@5 MDX_0M^?RH/P/Z,/[T?_\3N1IZ8_?GK\_B-'U1;O_(!C/1[_/"WW3'[_]\'N) M9PVI^K==HPXIZJ\@MPSYC3A!_=`FV#=@`_96RQ!9X@TYL&<8AL)UCX"-Y3NC'UH4WU!$&\(KJ0=@_>K@74$Z"*O7AKY2 MBP>(V3NAKEGZ@)9)IK&ZGF4`!M\2I>OH!V'Z[9&MU/ZA@O/N^`\\80!Q^3@( M0G:WS(MNO3"8Q1-O$V9>5%%1T0@FC``WZXW5J5VQ;^4"N6MOB*IYB;UD1.RI M@3,:7ON"U^W=^Q[P,TZ6'LAY1ZCJ2("U)[;K;<1"&'["F&+:$+S"<1H^X5GL M)VM\G:2L[N5\>>^]J)K'5@I(G8HNBAY4K[`1`533PAZBK')$(:5XSJ,J!T54 MA.O2%SVK)8[3U^0@(0B]9J+>B(K9R9)=$X-RS@7.O##&P=0C,9U7TXH"5W@9 M^J'JB*0)HWL7-%>GZG7M7!".9HI*:X2!H'3J2IV!%XRHX$2OJ[KDS&].<0&@ M[3+-:3K#U-X*]=$MVLC6I):\[+^ZD%'-D M*\;>?5GF"QT0:8\5%Z>*]\\K%!(.%W>G'Z#ZT$U._06&&U^*=#\:P?TPT148[YK]AVGT<)HM!C-T(H/UU@(*H8^\3S*O17B,;)R#LX=\Z(-OSL^5MT3W_V MUJPT7F)?E6J["#8U? MZ&B,TXP%,NGV(0V#T*-F?B@B3C(=K-2.*,F$(E-4R%UA-9AG!`FJOC5 M&]8P5.)>$[S>)*3R4=;TE""E:[BUGZ1\-+@8??S=?Q>)2((W%./*2W'@]CJ;O1K5$PM].NU' M`3;&CVQA"-WT@'XJ4P)Y:!ZQT54$&[JM5&"T6,Y+8")QWF@&O;1`, MYW:I0D$9X1!ND\J,N4D%8S#>\%$)G[MO$`UR+18&HOK,&C,7!7[ZB-_)F/850V.76O')GMO"5)L/5Y M)8H[3)Y"'Z=YD3%9Q*NC=IS1;`=>YC#5I.ZREFT89`\H6+R M./AI`9^<"'YK-O)4^(_TOFLJ-4[Q)\S'B46R\Z)LI_$_/;UC#S0!7_J@CMB= M%[:CD,PMG`4Q'FX,.1>8*QZAP[+0@>0Z@/EC9R589C1'S9+']9RP2/WC0.3] MO5B<@=AXA*JZ3`C/9)/P<96Q0&";XA&B@0'/>2?/\0CYF+#]R/HFP#II_'GD46\:C$3_9 M[/C?1BC#_BI.HN21+F#67KQ=>GZV)>Q3&Y+002@=H3199L],/-.)>`%>>^27 M*BC1T93@$<>T<:)HMU?5BYZ]'16R#%]8C1,.)M]A8*;!2`*\P7'`,O#;#6U6 MWFQYFPN!3)V''?]#5'Z4M_-;-(Z+[9.UMRNZI$+&L;'>$+_B>QP>@Y4FI?32 M0#?>3K1LO@\A))\DU:_:K#Z]TSG.K'A1.?G=8&6QKD,J@)R*'&@MH5(G`AJX/[J?9?"E?H"EH(([F2T#6 MS^)7"&`.WS<`2$ZKI_EVOGNOL<'76`:Z.SYU5#.Z=9S/)$E3&E,ME444:T/-0P`<4DK_%J(HJ0&B59:T#3W5-G2G(>OZX+!;0!C#5@P M<,@E2V'[8,L?D8:A6HR#=1B'S/U881F]V;=R`2R3S!2I+9WT+"#+*1-(S56" MX!)'AFM\;A=<1X.O\T'[Q@*GF%K@BBIT18.4*-FPC)_>,UIX(*Y(&2A1OQVE M88"Y&-4*J&%4T_@QC#$FQ7@;[!D=WXVRQU[P<.`5+KD[N`GH3]8'P*&,Z5)V M$*&+4<@"\NR7'(3JZDPC3H$-4XS#$\!C._VU,)##[:]4MVE8I01TNB9@J=OM MR4`=[Q!&<\^/Y9'$I;--OBD-Y':M4/>.5[L^#^IV1[:O6Z?[E!`NU0:]ZDS. MX)I'Q"J2D!"%*K(0$X9R:8@?C6GXD*-3W"?2V>>B1FA;43J@TLY(KC2_P'ZJ ML:WUV/>PM'8Q7`Y4;7>K&(HXJ\[%.QSAO'05V*N._Z!6>K)-C'6*KTM%,$$(&2\P:N!V'./@\3X#E6 M3YX1S!-C(N6!,N^%'2Q]"E,*P'$P"=T.GDV1LW\P!\TYM;(L040S7.)\9+'&/U MG0`E-=30K03>'&8;I'!#H@**RE^AARQ+N)2\B.+1ZYP#I)IQGXWM.$;#6>O) M@0,:@%A,!K(6?U4)0&*N)@#I)4;G9?A-@=4G;'GE+)"XJE/#.CZ#8_"^P2TF M(9N]?59J#U]A\?^VBSX]"`8XX=-;<]0.!!TM%>:.44^PFX=X%(]\B)+8CB\F MG59)PR<_P"\WJ9I!?3:#+O7YOR(>&HR#?VW%VE[?:):]T/_GAS.FG*II34:> MOK\-/.N@=;9-B>$F)TT0!I6PO\&:L8Z=$T;'J$# MQ+`6?!5&VPP'AJJ6U/!6?`!<9\>18/ MLGQ-,7_'.O*W(FJ9+^G\Q99O+2N,CC(J4[>;ERH[:KE_L=)2@-,5RA$(FY5N MQ,M"6RJ'O>K'RN/Z>VEL&1^K%S;]:2MSHA.H^357(VJT#=?9S34MFLUM93! M.%R;H@8NIQ(Q(*?30QS$VK@?Y):NUWDYW=L9J8F7KF[96:T`!Y<[,?]!F^+H)`3EMU5/?@2):E%)!\85>8S;0SE8(^1K\C=2315I23?[C+^&,V/[O2XF/[<)7^EOWLLW&$ M'5'@/[`7#9^\B+,5,>_^5IP'-'#"M5OY,=0\DTO_W,\@[&Z0N\(;:@DASUW0 MGR.J@8L('$8F8XVJ&'Q5641FYPN/487M2@@8: M!;,HEBS5QW'Y\+QZUSQFY=CG2^K]U-.SW2W5(F,7PWBY5T6[F#(#%!.W4JM6 M4]R($Z2TN`4R946Y($PW2W)PR[8N=\8A#`8ABH,S./8>QPSG^2'G&<0:BL3N;+ M3V'LT<@A?F2%A-A#I5=AZK.77567.LW9`2)]2]5JT;LA+\188(>M&2Q6V)D+ M!04]\[`,DS6-M+V8/9S+SNVZ#9G[U:P4P"NUB4>(2AE#=+@.S3(TQ[)UIJ$Y MD*G3L#J`89IN*2OF9=+Z#+YZB(`=YPT\*N MO=\FI01YNTV#I'F&*$O\7\X>_'UR0NWV\S0HQ(\X13Z2(CSP_R6^>B3(Z MLSC-"#_+E6K,UIC+<4%81ZF"A M3EA1YZ3^VGJ(T94^`-?R68DP+UV9E"'5T`-=?->!;]Q4EQHU7@U'84)S$ M9WQK$&SFZH8[9SAI+5+S%,=)VM[UWN$2$X(#N[)QK5P0.X9&BM0W"[4L,/N$ M!I`DNVN"JU*(T/%C=$?B-B\TY[208JW<0>7AU(>(-TW)_ ML"47`WZJI:GIV!>9R07VUN3#ZCXJ2&N9K(M)V1G MV')*8#\RAJ[PH%*CA40CM^\&G:97H-V?U62.Z=="Y7/'+3Q#<'B)$GI/KS`, MP\4;@*0OO3&*';!'FR"5NG*%<2@NW*G5H3WVEN"-%P;%,C]?VH_C@`?"8[Z< M,FX!,V%#\'$;M?7.;R)I&*.".5+)@0_.6K[QS1?8"4^5B!4W\#!RA&J*\:70 MN(AUF<(B-S0^4!AVT''3J="CU&2;9LD:DRN\2=+08D1J,@YA]%&IHQ]I#KF& M,:K(436C]9P,!3D=$AA"%LQ.I3:7#6T@7:5(CZX%6>?V-E_WR=;.J[L\R'6 M48E>V!!.5!U%YD?DQ*T5P5W-G`TDX.^@85L*X+:B>"X4 M7N4 MNBP.=7'ZO%#/_3#4`AJ*!K`1,.2"&3+/-^<&>MC("IVTT$*W2]\#+9;17Y$, MH/>4X/MS$*./>$FQA_(]6D&#&8T,U#48E312AE2^IQ5F:_F>4L+0RO?8J]8R M,LDT!=]CIW%*7G]C[-/AA>#:#5T:$;5=?;<1X-Y'[=6K^J8Y-\2*P1:=I"9* M$(K'@;.$/9#)F4=HPR^.LUD'-R^/._#'H_4J!#"U]5:1B:9IN`!R0)O\F71 M?'F=Q(_WF*PU1774Y.[]KPUZUGF]C0-,@.MA6&+?D[/[_8SA MC..'*Y)SLL9WG$<@B8]QD+(A=)87?9@O)\EZG<3\GKPJ!FKG`\@:F"I32Q:T M,8'D",Q`R4HP<3[$&J:X;YPLEYCP.O&Q>,*R.-KE-CW0BTH%)U-#\"+./`3_ MX4#F&Q[93U\P\<-4^4J:`1^L_VB54?F/E`G:?S2@VOPGIV;&EC(I*!%BP!RG MNRZ<$^6LJ.2%V*UWUCE#C5J/CA^&':4>%YT.*&>F1&>98]E4PKAE&;P-*V]F MIZME=#J@O)G[/G4["DWI8L_/YLOIB\]O0B]H(#./64N,XX#];[I70M%R=B(` MGG7MH&+MK5<+?I`'8*WQ-=])GMP-.K^H40A"3PLIZ3@H/ MY3]41$&L;%SVG-MA1:[#+8TKD^#P]*6B<>Q$N!]6NJA8'59L^"&&%7M\BN(: M;+M(.3$Z'5KZ4$DU?HR0D(,DYYXAUC.NNZ\WS38OS%=Q!&RHVNK M'[U(>8Y[HE)GA![P8QBS]\?9D"J@G$S'::Q-&9](0\SN9\IUQ8ZU8E)/2NY8ZE?5W#?FO1BHV1L9I9?TIY/, M3?I2AK&C@A$`<4BB;WX4W,(UQ<<<#O'DLZH+BE,&XP9JBF0U"D+O%"K@'EXD/ MJ(!N#TM1R&[>PA2'M47(*;FYCM@#K6`%SC>]N1_?S^8W;JN[NU&T^ID1JGV(ISFJGZH\Z4,CM/W7 MT/YSZ!_L@XA_\9^_RF&G)4/2D^Q?V0"CRZ[T(A@D]](C\N8`XJ5A*MZ3K3B0 M/'\Q[+&D-T7=#@)Y)2%6U5OLV+'[@(0D9)(0@GU^0JEM86$I`^"9O"Y*UM[- MLQ$`\I">/<#FH?7IA$[A:#R9S+_>W,]N/M-9?7Y#?YY,O]`_W+E]5J\'A?8R M4%%FGU_'96)01B;@8).2(@`T3Q$75-\ZD$X&C_9N>]+V?3_YR1@/SZ14: M_VV\N+I#XYLK=#M=H+L_CQ=3-+OY-%]\.4VDWKKS`:FCDZ%$MQ5J*V&0`XER M7]2.W>4BN3,\Q5.\IH.)VYGZ_Y^6/8TF;=J>=##I:UI;\NT8\`W M($_334&M3"`3D2$J2^,#FJ+<*>/6>3XG2?`<1A%5:4:CMO@Q9*^=\$>XS*QZ=C^;BIG[:OIINEC0/RRF/TYOOD[=)_QA MM',[;Q^H8SQ7&_"YGY^-E:G.R:U,(/.P(:HCQ@V861A$KR/GX$LO_N4ZC%E! M3OJE,..CP$.FG7;;>1S/M*9*E)-K&X.[^=0,B>00=/P+8GR\'"KGS$WF(8.= M-CLJ=#V[F;+K+Q,Z;\SN\VGDLO\4;>O$V!'__0I7JB#P6]%A96_?>TBV&4I7 M"81PLX#KD5QC^=5Z*^H##_:!FP\6(MG:FEW/R2$),]A M_%C4E,8>I8QR8_`YZA&*DPP7-:9'B,+QXEW^FCMU)SZ*;#T:@#\2S#_)7J1A M#\#O$+M)G8KW=@1L=B.:?RG:\5)W-9R$*^A%0FR4_2F_\\J*7M%_^TD4T9\(Q5A4W*,?HP0DS,\:4^E;4074V\TW5O0+A>L- M[3-/M`_]'.%=P%ID65Y,2LNK"R.4;FE?4*49!>85O3@#'8+WI0+I1^(DUF-Y M"[=H>L@L5DIR8HCED0YV?4TDHP1:"*FA-$=(U6@/M=@Y$7;'Y>V2]3K,Q+VC M.)@D_#@UIHZ*+3+MMD(`2MQU4K-6Y,Y*`DB9NPX(FR5!YE^^S.[Y+1V^")G, M^06>ZB*AU5Q4SM#R[D<8M,Y*EC(%ZHF[^LA(`,JUU0&AI MN$!S'HQBCNOYX4<&;H'9NI<",Y\%C3@!ZOB9*U2KX=?.!C')&<-JGLZ>?F;3 MVDEOK>B1KM1S MQ4J;NWTZ%L`JEL9W^]3TH)4M;YV<\]1!#C\>4R#BX`%&)\B[U'M#BGV MWSXF3^\HB_`$^L.A`TC$N3-AI2[,9AM_M!J+5:TE[R1KR_BA%(J85/-W+"JX M)EM"&"JZ.O"BG[!'IG%PY67X^`Y52W;;MVT:%MVLHNO:XWIYQW=^+A^)#R#V M!31EQV[H-SJ9PE6>,+@M'CSKQPX48MT:@5:WP@*D1%V[7R/L^+XOA!=/]/32 M[_>4KK_N%M)@>KFJR6'GLK\=VZ=[&3UV)1/:J?^F<19FNPE/Y46S.,`O?\&[ MXSM2(=9MCVIU*[I62M2UCS7"CN]L(1SETA$7CZC\8_H]6:^3F%=WX\7P>S,"[3=`+,)`ZP/ST'`<:2NMDOLS'/XIQ+\U$@4&4U3YW!%V]"F, M,)G0.>0Q(;V-'@="(2Q%JE?=-&HDQ]F"1%1OG<]EHT+X$5V]P(\AB_WB[,9; M]S#ERZ5"=+9R\<,>E'K>U$D%"\FNAOT_X6>A+1,*L^ MI8Z'2\`&X;'K087`'A>'>9"7+_?Y-WJP!Q8SGL0:*H(A;:&AG]P22K)^[.!` M7/]6P$/]`QMPG*DN[L-5GO>Y3=+0Y#UP(U:`#+:%2K5LM@%?_YEM;6K8&)'L M=$K^DA,.T*47\;N+=RN,CWQQHG>K$YN4_(C^>D/P"L=I^(3SWQH;H)D44%NT M451AEB8BP"S4')S>6"M/![);B%5AZ#I)!V:^Q4OVK5M\6A90PU2JH+#"!CV8 MR2F06-D7>U:&UL550)``/")JQ/ MPB:L3W5X"P`!!"4.```$.0$``.U=6W/;N))^/U7G/W!]7F:J5K;E)#/)U,F> M4GQ)N8XG=LF>3Z>GYB0.0%RPA6G\^B<.)&WH0GOSMO_[\I[_^QV3B M_.O+_,[Y"A#`;@26SBN,-NRS7UW\W;D,MCL,UYO(^>'R1V>Q<^9SYRI`"/@^ MV#F3"6?RQ0T);8`2;A>GT_0['Z+O"_*=0V1"X2]O(?Q\LHFB[2]G9Z^OKZ>O M[TX#O#Z[.#^?GOWKU[M';P.>W0E$8>0B#YPX9/PO(?OP+O#'>6_99T!/W?A`^;T(\FTXO)N^GI6[@\2434X'_"E:$?B-29?OKTZ8Q]>T)M M@`,?S,'*H?_^-K_-*!8P\`F[4R]X/J/?G5T%7OP,4#1#RVL4P6AWBU8!?F9Z MDQ^E#'^)=EOP^22$SUL?\,\V&*P^GRS\"!*=IA?G[Q*-_J+F=U:4K3US@C@, M[UC2H*J0Z49`X\JJ3G!3'1$JT?<(#(GQZ@NH<:0C4Q.%"^QRCP MOK,),GMU\3(D<#P`_+AQ,2@!TBBG+J,#Y;U%+T3O`.\T1"J,/?!7B=&W`$>[ M!]]-//:/&&XI`!I2*&@/M@59B=9PX8-9&(*(FOQK$"Q?H>]K64=!?:!DQ%UQ M#)9WT%U`'T804.Y78`4P!LLY(+#$0$-$/38'RGH'$;A?71*.,&+L%SJH"JD. ME.0R>'Z&$9O7A.5EP.8[V1V)WAH2*:D/727`FC)NN2((B`ZV$**K(6;<](Q2 M)CAXQA'.X,E]TT*D-/I0!.)%"/Z(B2[7+YH[1YV$R;`M;&_$B[^G/TQ)#MS] M8419G)\[$X>/+_[IHJ63$#O2LP-XBP!:@B4[F_B!5_K2I\>L`#>9BG[RNTK@ MV2(D'N%%G)'O+H"?<-*D.],6+S4H.ZR%P#M=!R]G2P#)H6TZI7]0T:>3\VEZ MT/L+^2B3X8FPK`EP)]//IR>OSMQXI#(%&PIM>OW;=T9$6))!;GQW;7`O)7O M1V/?BMRY@3\'+\@P&1?WE%GMT4?EP9-QJ#2^3/#?_^R(9/))^#-:0" MH^B;^RRRNWC8:,PN%C^W^M2(U2_9*<._)9O7V]_!3FKVVKB1V;TF?V[XBR,; M_C+&5,D;&'JN_V_@8OE2(Q\Z&O/+5<@1^&C$]6^@#_`E$67-'K4ECE\9-1J[ M"Z7/3#X]MM.GLY`\ZP6(A5Q8A"6\CR,:EJ1A5/G2HR0:&2!J97)\CKT'9H<#6[(9Z'B`"08.QHT%#KDZ]+/1D&@BZ4>!(61(P6@H$%N_I_$YC^K1@(. MC;G[]+W(XP8`K?!$9?S!$?\"MP=FY@V(H.?JA$)5Q`?'U\FFP8)R]RNR9A&3 M;P`*X0M(@D-:@?4&#EU*Z(:;&S]XU0HOB>E4,:9*C$I,G$P. M\O=E@,+`ATOVLC"E=!)2YX??D!LO(?GF1_WH4G'U6;GA@DWI.)RL77>;+$'` MCT+^274M2C_^/1/Q?G4#$1$*DJ4R"*$B&$6DT23;;RG=7YGT;8%<[.J`8R^E M^J;+5U*1W.D".CVM+9]$F>0=Q%VBM518)ND+P(L@!&PLI84!)DL[84Q-XS@F MT$L?)AI!K(TS@:78X76?IRQWR#WV-^.+Z['5/=.EB MO",GWW^X?EQ]_J5&TJ0SAZ[$(3G(FO*GH+^C624UT`O`'>(!1U]NDS?_()6%C-_Y+`'IP<, MMBY<7K]MR:D;D$7HGCP;X))Q!/!I40T652WI4[!_ZA;L"&!S2VT#J&.!3PS4 MSQT#%42N;VQ.2E*JQ&NI>OCPCK1J>5,X/]JTR%9ST8BBUV^>']-H;IZ4)M@D M=W"G0GVP"6@'FD`&K@3(]MPD5GE+YY+YE#ODM0)YT)VPB&!Z"31)S M7*KBALP0#-@7358!.(MW5E`>JR8/OTPVD] M'6;$./.@Y(.[HQ')YJ!K=:!A?#5CKE6I.9H=1W:,A]$KI41*.&5C!X^H3'`. M:L=1(+.@7L9A%#P#?`6V=,]20"H=.6Q`I6)S.*V*`E4J^^1HR@8.&TR9U!S+ MC@,])I]>M);9\:VOBH7UHN.`D,FGG4*LI*"Q;D!(0C*FLVZS-AQUJ\)%E05* M"W#!V#$B+5"#0]QQ4&D`$4'=2:T:/":057IPE+L.5@UC\U7ONN-"L20XAZWC ME""3NZZR?T/]@::QV\-(8%4JPF'^(`P@CG0-;A4^'EK`>%^8-<+$%^*`TVC# MAP]<=*:[+#57.,K,JP!=+(4B7(V=5+&FV7,)$ MB0<7+F_1I;N%9&\O:"\*_&H0#1M='0TXWE8E%LT\+WZ.?5KXQ8[[@DJYNR"D M61_W*_)8+X[ZM^,P<$]HJPXOGK`JLVD.(A_*5=/&J:YSE23YAX(8QWHG6\I:TP\6RI2(5Z&H3PEZ"*SIO!_,PZ[60^[0\1-)S/&S*";5]+2_ M1[[;N,(6S=IPU#LN>JNA+NS6T5>?A4H/C)0K;[JP9]<%YX<2VQ]/G/]OPW#` M`X_O!Z_4TC>C26B](>J3-XFA#M/F??$^0HE\G&"?J=3URM$7) MRA:A?1N&L3;2?/"84>8ZY`C7>TM;A;"\ZZ/,1$9;/G:)M:C=(P&\WNYQM(`7 M8O8M]G`MJK$`KZ5,_OK*HMV[UMY4N74K1X\0;/FF_=&F3;NFL73'EHX<+;C5 MO?JC37MUB_;,0N.,RQ MM-!'@%^@!\+LSK?ZZU[5:,.3K8W%L[>^*GVRSK2#R-20P'='1$8AN`'LUJ\E1K_3]"$&L:-!/@UF3<_$K)B<.LH>LA!ENI6]'"%])_GZZSIJM\Y>6Y*.["JNNTKQHX06(4V6;]9JWH)/0*?\%P3*]$K[4%!=='VJ1AL`NQ& M/\WV3(7@_;2G-=SF$B!B&9_H.UL^0\1N*HR(\\NA;:08-+Z-TMO8M'9.L"!V MW+#KOU^`'[`>O7*(&\8/&N`&V?MI56OR_%2SC,[6.W`0!?+VU,YV$(>GO,A% MA5UQU)@/3$4]>FIF:Q+5FP`#N$9)XIZW>\(N"HDYB%)?78BHVE_`BHP1UW:U MHAZA%[32KZ=NN:8[R+^`D+412"QUB\CN03X1.(-\Z`B1ERO34QM>TS`GZLE/ M6;41HP2UHD/>2'<0I4&2B/^W`&%`.^N0[>ARX^(U^`VYSP&.:`['%5A$<\!* M$&GP30S@_FQ&AO+^BN:]=@?A"MU,:V*)H'R0D4]PQ=B1.4&#-CWUX35YBLL/ MJ3?$@$FSGYAHGIYB`Y2>4Y)QY+0"PE\A8IKR-9&8M\PE*<3Z%42;8)GOAJ(S M_U%_?82^>%3[]-20V+QW$[ND4_@+0$#\_D4Z(]"EIQ[%)J-"WT"DC"I4 MOA\AFA4-^NI-;#(^I-$-Y0$0W>A*1K/?P!5(_E6]A>N`Z0B]I0NU\P;*5KW8 MDYE&'JHAIF?_\Q/PE_\=)YNEVI`MG+'[GS82[NYL_C9Y1L.I,.G),4&9"Y[VD!P&FK.,=*['Y M+02L>:?OQ<&7A98Z6MG-6F*#=(74J51MS<$F7Y%K M>;P.VD>MAW3#S8T?O&:!3EX%^:Y%%23AX3`F`ZE^S)32*W44##<0!%^2#H5RE?9A8OB93(I4(53=6J>L]$%)[:?@\*6@GY\9IT_U8XNL(-2J1>8*$.$]R,`E M?_L@#83/DHPE]KG`W?3(3+A/G_,MOU]01_M^RD\-ET"EB4EQ\Q8=?K1);?49?0O8 M6)BKTKZEN_S?=!$[2WGY2S_`7D``%,I.L[*!MKJ"3-]^"GX[?I?&C$X,6!3!8IBK(V.T:!RU\7&@SAB7J6B MZJ?T-U+8ZAJ-BEM:;US.!BR8++US51&";4-LJ]NTL4%>RFQ51+5N@OI-15K> M(R(SX3?M)X7<&T0Z#:P,NB\OH'5RB/P:%':=:1@_=MQ+REA9[%S7^0&#K0N7 M?"=--]`92FYNGH4AD-6S[L5H["ZBIV77Y=,#]9U+LE.3/1E?@2UMY:[G)W6B ML?M$7:.>"HR'=NSD^^2#NZ.;)'VWZ'DX)MKD5Y>V.D2H&8W=3_2T[*ET>6B^ MPU=0>:=G#9JQ>T1-H;YJGLW6K6L^KAV4.SC6-*`V&N;ERM94\$G43]IU')AA MJF0RT@Q3I4YYB:]5L0JR7Z;QH)GW1PPQ**6ED&U4E=+3AGA`*XC&!,BNJ&RA M8=?FP[3M,EEIPR`ZC9#+2'4:I4UZ5;-4.,P?; M=!&]7]T%:/T$\+,DY4\^=$"K@X9SY]W59?IT7;0\B+V"6,H#8,GZP]%[0(F9 M`+M^C]\?*3I"--.,$WL-Q?*R98NB$46]F9[W3*?P^@U@#X:2B^L;:<;O!!+% M>JI('F!40F"W@TX#8W6*-AKV5(%LM*_0:@4\((OS^]&`;"7>4K M)'<*4!L(4Q.*7QMI--729:O7^R22<_0&TI>PLUP3?D4$U5)\&[QHT+APK,O/ MT>P_5M=W*S#:"2^D[0=RCID!TD9@/YV?3YV)0VN&_2",,2#_862T]5>)\-C5 M7'CMHK2"->].EK3>*,J55;>Z?MZW3-7FOQN^1R]N.T3L'-TGXD!??'%\OON? M,-(-O$N_R6KG.C=-UL5L[&L,+>Y`49J329=<'"#RIP=*5S@5EIN+ZG*3<'!R M%DZ%Q[$;#&2"7+)`'>VI<(UQ@"\#`@2[/$#9G*L5^=&[)VA(IUHD6M(;*7W; M`[^L;T([]:R9Q>R-%6L2,'MU\9*JS5NL%IYS!+/Y774V,TX3QLI)>#DN6CJ$ MF\/8.45^![?:UA);V6B[)8?#NX-K_:!L"N['PDP+W[VPR5N#MU72FKG(R^=V M@NGVOCK=\L$&;FMF/YR+HRR75HPV<=%T11C5EJ<>;J9VHM'VQTT*2X^+7C%!BQ&5$0A@QC1>B`^['ZJ2C9.PJ%T:8SK?%T8^V]#FKE!ZRU@TO&,W4+'HK@`>87<\\(<^52=(P5R M-D'*#(Y_(Z],%ZT)U)+>P(7#S>*ISIEM&9B8H7MA6+B!N)6"ULSB1["F6BM? M.DS/:R\=$JK]WBUTE,^8B#`'6]IY&ZU5"8S2H4=/PJQ(HC?[M*B,)%\V8)`E M7NHH8,V4(JL'?<&.&2_!7CBM)0!5*`X]=979*;-`)2,//OB5&2O/>]*A9O+: ME+;+$TUE0EOCQ85,/8$+UY)*DN%.,MY4YJ3FJS'%:&-)G[JOQE3##;45:[)] M+??3[N7_,5Z$X(^8<+M^$:=D3>M)'!F-DQ(=O3JD++2R'$0V]/@E+65)E&^K MUP8``)@O```1`!P`8FQT:2TR,#$R,#,S,2YX[MWK9:N^G.%Q+8(6FG? M5B89P&JP6=LI<'_]C>T$$I)0:&_5[M&'*M@SGV>^<2;C3#Y_F4\B\@!2,<%; MM6:]42/``Q$R/FK58N51%3!6^W+R]LWG/SR/?#_K=C.94\$8)I2@ M15RU:F.MI\>^/YO-ZK/#NI`C_Z#1:/K?OW7Z5J[V]@W!/RM]/!_(B.5TS$BJ M=>@SKC3E`>24(L;O-^B8Z0&:FE^HH)08USPZ.O+M;"*OJ1R!OJ834%,:P%)G MP$2$J/5`3'"=YD'C\+"96V(0:;:--$0P`:ZOA)Q3$'E510$]9%X\--98WG3 M:S0]M#VGSG%WQ)/R&(1:^D;;1R$/I4"R8$W[<=5$S>PNRKG05.,^M[^F4\:' MPER:F!U+$<$MJA!S<==KEP;`S/D7(H@-[Z<\O.2:Z44;<>3$(M<("UNUC1(G MQ@.W9@A#QIFUJ-$@'DGULI>4A\2!D`S*9W\=8(4:X\UUPT_L]52"0A2KT\&! M1"\1*==9@6ZK$=`HB*/*19+?*<-/H/R,1N;F[8\!M'(_ M;X%8,J9NAN=B@EZ-@2OV`&U\(D_`1>,QH8J0'&R*R`J3B"')H9*.4/M\<^3H MIFI\%8F9*HG$T5.0>M'%VLX>?'[& M;&KN;L=E]70UMQ_7N4U!/A`+X\Y&*=">\=U&%_B(#2(X50K+:.3TJQ#AC$51 MNGNK!:HY_U3PP.F`1F@:&U0L8@I00]@#O_#BI MTK>2K`[#7^MA2/!(!M`&(H4D">:>!011`8MO)(!I2_`@R3=E$]5T_[U.MU&W MI;@%2)@>[%N.P8/@A&E;HB&'>&(QM1OP`#>?8WF30#7;1^ML9V`LU3F@/>.\ M#R-#1+$0+(Y7,MQL%(H^I[W'M1WN*7,(D7:)Y?;-C57S63A#YC7WC$KWHNF6 MSM,TD!VH)K%P+'1JQ.KM&87]>*#@9XR>7#ZL3MR%T6HRB\>ZI2YQRK\YHRFG MYI]IPO5@2&QW[=@T=EHUQ2;3"(LM-S:6,&S53./,2YMD/W#)^GP2I2(&>T.S MSX9ES_7Q7$MT44A-> M:!IOZ&@3US;OB,#";%`QO[Q4SS-#7O/`.VS6YRHTQNUFP,KKW0Q(]9YC0*'! MNY4-ZUK&@B-C0?-3:@%Y@@G9]O1N9@A^_31+AE0-+%9IA[W""&M`5G-$Z=0J M^A!IM<3R5E@[&[.$?+XM9F174W)?'X3`MC9E7<=<5"QNOF!)/KU0R8XW)BHGPUL*$L4R.%C19H%73TKR[X"S"M&BRE_OMNT=QWD'["GDL MHA"D,N_?].)R'D2Q^6;H5@+%BF1A13).;J^2=70B.&@J%UN[NFY^T767_G0Z M-7"]Z%8ML"?])`GEW>U*$<:!/>+V03ZP`%3N78]U<)/0+W9I%J@@5S! M%=@74SVQH)%>%+W:+/8*_;H67$(02W.#G(_-%UAW.(')@OT#]BU0#R+3ZJZQGD M&8EJ%S)*W+[18Y`NN;3Q+I*Q3L=?EZ-E=^F. MBJ\GMMOT1R\;UC/+[3K$!4>;7XZ(OZTK^16>9!Y42K\GPLL18(?"2 M]XKOCBAX^2]02P$"'@,4````"`")A*I`QV,^S`I2```P=P,`$0`8```````! M````I($`````8FQT:2TR,#$R,#,S,2YX;6Q55`4``\(FK$]U>`L``00E#@`` M!#D!``!02P$"'@,4````"`")A*I`-WYJ?ET,``#(C0``%0`8```````!```` MI(%54@``8FQT:2TR,#$R,#,S,5]C86PN>&UL550%``/")JQ/=7@+``$$)0X` M``0Y`0``4$L!`AX#%`````@`B82J0.4%V9#?)0``X_`Q0````(`(F$JD#`9R,MY1,``*0D`0`5`!@```````$` M``"D@2^%``!B;'1I+3(P,3(P,S,Q7W!R92YX;6Q55`4``\(FK$]U>`L``00E M#@``!#D!``!02P$"'@,4````"`")A*I`O=,WJ]<&``"8+P``$0`8```````! M````I(%CF0``8FQT:2TR,#$R,#,S,2YX`L``00E#@`` ;!#D!``!02P4&``````4`!0"_`0``A:`````` ` end XML 31 R5.htm IDEA: XBRL DOCUMENT v2.4.0.6

Consolidated Statements of Cash Flows (Unaudited) (USD $)
In Thousands, unless otherwise specified
3 Months Ended

Mar. 31, 2012

Mar. 31, 2011

Cash Flows From Operating Activities:

Net loss $ (1,672) $ (750)

Adjustments to reconcile net loss to net cash and cash equivalents used in operating activities:

Depreciation and amortization 125 228

Loss on disposal of assets, net 7

Provision for bad debts 16 10

Amortization of discounts on term loan payable 78

Amortization of debt issuance costs 99

Stock-based compensation 583 220

Other equity instruments compensation 25 96

Other non-cash compensation 62 61

Deferred income taxes (1)

Changes in operating assets and liabilities:

Accounts receivable (100) (2,645)

Inventory 975 (191)

Prepaid expenses and other assets 606 212

Customer deposits (145) (2,923)

Accounts payable and accrued liabilities (957) 431

Deferred revenue (111) 4

Net cash and cash equivalents used in operating activities (593) (5,064)

Cash Flows From Investing Activities:

Additions to property, plant and equipment (266) (18)

Net cash and cash equivalents used in investing activities (266) (18)

Cash Flows From Financing Activities:

Payments under term loan payable (2,700)

Proceeds from equity offering, net of expenses 7,049

Proceeds from exercise of stock options 277 594

Net cash and cash equivalents provided by financing activities 277 4,943

Effect of exchange rate changes 47 77

Change in cash and cash equivalents (535) (62)

Cash and cash equivalents, beginning of period 3,307 1,694

Cash and cash equivalents, end of period 2,772 1,632

Cash activity during the period for:

Interest 3 73

Income taxes $ 21 $ 8

X

- Details

Name: blti_CashPaidRefundedDuringPeriodForAbstract

Namespace Prefix: blti_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition

Other equity instruments compensation

+ References

No definition available.

+ Details

Name: blti_OtherEquityInstrumentsCompensation

Namespace Prefix: blti_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Details

Name: us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition

The component of interest expense comprised of the periodic charge against earnings over the life of the financing arrangement to which such costs relate. Alternate captions include Noncash Interest Expense.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 225

-SubTopic 10

-Section S99

-Paragraph 2

-Subparagraph (SX 210.5-03.8)

-URI http://asc.fasb.org/extlink&oid=6880815&loc=d3e20235-122688

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Article 5

-Section 03

-Paragraph 8

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 04

-Paragraph 8

-Article 9

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 28

-URI http://asc.fasb.org/extlink&oid=6943989&loc=d3e3602-108585

+ Details

Name: us-gaap_AmortizationOfFinancingCosts

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition

The component of interest expense representing the noncash expenses charged against earnings in the period to allocate debt discount and premium, and the costs to issue debt and obtain financing over the related debt instruments. Alternate captions include Noncash Interest Expense.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 95

-Paragraph 28

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 28

-URI http://asc.fasb.org/extlink&oid=6943989&loc=d3e3602-108585

+ Details

Name: us-gaap_AmortizationOfFinancingCostsAndDiscounts

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition

Includes currency on hand as well as demand deposits with banks or financial institutions. It also includes other kinds of accounts that have the general characteristics of demand deposits in that the Entity may deposit additional funds at any time and also effectively may withdraw funds at any time without prior notice or penalty. Cash equivalents, excluding items classified as marketable securities, include short-term, highly liquid investments that are both readily convertible to known amounts of cash, and so near their maturity that they present minimal risk of changes in value because of changes in interest rates. Generally, only investments with original maturities of three months or less qualify under that definition. Original maturity means original maturity to the entity holding the investment. For example, both a three-month US Treasury bill and a three-year Treasury note purchased three months from maturity qualify as cash equivalents. However, a Treasury note purchased three years ago does not become a cash equivalent when its remaining maturity is three months. Compensating balance arrangements that do not legally restrict the withdrawal or usage of cash amounts may be reported as Cash and Cash Equivalents, while legally restricted deposits held as compensating balances against borrowing arrangements, contracts entered into with others, or company statements of intention with regard to particular deposits are not generally reported as cash and cash equivalents. Includes cash and cash equivalents associated with the entity's continuing operations. Excludes cash and cash equivalents associated with the disposal group (and discontinued operation).

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.1)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 1

-Article 5

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 95

-Paragraph 7

-Footnote 1

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 4

-URI http://asc.fasb.org/extlink&oid=6943989&loc=d3e3044-108585

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 95

-Paragraph 8, 9

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 6: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section 45

-Paragraph 1

-Subparagraph (a)

-URI http://asc.fasb.org/extlink&oid=6361293&loc=d3e6676-107765

Reference 7: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Cash

-URI http://asc.fasb.org/extlink&oid=6506951

Reference 8: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 95

-Paragraph 7, 26

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 9: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Cash Equivalents

-URI http://asc.fasb.org/extlink&oid=6507016

+ Details

Name: us-gaap_CashAndCashEquivalentsAtCarryingValue

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition

The increase (decrease) during the reporting period in cash and cash equivalents. While for technical reasons this element has no balance attribute, the default assumption is a debit balance consistent with its label.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 95

-Paragraph 26

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 24

-URI http://asc.fasb.org/extlink&oid=6943989&loc=d3e3521-108585

+ Details

Name: us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: na

Period Type: duration

X

- Definition

The component of income tax expense for the period representing the increase (decrease) in the entity's deferred tax assets and liabilities pertaining to continuing operations.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Deferred Tax Expense (or Benefit)

-URI http://asc.fasb.org/extlink&oid=6510177

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 08

-Paragraph h

-Article 4

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Staff Accounting Bulletin (SAB)

-Number Topic 6

-Section I

-Subsection 7

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 109

-Paragraph 45

-Subparagraph b

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 109

-Paragraph 289

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 6: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 95

-Paragraph 28

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 7: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 740

-SubTopic 10

-Section 50

-Paragraph 9

-Subparagraph (b)

-URI http://asc.fasb.org/extlink&oid=6907707&loc=d3e32639-109319

Reference 8: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 235

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.4-08.(h))

-URI http://asc.fasb.org/extlink&oid=6881521&loc=d3e23780-122690

Reference 9: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 28

-Subparagraph (b)

-URI http://asc.fasb.org/extlink&oid=6943989&loc=d3e3602-108585

Reference 10: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 740

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SAB TOPIC 6.I.7)

-URI http://asc.fasb.org/extlink&oid=6889476&loc=d3e330036-122817

+ Details

Name: us-gaap_DeferredIncomeTaxExpenseBenefit

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition

The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 28

-Subparagraph (b)

-URI http://asc.fasb.org/extlink&oid=6943989&loc=d3e3602-108585

+ Details

Name: us-gaap_DepreciationDepletionAndAmortization

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition

The effect of exchange rate changes on cash balances held in foreign currencies.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 95

-Paragraph 25

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 830

-SubTopic 230

-Section 45

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=6450594&loc=d3e33268-110906

+ Details

Name: us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition

The difference between the sale price or salvage price and the book value of a property, plant, and equipment asset that was sold or retired during the reporting period. This element refers to the gain (loss).

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 95

-Paragraph 28

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 28

-Subparagraph (b)

-URI http://asc.fasb.org/extlink&oid=6943989&loc=d3e3602-108585

+ Details

Name: us-gaap_GainLossOnSaleOfPropertyPlantEquipment

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition

Amount represents the difference between the fair value of the payments made and the carrying amount of the debt at the time of its extinguishment.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 470

-SubTopic 50

-Section 40

-Paragraph 4

-URI http://asc.fasb.org/extlink&oid=6850294&loc=d3e12355-112629

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher AICPA

-Name Accounting Principles Board Opinion (APB)

-Number 26

-Paragraph 20, 21

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 28

-Subparagraph (b)

-URI http://asc.fasb.org/extlink&oid=6943989&loc=d3e3602-108585

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 470

-SubTopic 50

-Section 40

-Paragraph 2

-URI http://asc.fasb.org/extlink&oid=6850294&loc=d3e12317-112629

+ Details

Name: us-gaap_GainsLossesOnExtinguishmentOfDebt

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition

The amount of cash paid during the current period to foreign, federal, state, and local authorities as taxes on income, net of any cash received during the current period as refunds for the overpayment of taxes.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 95

-Paragraph 29

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 95

-Paragraph 27

-Subparagraph f

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 50

-Paragraph 2

-URI http://asc.fasb.org/extlink&oid=6367179&loc=d3e4297-108586

+ Details

Name: us-gaap_IncomeTaxesPaidNet

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition

The increase (decrease) during the reporting period in the amounts payable to vendors for goods and services received and the amount of obligations and expenses incurred but not paid.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 95

-Paragraph 28

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 28

-Subparagraph (a)

-URI http://asc.fasb.org/extlink&oid=6943989&loc=d3e3602-108585

+ Details

Name: us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition

The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 95

-Paragraph 28

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 28

-Subparagraph (a)

-URI http://asc.fasb.org/extlink&oid=6943989&loc=d3e3602-108585

+ Details

Name: us-gaap_IncreaseDecreaseInAccountsReceivable

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition

The increase (decrease) during the period in the amount of customer money held in customer accounts, including security deposits, collateral for a current or future transactions, initial payment of the cost of acquisition or for the right to enter into a contract or agreement.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 95

-Paragraph 28

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 28

-Subparagraph (a)

-URI http://asc.fasb.org/extlink&oid=6943989&loc=d3e3602-108585

+ Details

Name: us-gaap_IncreaseDecreaseInCustomerDeposits

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition

The increase (decrease) during the reporting period, excluding the portion taken into income, in the liability reflecting revenue yet to be earned for which cash or other forms of consideration was received or recorded as a receivable.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 95

-Paragraph 28

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 28

-Subparagraph (a)

-URI http://asc.fasb.org/extlink&oid=6943989&loc=d3e3602-108585

+ Details

Name: us-gaap_IncreaseDecreaseInDeferredRevenue

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition

The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 95

-Paragraph 28

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 28

-Subparagraph (a)

-URI http://asc.fasb.org/extlink&oid=6943989&loc=d3e3602-108585

+ Details

Name: us-gaap_IncreaseDecreaseInInventories

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Details

Name: us-gaap_IncreaseDecreaseInOperatingCapitalAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition

The increase (decrease) during the reporting period in the value of prepaid expenses and other assets not separately disclosed in the statement of cash flows, for example, deferred expenses, intangible assets,or income taxes.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 95

-Paragraph 28

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 28

-Subparagraph (a)

-URI http://asc.fasb.org/extlink&oid=6943989&loc=d3e3602-108585

+ Details

Name: us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition

The amount of cash paid for interest during the period.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 95

-Paragraph 29

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 25

-Subparagraph (e)

-URI http://asc.fasb.org/extlink&oid=6943989&loc=d3e3536-108585

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 50

-Paragraph 2

-URI http://asc.fasb.org/extlink&oid=6367179&loc=d3e4297-108586

+ Details

Name: us-gaap_InterestPaid

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition

The net cash inflow or outflow from financing activity for the period.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 95

-Paragraph 26

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 24

-URI http://asc.fasb.org/extlink&oid=6943989&loc=d3e3521-108585

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 26

-URI http://asc.fasb.org/extlink&oid=6943989&loc=d3e3574-108585

+ Details

Name: us-gaap_NetCashProvidedByUsedInFinancingActivities

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Details

Name: us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition

The net cash inflow or outflow from investing activity.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 95

-Paragraph 26

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 24

-URI http://asc.fasb.org/extlink&oid=6943989&loc=d3e3521-108585

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 26

-URI http://asc.fasb.org/extlink&oid=6943989&loc=d3e3574-108585

+ Details

Name: us-gaap_NetCashProvidedByUsedInInvestingActivities

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Details

Name: us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition

The net cash from (used in) all of the entity's operating activities, including those of discontinued operations, of the reporting entity. Operating activities generally involve producing and delivering goods and providing services. Operating activity cash flows include transactions, adjustments, and changes in value that are not defined as investing or financing activities. While for technical reasons this element has no balance attribute, the default assumption is a debit balance consistent with its label.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 24

-URI http://asc.fasb.org/extlink&oid=6943989&loc=d3e3521-108585

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 25

-URI http://asc.fasb.org/extlink&oid=6943989&loc=d3e3536-108585

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 95

-Paragraph 28

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 95

-Paragraph 26

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 28

-URI http://asc.fasb.org/extlink&oid=6943989&loc=d3e3602-108585

+ Details

Name: us-gaap_NetCashProvidedByUsedInOperatingActivities

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: na

Period Type: duration

X

- Details

Name: us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition

The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 944

-SubTopic 225

-Section S99

-Paragraph 1

-Subparagraph (SX 210.7-04.22)

-URI http://asc.fasb.org/extlink&oid=6879464&loc=d3e573970-122913

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 28

-URI http://asc.fasb.org/extlink&oid=6943989&loc=d3e3602-108585

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 225

-SubTopic 10

-Section S99

-Paragraph 2

-Subparagraph (SX 210.5-03.18)

-URI http://asc.fasb.org/extlink&oid=6880815&loc=d3e20235-122688

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher AICPA

-Name Accounting Research Bulletin (ARB)

-Number 51

-Paragraph 38

-Subparagraph a

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 260

-SubTopic 10

-Section 50

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257

Reference 6: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 220

-SubTopic 10

-Section 45

-Paragraph 6

-URI http://asc.fasb.org/extlink&oid=6920043&loc=d3e565-108580

Reference 7: http://www.xbrl.org/2003/role/presentationRef

-Publisher AICPA

-Name Accounting Research Bulletin (ARB)

-Number 51

-Paragraph A7

-Appendix A

Reference 8: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 130

-Paragraph 10, 15

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 9: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Other Comprehensive Income

-URI http://asc.fasb.org/extlink&oid=6519514

Reference 10: http://www.xbrl.org/2003/role/presentationRef

-Publisher AICPA

-Name Accounting Research Bulletin (ARB)

-Number 51

-Paragraph 38

-Subparagraph d

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 11: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Emerging Issues Task Force (EITF)

-Number 87-21

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 12: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Net Income

-URI http://asc.fasb.org/extlink&oid=6518256

Reference 13: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 944

-SubTopic 225

-Section S99

-Paragraph 1

-Subparagraph (SX 210.7-04.19)

-URI http://asc.fasb.org/extlink&oid=6879464&loc=d3e573970-122913

Reference 14: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Article 5

-Section 03

-Paragraph 19

Reference 15: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 95

-Paragraph 28, 29, 30

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 16: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 04

-Paragraph 20

-Article 9

+ Details

Name: us-gaap_NetIncomeLoss

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition

Other income (expense) included in net income that results in no cash inflows or outflows in the period. Includes noncash adjustments to reconcile net income (loss) to cash provided by (used in) operating activities that are not separately disclosed.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 95

-Paragraph 28

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 28

-URI http://asc.fasb.org/extlink&oid=6943989&loc=d3e3602-108585

+ Details

Name: us-gaap_OtherNoncashIncomeExpense

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition

The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 13

-Subparagraph (c)

-URI http://asc.fasb.org/extlink&oid=6943989&loc=d3e3213-108585

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 95

-Paragraph 15

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 95

-Paragraph 17

-Subparagraph c

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Investing Activities

-URI http://asc.fasb.org/extlink&oid=6516133

+ Details

Name: us-gaap_PaymentsToAcquirePropertyPlantAndEquipment

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition

The cash inflow from the additional capital contribution to the entity.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 14

-Subparagraph (a)

-URI http://asc.fasb.org/extlink&oid=6943989&loc=d3e3255-108585

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 95

-Paragraph 18

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 95

-Paragraph 19

-Subparagraph a

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Financing Activities

-URI http://asc.fasb.org/extlink&oid=6513228

+ Details

Name: us-gaap_ProceedsFromIssuanceOfCommonStock

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition

The cash inflow associated with the amount received from holders exercising their stock options. This item inherently excludes any excess tax benefit, which the entity may have realized and reported separately.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Financing Activities

-URI http://asc.fasb.org/extlink&oid=6513228

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 718

-SubTopic 10

-Section 50

-Paragraph 2

-Subparagraph (j)

-URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 123R

-Paragraph A240

-Subparagraph i

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 14

-Subparagraph (a)

-URI http://asc.fasb.org/extlink&oid=6943989&loc=d3e3255-108585

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 95

-Paragraph 18

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 6: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 95

-Paragraph 19

-Subparagraph a

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

+ Details

Name: us-gaap_ProceedsFromStockOptionsExercised

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition

The cash outflow for debt initially having maturity due after one year or beyond the normal operating cycle, if longer.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 15

-Subparagraph (b)

-URI http://asc.fasb.org/extlink&oid=6943989&loc=d3e3291-108585

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 95

-Paragraph 18

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 95

-Paragraph 20

-Subparagraph b

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Financing Activities

-URI http://asc.fasb.org/extlink&oid=6513228

+ Details

Name: us-gaap_RepaymentsOfLongTermDebt

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition

The aggregate amount of noncash, equity-based employee remuneration. This may include the value of stock or unit options, amortization of restricted stock or units, and adjustment for officers' compensation. As noncash, this element is an add back when calculating net cash generated by operating activities using the indirect method.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 95

-Paragraph 28

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 28

-Subparagraph (a)

-URI http://asc.fasb.org/extlink&oid=6943989&loc=d3e3602-108585

+ Details

Name: us-gaap_ShareBasedCompensation

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

XML 32 R10.htm IDEA: XBRL DOCUMENT v2.4.0.6

Property, Plant and Equipment
3 Months Ended

Mar. 31, 2012

Property, Plant and Equipment [Abstract]

PROPERTY, PLANT AND EQUIPMENT
NOTE 5 – PROPERTY, PLANT AND EQUIPMENT

Property, plant and equipment, net is comprised of the following (in thousands):

March 31,
2012 December 31,
2011

Land
$ 254 $ 247

Building
326 317

Leasehold improvements
957 957

Equipment and computers
5,849 5,729

Furniture and fixtures
1,042 1,036

Construction in progress
169 26

8,597 8,312

Accumulated depreciation and amortization
(7,259 ) (7,164 )

Property, plant and equipment, net
$ 1,338 $ 1,148

Depreciation and amortization expense related to property, plant, and equipment totaled $92,000 and $195,000 for the three months ended March 31, 2012 and 2011, respectively.

X

- Details

Name: us-gaap_PropertyPlantAndEquipmentAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition

The entire disclosure for long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale. Examples include land, buildings, machinery and equipment, and other types of furniture and equipment including, but not limited to, office equipment, furniture and fixtures, and computer equipment and software. This disclosure may include property plant and equipment accounting policies and methodology, a schedule of property, plant and equipment gross, additions, deletions, transfers and other changes, depreciation, depletion and amortization expense, net, accumulated depreciation, depletion and amortization expense and useful lives, income statement disclosures, assets held for sale and public utility disclosures.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 205

-SubTopic 20

-Section 50

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=6360339&loc=d3e1361-107760

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.13-14)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher AICPA

-Name Accounting Principles Board Opinion (APB)

-Number 12

-Paragraph 5

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 360

-SubTopic 10

-Section 50

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 360

-SubTopic 10

-Section 50

-Paragraph 2

-URI http://asc.fasb.org/extlink&oid=6391110&loc=d3e2921-110230

+ Details

Name: us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

XML 33 FilingSummary.xml IDEA: XBRL DOCUMENT 2.4.0.6 Html 7 113 1 false 0 0 false 3 false false R1.htm 00 - Document - Document and Entity Information Sheet http://biolase.com/role/DocumentAndEntityInformation Document and Entity Information true false R2.htm 01 - Statement - Consolidated Balance Sheets (Unaudited) Sheet http://biolase.com/role/BalanceSheets Consolidated Balance Sheets (Unaudited) false false R3.htm 011 - Statement - Consolidated Balance Sheets (Unaudited) (Parenthetical) Sheet http://biolase.com/role/BalanceSheetsParenthetical Consolidated Balance Sheets (Unaudited) (Parenthetical) false false R4.htm 02 - Statement - Consolidated Statements of Comprehensive Loss (Unaudited) Sheet http://biolase.com/role/StatementsOfComprehensiveIncome Consolidated Statements of Comprehensive Loss (Unaudited) false false R5.htm 03 - Statement - Consolidated Statements of Cash Flows (Unaudited) Sheet http://biolase.com/role/StatementsOfCashFlows Consolidated Statements of Cash Flows (Unaudited) false false R6.htm 06001 - Disclosure - Basis of Presentation Sheet http://biolase.com/role/BasisOfPresentation Basis of Presentation false false R7.htm 06002 - Disclosure - Recent Accounting Pronouncements Sheet http://biolase.com/role/RecentAccountingPronouncements Recent Accounting Pronouncements false false R8.htm 06003 - Disclosure - Stock-Based Awards and Per Share Information Sheet http://biolase.com/role/StockBasedAwardsAndPerShareInformation Stock-Based Awards and Per Share Information false false R9.htm 06004 - Disclosure - Inventory Sheet http://biolase.com/role/Inventory Inventory false false R10.htm 06005 - Disclosure - Property, Plant and Equipment Sheet http://biolase.com/role/PropertyPlantAndEquipment Property, Plant and Equipment false false R11.htm 06006 - Disclosure - Intangible Assets and Goodwill Sheet http://biolase.com/role/IntangibleAssetsAndGoodwill Intangible Assets and Goodwill false false R12.htm 06007 - Disclosure - Accrued Liabilities and Deferred Revenue Sheet http://biolase.com/role/AccruedLiabilitiesAndDeferredRevenue Accrued Liabilities and Deferred Revenue false false R13.htm 06008 - Disclosure - Line of Credit and Debt Sheet http://biolase.com/role/LineOfCreditAndDebt Line of Credit and Debt false false R14.htm 06009 - Disclosure - Commitments and Contingencies Sheet http://biolase.com/role/CommitmentsAndContingencies Commitments and Contingencies false false R15.htm 06010 - Disclosure - Segment Information Sheet http://biolase.com/role/SegmentInformation Segment Information false false R16.htm 06011 - Disclosure - Concentrations Sheet http://biolase.com/role/Concentrations Concentrations false false R17.htm 06012 - Disclosure - Income Taxes Sheet http://biolase.com/role/IncomeTaxes Income Taxes false false R18.htm 06013 - Disclosure - Subsequent Events Sheet http://biolase.com/role/SubsequentEvents Subsequent Events false false All Reports Book All Reports Process Flow-Through: 01 - Statement - Consolidated Balance Sheets (Unaudited) Process Flow-Through: Removing column 'Mar. 31, 2011' Process Flow-Through: Removing column 'Dec. 31, 2010' Process Flow-Through: 011 - Statement - Consolidated Balance Sheets (Unaudited) (Parenthetical) Process Flow-Through: 02 - Statement - Consolidated Statements of Comprehensive Loss (Unaudited) Process Flow-Through: 03 - Statement - Consolidated Statements of Cash Flows (Unaudited) blti-20120331.xml blti-20120331.xsd blti-20120331_cal.xml blti-20120331_lab.xml blti-20120331_pre.xml true true

Large accelerated filer

Accelerated filer

Non-accelerated filer

¨ (Do not check if a smaller reporting company)

Smaller Reporting Company